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Abstract 
In recent years, the design and synthesis of structures that can potentially mimic the 
properties of the peptide bond have been of great interest to biological chemists. 
We are investigating the synthesis of novel pyrazoline-based structures as potential 
peptide mimetics. The pyrazoline unit is assembled by 1,3-dipolar cycloaddition of 
nitrile imines, which are generated in-situ from hydrazonyl chlorides. We have 
investigated two routes to afford the hydrazonyl chloride: I) via a hydrazone; and 2) via 
a hydrazide both of which have resulted in the successful synthesis of the desired 
pyrazolines. Subsequent syntheses have been carried out using a variety of different 
dipoles and dipolarophiles .. 
We have taken approach I and used this to synthesize a pyrazole as one major 
enantiomer. 
NHBoc 
This pyrazole has been subject to peptide couplings to form a complete peptide 
mimetic. 
)'" 
BocHN 
NMR studies have been carried out on the synthesized peptide mimetic to determine the 
degree of hydrogen bonding and ~-turn characteristics. 
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1.0 Introduction 
1.1 1,3-Dipolar Cycloaddition 
I ,3-Dipolar cycloaddition is a classic reaction in organic synthesis. The scope of this 
type of reaction and its popularity has been confirmed in the last ten to twenty years by 
the number of books and reviews that have been published on the subject.1.2 
1,3-Dipolar cycloaddition can be described simply as the addition of a 1,3-dipole to an 
unsaturated system such as an alkene for the synthesis of five-membered heterocycles. 
If we look historically at the 1,3-dipolar cycloaddition reaction we have to go as far 
back as 1883 when Curtius discovered diazoacetic ester,3 a 1,3-dipole, but it was then 
his younger colleague, Buchner who studied the reactions of diazoacetic ester with a,f3-
unsaturated esters4 and therefore went on to describe the first 1,3-dipolar cycloaddition 
reaction. In a matter of years Beckmann, and Wemer and Buss, discovered nitrones5 
and nitrile oxides6 respectively. Therefore the evolution of 1,3-dipolar cycloaddition 
reactions has been over I 00 years in the making, during which time many more dipoles 
have been discovered and classified. 
It was Huisgen who, in the 1960's, established the general application of 1,3-dipoles in 
organic synthesis. 7 This, along with work by Woodward and Hoffman regarding the 
concept of conservation of orbital symmetry8 led to a new understanding of the 
mechanism of concerted cycloadditions and in addition gave chemists the ability to 
predict relative reactivity and regioselectivity. 
Page 12 
In simple terms, a 1,3-dipole can be shown as an a-b-e structure that reacts with, for 
example, alkenes to give a five-membered heterocycle (Fig 1 ).9 
Fig 1 
Allyl anion type 
Propargyllallenyl anion type 
e e 
a=b=c 
Fig 2 Types of Dipolarophile 
Page J3 
The term 1,3-dipole was given because it is impossible to write electron paired 
resonance structures for these species without incorporating charges. This does not 
mean that the compounds are particularly polar as the charges are not localized. 
I ,3-Dipoles can be categorized into two different types (Fig 2). The allyl anion type is 
characterized by four electrons in three parallel Pz orbitals which are perpendicular to 
the plane of the dipole and that the 1,3-dipole is bent. This allyl anion type 1,3-dipole 
can be drawn as resonance structures, two in which the three atoms have an electron 
octet and two in which a or c has an electron sextet. The central atom b can either be 
nitrogen, oxygen or sulfur, but must have a lone pair. 
The second type is known as the propargyl/allenyl anion type whereby an extra 1t 
orbital is located in the plane orthogonal to the allenyl anion type molecular orbital. 
Therefore the former orbital is not involved in the resonance structures and reactions of 
this dipole. In the case of the propargyl/allenyl anion the central atom b is limited only 
to nitrogen. 
The vast majority of 1,3-dipoles consist mainly of elements from groups IV, V and VI 
in the periodic table. As the main elements used are carbon, nitrogen and oxygen, this 
leads to a possible 18 dipoles; 12 of the allyl anion type and 6 of the propargyl/allenyl 
anion type (Fig 3). 
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Allyl anion type 
Nitrones 
I 
Carbonyl Ylides 
---- ~~........_e---c N I Azomethine Imines 
Carbonyl Imines 
I 
--- -::7'~ .......... 6/ c c I I Azomethine Ylides Carbonyl Oxides 
I 
--- -::7'~ .......... 6/ N N 
Azimines Nitrosimines 
I 
..__ .::7' ~ ........._ 6 
N 0 
Azoxy Compounds Nitrosoxides 
I 
N a:?'@""'-~ 
Nitro Compounds 
Ozone 
PropargyVallenyl anion type 
_® e 
--C-N-N 
- "' 
_® e/ 
Nitrile Oxides 
Nitrile Imines 
--C=N-C 
"'Nitrile Ylides 
Fig 3 Different Dipole Structures 
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N ~-~ 
"\. Diazoalkanes 
_® e 
N-N-N 
- "' 
Azides 
Nitrous Oxide 
The transition state of the concerted I ,3-dipolar cycloaddition reaction is controlled by 
the frontier molecular orbitals of the substrates. It was Sustmann who classified 1,3-
dipolar cycloaddition reactions into three types based upon the relative frontier 
molecular orbital energies between the dipole and the dipolarophile (Fig 4).10 
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Energy 
Dipole Dipolarophile Dipole Dipolarophile Dipole Dipolarophile 
LUMO 
+ 
+ HOMO 
Type! Type 11 Type Ill 
Fig 4 Molecular orbital description of the three types of interaction 
For type I 1,3-dipolar cycloaddition reactions the dominant interaction is that of the 
HOMOdipole with the LUMOdipolarophile· For type !I, the FMO energies of the dipole and 
dipolarophile are similar and therefore this implies that both HOMO-LUMO 
interactions are important. Finally 1,3-dipolar cycloaddition reactions of type Ili are 
dominated by the interaction between the LUMOdipole and HOMOdipolarophile· 
Certain dipoles have been categorized into these types. I ,3-Dipolar cycloaddition 
reactions of type I are common with dipoles such as azomethine ylides and azomethine 
imines. Reactions of nitrones generally come under the category of type !I along with 
nitrile oxides, but some classify these as borderline type Ili since nitrile oxides have 
low lying HOMO energies. Finally, dipoles such as ozone and nitrous oxide come 
under the type Ili heading. These groupings are not exclusive as the introduction of 
Pagel7 
electron-donating and electron-withdrawing substituents on the dipole or the alkene can 
alter the frontier molecular orbital energies. 
Reactions are therefore favoured if one component is strongly nucleophilic and the 
other is strongly electrophilic. Therefore, for a given I ,3-dipole, the dominant 
interaction is more likely to be of type I for dipolarophiles with conjugative electron-
withdrawing groups and for type III, cycloadditions are most likely to take place with 
enol ethers, enamines and other electron-rich dioplarophiles. 
Arguably the most well known and commonly taught example of a I ,3-dipolar 
cyaloaddition reaction is the ozonolysis of an alkene bond. The reagent for this type of 
reaction is ozone 0 3• Ozone is a symmetrical bent molecule with a central positively 
charged oxygen and two terminal oxygen atoms carrying the negative charge; it is a 
typical 1,3-dipole. The mechanism for the reaction is shown below (Scheme I) 
oJ Co 0 (~' \+ ;;:< 0 0) <0 ~ :J R R R R 
Scheme 1 
The product of the cycloaddition reaction is a very unstable compound due to the weak 
0-0 single bond. It immediately decomposes by a reverse 1,3-dipolar cycloaddition to 
give a simple aldehyde, or ketone, and a new I ,3-dipole known as a carbonyl oxide. 
This, being a 1,3-dipole, adds to the carbonyl compund in a third cycloaddition step. It 
is possible that it could add back reversing the way that it was formed but it prefers to 
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add with the opposite regiochemistry with the nucleophilic oxyanion attacking the 
carbon atom of the carbonyl group as shown below (Scheme 2). 
Scheme2 
The product of this I ,3-dipolar cycloaddition reaction is known as an ozonide. This is 
often decomposed using dimethyl sulfide, which attacks the ozonide to give DMSO and 
two molecules of aldehyde (Scheme 3). 
Me ('( 
R Co Me 
\-£( 
R 
Scheme3 
The I ,3-dipolar cycloaddition reaction has proved useful in the synthesis of the drug 
celecoxib. Celecoxib 1 is an NSAID (non-steroidal anti-inflammatory drug) that is used 
in the treatment of osteoarthritis, rheumatoid arthritis and menstrual symptoms and is 
marketed under the brand name Celebrex. 
Pagel9 
F,c 
Me 
1 
A common approach to the synthesis of this structure involves the reaction of 4-
sulfamidophenylhydrazine with a diketone (Scheme 4). 
F 
MZACF, 
NHNH2 
0 0 
~ ~ + + CF, 
Mo # # Mo 
S02NH2 
S02NH2 S02NH2 
Scheme 4 
However this leads to a regioisomeric mixture of pyrazoles which then requires 
recrystallization to give the desired regioisomer. A publication by Oh has shown that 
celecoxib can be synthesised from a nitrile imine via a I ,3-dipolar cycloaddition 
strategy (Scheme 5).11 
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F,c')j F,c 
'" r'~ - /N+ 1 i ~ N 0~ A' 
9 "' ''- """ N '-, """ 9 d' "' 9 d' Mo S02NH2 S02NH, 
SO:zNH2 
SchemeS 
In conclusion this type of reaction is extremely versatile for the synthesis of a number 
of heterocycles. For that reason, and for tlie purpose of this thesis, it was considered 
very favourable when considering strategies for the synthesis of novel heterocyclic 
peptide mimetics. 
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1.2 Peptides 
Peptides are sequences of amino acids linked together via the formation of an amide 
bond. The smallest possible peptide could be formed by the condensation reaction of 
the acid terminus of one amino acid and the amine terminus of the other amino acid to 
give what is known as a dipeptide; many can link together to form a polypeptide 
(Scheme 6). 
-H20 
Scheme 6 
In general, these chains of linked amino acid residues are considered peptides if they 
are up to 50 amino acids in length; anything above this can be classified as proteins. 
The peptide unit formed is a relatively rigid, planar structure due to the restricted 
rotation around the C-N bond. This means that two isomers should be possible - a cis 
and a trans. In nature, nearly all peptide units are found to be trans. This is not 
surprising when comparing the cis and trans structures as the cis structure can be seen 
to be more crowded. 
The driving force of peptide formation is the elimination of water and. also the fact the 
peptide bond is stable. This can be understood by looking at the hybridisation of the 
atoms in the peptide bond 2. 
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As the nitrogen atom is next to the sp2 hybridised carbon of the carbonyl group, the lone 
pair of electrons on the nitrogen can be conjugated with the carbonyl group. This is 
known as resonance. It is this phenomenon, whereby the lone pair and n electrons in the 
peptide bond are delocalised as represented by extreme resonance forms that adds to the 
stability of the amide bond (Fig 5). 
Fig 5 Resonance forms ofthe Peptide Bond 
It is also the hybridisation of the nitrogen atom itself that adds to the stability of the 
peptide bond. The nitrogen of an amine is sp3 hybridised whereas the nitrogen atom of 
an amide or peptide bond is sp2 hybridised. In the sp2 hybridised nitrogen, the lone pair 
is delocalised and thus is unavailable, therefore the amide nitrogen has little 
nucleophilic chemistry (Fig 6). 
Fig 6 Nitrogen Hybridisation 
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1.3 Peptide Mimetics 
For a number of years now, peptide mimetics have become of great interest to both 
organic and medicinal chemists due to the advantages they have over physiologically 
active peptides. Biological tests on a number of peptides and proteins have shown their 
potential for use in drug form but the use of natural peptides as drugs is limited due to a 
number of factors. They have low metabolic stability towards proteolysis and poor 
absorption after ingestion, which is mainly due to their high molecular mass. Also they 
undergo rapid excretion through the liver and kidneys. These factors have led organic 
and medicinal chemists to design and synthesise molecules that can mimic the 
biological activity of natural peptides but also overcome the problems discussed above. 
These types of molecules are known as peptide mimetics. 
A peptide mimetic is described as a compound that, as the ligand of a receptor, can 
imitate or block the biological effect of a peptide at the receptor leve1. 12 For example, 
morphine 3, an opioid alkaloid, is a classic example of a nonpeptide ligand that has 
been found to mimic the effects of f3-endorphin, a peptide consisting of 31 amino acid 
residues. 
3 
Page [14 
The tetrapeptide 4 was identified as a potent reversible inhibitor of ICE (interleukin-I p 
converting enzyme). lnterleukin I p contributes to the pathogenesis of inflammatory 
diseases such as rheumatoid arthritis and osteoarthritis. The X-ray crystal structure of 
the compound bound in the active site of ICE was published and defined key spatial, 
lipophilic and hydrogen bonding interactions for potent ICE inhibition. These were 
highlighted and include a lipophilic moiety (the tyrosine side chain), a 'bent' dipeptide 
central core, a hydrogen bonding backbone and an aspartic acid-like cysteine trap. 13 
HO 
Rigid peptide mimetic compounds have been identified as potent reversible and 
irreversible inhibitors. One compound of significance was Pralnacasan® 5, which was 
characterised as a selective reversible inhibitor for ICE and was progressed into late 
stage clinical trials. 
0 
N 
I ~R 0 N 0 0 \ / OEt 
5 
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Pralnacasan® incorporates a bicyclic core to mimic the central dipeptide region and to 
constrain the structure into a conformation that maintains the key hydrogen bonding 
points. 
When designing molecules as potential peptide mimetics there are a few requirements 
that exist in terms of their desired pharmacological properties. They must have good 
metabolic stability, good bioavailability, high receptor affinity and minimal side effects. 
In order to meet this brief there are guidelines that can be followed to give the best 
possible chance of achieving the above. 14 
If possible, the majority of the peptide backbone should be replaced as long as bond 
surrogates have shown some retained biological activity or peptide bonds are not at the 
forefront of the most bioactive conformation. It is important that peptide side chains are 
retained as far as possible as it may be these groups that are recognised by receptors. 
For example, if replacing an amino acid residue such as lysine, initially this should be 
replaced by a mimetic that has a primary amine present at the end of an alkyl chain. 
Finally conformational flexibility should either be maintained in mimetic structures so 
that they are able to adopt conformations matching that of the original peptide, or 
constrained to bioactive conformations. 
Looking from a structural point of view there are many ways in which it is possible to 
mimic a peptide, from simply making changes to the amino acid side chains to creating 
structures that have no peptide structural character at all. 
A very simple method of modifying the amino acid is to replace natural amino acid 
residues with unnatural amino acid residues, that is swapping L- for D-amino acids. 
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Other ways of modifying amino acids include exchange for a,l3-unsaturated, cyclic and 
13-amino acids. The structures of some analogues of phenylalanine and tryptophan are 
shown below (Fig 7).12 
Fig 7 Peptide mimetic analogues of phenylalanine and tryptophan 
Replacing individual units for other atoms can also modify the peptide backbone. 
Examples of appropriate changes are given in Table 1. 15 
Pagel17 
Exchange oflndividual Units 
-j NH CH 
~ l C-alkyl r 
~ 
CO r 
~ 
~ 
~ 
n= 1,2 
l P=O(OH) r 
l B(OH) ~ 
Extension of the Peptide Chain Replacement of the Amide Bond 
-NH~CH---co- CO-NH 
-E)- l NH-CO ~ 
~ l CH(OH)-CH2 ~ 
l CH=CH r ~ l CHrCH2 r 
-1 P=O(OH)-CH2 ~ 
Table l Suggested Peptide Chain Modifications 
As said previously, it is important to maintain conformation when designing peptide 
mimetics. This can be achieved by the introduction of bridges between different parts of 
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the molecule. Bridging can take place within a single amino acid residue e.g 6, or the 
bridge can be a link between two side chains, e.g 7. This can be achieved, for example, 
by the incorporation of lactams or piperazinones and the compounds are known as 
dipeptide rnimetics. It is also possible to have bridges that link two peptide backbone 
units, e.g 8, or even link a side chain with a backbone, as in 9. 15 
0 
NH 
-N ,)y 
H 
6 0 0 7 
8 
When considering maintaining the conformational structure of a peptide, it should be 
noted that natural peptides have secondary structures such as turns and folds. Turns are 
segments of a polypeptide chain where the peptide chain reverses its overall direction. 
Perhaps the most significant turning point is the 13-turn. It can be described as any 
tetrapeptide sequence in which the Cai - Cai+3 distance in a nonhelical region is less 
than 7 A. 16 This type of turn is formed from four amino acid residues and is stabilized 
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by a hydrogen bond interaction between the carbonyl of the first amino acid and the 
proton situated on the NH of the fourth amino acid (Fig 8). 
FigS 
Another type of peptide turn is called a y-tum which is made up of only three amino 
acid residues, where the stabilizing H-bond is between the carbonyl of the first residue 
and the proton on the NH of the third amino acid (Fig 9). 
Fig 9 
From the examples shown below (Fig I 0), it is clear that mimicking the 13-tum can be 
achieved by structures that are recognizable derivatives of peptides whereas some 
structures are clearly non-peptidic. 15 
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H3c CH3 H 
s 
0 ~'-.N 0 
I 0 H 
0 
Fig 10 Examples of Jl-turn mimetics 
Modification to the peptide backbone can lead to an increase in the biological half life 
in comparison with that of the parent compound. 
Due to the many synthetic possibilities, peptide mimetics can be categorized due to the 
type of modification to the peptide backbone _IS 
Carbapeptides are those where the NHC=O unit of the amide bond is replaced by a 
carbon group such as CH2C=O. This group can also be extended to hydroxyethylene 
and carba modifications. Compounds containing dipeptide-analogous hydroxyethylene 
groups are among the most active inhibitors of renin and HIV -1 protease. Umezawa 
and eo-workers have isolated the arphenamines, both naturally occurring ketomethy1ene 
analogues (Fig 11 )P 
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OH 
0 
Fig 11 
Synthetic approaches for the synthesis ofhydroxyethylene dipeptide analogues have 
been reported. One example of a synthesis is by Fray et ai. 18 The starting point is a 
Hoc-protected amino aldehyde, which is treated with the lithium derivative of ethyl 
propiolate. The lactone is formed after hydrogenation and is then metalated and treated 
with methylallyl bromide. The a-substituted lactone is formed by a final hydrogenation, 
and can then go on to ring open with suitable nucleophiles to form linear peptide 
analogues (Scheme 7). 
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u--===--co,Et 
Boc-~ CHO 
I.H2, Pd, BaS04 
2.~ 
3. separation 
Boc-~ 
Scheme7 
I.LiN(SiMe3), 
2.CH3C(CH2)CH2Br 
3.H2/Pd-C 
Boc-~ 
OH 
Boc-~ 
Azapeptides are another class of backbone modified peptides that have proven to be of 
importance in the pharmaceutical industry. Here the a-CH group of one or more of the 
amino acid residues is replaced by a nitrogen atom with retention of the original side 
chain (Fig 12). 
R 
H I 
--N-C-CO--
H 
R 
H I 
--N-N-CO--
Fig 12 
Peptoids are oligomeric analogues that contain N-alkylated glycines joined together in a 
peptide -like manner. The a-CHR groups have been replaced by NR groups and the 
eo, Et 
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NH groups replaced by CH2 units. The position of the side chains and carbonyl groups 
of the original peptide chains remains unchanged. Peptoids are not chiral since the side 
chains corresponding to the normal amino acids are attached to the N atoms and only 
achiral CH2 groups are present instead ofNH groups (Fig 13). 
~N~I~N~ 
I 11 I 
R 0 R 
Fig 13 
Conformational studies have shown that peptoids have much greater conformational 
flexibility than peptides. This is due to the absence of the CO-HN hydrogen bonds, as 
there are no NH bonds present in the peptoid chain. 
Peptide mimetics have also been categorized based on the nature of their structure as 
opposed to the way in which the structure has been modifiedY 
Opioids are a class of peptide mimetics based around the structure of morphine, the 
main constituent of opium. Countless numbers of morphine derivatives have been 
synthesized in an aim to develop a more nonaddictive analgesic. With the help of these 
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compounds it was possible to discover various opioid receptors in animal organisms. It 
was later shown that the opium alkaloids were mimetics of the endogenous opioids. 
Naltrindole 10 was shown to mimic the action of the peptide sequence 11.12 
10 
Tyr- Gly- Gly- Phe- Leu- Arg- Arg- Lie- Arg -Pro- Lys- Leu- Lys 
11 
Tachykinins are peptides with a length of ten or eleven amino acids that act as 
neurotransmitters or neuromodulators in various parts of the central and peripheral 
nervous systems. These peptides possess a common C-terminal sequence Phe-X-Gly-
Leu-Met-NH2. The best known and most investigated of these substances is substance P 
and was discovered in 1931 by von Euler and Gaddam.19 The receptors for substance P 
are designated NK 1-3. The first nonpeptide antagonist for the NK 1 receptor is 12 
which emerged from a screening process. Other potent non peptide antagonists for the 
NK 1 receptor are 13 and the steroid derivative 14.20•21 
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13 
12 
14 
Somatostatin 15 is a cyclic tetradecapeptide which is formed in the hypothalamus and 
inhibits the release of growth in the pituitary gland. 22 It has also been found in the 
secretory cells of the intestine and the pancreas. Compound 16 was described as the 
first nonpeptide somatostatin mimetic.Z3 
H-~-~-~-~-~-~-~-~ 
HO- Cys- Ser- Thr- Phe- Thr- Lys 15 
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16 
Literature searches show that there have been many significant contributions to the field 
of peptide mimetics. 
Novel approaches have shown designs involving organic templates. The pioneering 
work ofFiegel introduced the phenoxanthiin ring system as a template as well as a 
range of biphenyl systems as a method of stabilizing the P-structure in peptide loops 
17.24 
HI 17 
Templates of this kind have also been developed by Muller and Obrecht.25•26 Other 
groups have reported studies of linear and cyclic peptides that can be made to assemble 
into P-hairpin structures to various extents, either in organic solvents or water. 
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Templates derived from proline and related derivatives have proven to be attractive due 
to their non-aromatic and polar character since extended aromatic systems tend to be 
highly immunogenic. Robinson and eo-workers have carried out significant studies in 
this area?7 Examples of some proline based templates are shown (Fig. 14) 
0 ~-~ 
NH ~ro y 
NH 
~-<' 0 0 
Template 1 Template 2 
Fig 14 
The synthetic schemes for these templates are shown below. 
Template 1 
( ex~~~ 
~ COOtBu 
z 
a-c d-g 
(a) 0 3 then Ph3PCHCOOMe; 100%, (b) H2,Pd; 93%, (c) DMAP, toluene, 
reflux; 79%, (d) LDA, THF then 'BuOOC-N=N-COO'Bu; 88%, (e) LDA, 
THF then 'BuCOOH, (f) TFA, CH2CI2, (g) H2, Pt, H20; 68%, (h) Fmoc-
CI, dioxane, aq.Na2C03; 61% 
SchemeS 
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h 
0 
NHFmoc 
Template2 
C(~ ----a---d---• 
z 
f-g 
0 
Scheme9 
X=N3 R='Bu -:J 
' h-j 
X=NHFmoc, R=H 
Page 129 
e 
•>~lllliOH 
(a) SOCI,, MeOH; 100%, (b) LDA, -78 'C, then BrCH2COO'Bu; 80%, (c) MeOHI H20, LiOH.H20; 83%, (d) H-
Pro(OH)-OMe.HCI, ;Pr2EtN, HBTU, CH2Cl2 and separation of diastereoisomers; 42%, (e) H2, Pd/C, EtOAc; 83%, (f) 
TosCI, Pyr; 91%, (g) NaN3, DMF, 78 oc; 91%, (h) H2, Pd/C, EtOAc; !00%, (i) FmocCI, ;Pr2EtN, CH2CI2; 98% G) 
H20/TFA; I 00% 
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1.4 Nitrogen-Containing Heterocyclic Peptid~ Mimetics 
Heterocycles can be very useful tools for the construction of peptide or P-tum mimics. 
The nature of these structures can force the molecule to curve like the P-tum structure 
to encourage hydrogen bonding and the rigidity of the heterocycle means that they are 
not broken down easily; a highlighted problem with peptides. 
To look at examples ofN-heterocyclic peptide mimetics it is sensible to start with some 
examples studied within the Jones group. 
In 1995 a paper published by Jones with Crockett, Gilbert and Rees describes the 
synthesis and application of imidazolines as amide bond replacements.28 The 
similarities between the amide bond and imidazoline structure were highlighted 
including the presence of two heteroatoms, similar configuration of double bonds, 
similar hydrogen bonding possibilities and similar steric properties (Fig 15). 
Type I Typell 
Fig 15 
There had been previous reports in the literature by Jones on imidazolines of type I as 
an amide bond replacement.29 For the purpose of the more recent paper it was decided 
that imidazolines of type 11 would be synthesised. The R group ofimidazoline type 11 is 
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no longer attached to the imidazoline ring, and hence is differently conformationally 
constrained. 
The strategy for the synthesis of the imidazoline was to carry out a condensation 
reaction of theN-protected amino acid 18 with the diamino compound 19. 
0 N\/CH2R HZN ,A N co2Me H 
R' 
HZN, 1 
~ 'oH 
R' 18 19 
The synthesis of the diamino compound 19 is shown (Scheme 10). 
4-chlorobenzaldehyde Ar~ 
-Nyco,Me 
Et3N, MgSO,, CH2CI2 
1 
CH2R 
I. LOA 
2. N- Bromomethylphthalimide 
3. HCI, H20; then NaHC03, H20 
H2N\-" 
.... ~CH2R 
H2N C02Me 
H2NNH2.H20, MeOH 
I 
0 
R=Ph, (CH2) 2CH3, (CH,)3NHZ [Z = PhCH20C(O)) 
Scheme 10 
The N-protected amino acid was converted to the S-methylthioimidate salt using a 
previously reported method. The N-benzyloxycarbonyl protected amino acid was 
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converted to the piperidine amide via the pentafluorophenyl ester, then treatment with 
Lawesson's reagent gave the thioamide. This was converted to the S-methylthioimidate 
salt by treatment with methyl iodide. The condensation reaction was carried out with 
the diamino compound to give the required imidazoline (Scheme 11). 
HZN, 1 
~ 'oH 
R' 
I. Pentatluorophenol ' 1 
2. :i:~~:~.CI, HZN I '0 
R' 
Lawesson ~ s reagent 
~ru Me! 
MeOH j Diamino Compound 
R1 = PhCH2; R = Ph 
yZN\ /CH,R HZN .... A N C02Me H 
R' 
Scheme 11 
R1 = Indole-3-CH2; R =Ph 
R1 = (CH2) 4NHZ; R = (CH2) 3NHZ 
R1 = Indole-3-CH2; R = (CH2) 2CH3 
More recently in 2007, Sachettii reported the synthesis of two benzimidazoles as 
tetrapeptide mimics 20 and 21.3° 
(i ~NHMe 
~~.!-
20 
(i ~NHMe 
~_::N 0 ~ N)L_ 
21 
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The synthesis of both was carried out using a different strategy to that of Jones and both 
benzimidazoles were synthesised in few steps (Scheme 12). 
_b -0}--<~-c _c- 20 
C( 
•. j " 
b* ():}-D c• 21 
(a) N-acetyl-L-alanine, isobutyl chloroformate, NMM, DMF; (b) AcOH, 65 •c, I h; (c) I. BrCH2C02Me, NaH, 
DMF, 80 °C, 2 h, 2. MeNH2, MeOH. 
(a*) N-acetyl-L-proline, DCC, HOB!, DCM; (b*) AcOH, 65 •c, l h; (c*) I. BrCH2C02Me, NaH, DMF, 80 •c, 
2 h, 2. MeNH2, MeOH 
Scheme 12 
A paper by Jones in 2000 described the synthesis of 3-(1-aminoalkyl)isoxazole-4-
carboxylic acids as peptide bond replacements. Isoxazoles are five membered 
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heterocycles containing two adjacent heteroatoms; one being oxygen and the other 
nitrogen 22.31 
N-O 
H2N ~# 
R' 
R' co2H 22 
The strategy for this synthesis is of particular interest, in ~;unnt:~;uun with this thesis, as 
the heterocyclic framework was constructed via a I ,3-dipolar cycloaddition from the 
nitrile oxide 23 and the enaminoester 24 (Scheme 13). 
NOH 
N-0 
BocHN ~ # Me 
___ c__ Cl ~ Me 
~ n ~ ~s ~ 
l d 
N-O 0 ~ N 
BocHN 
BocHNYC02Me a-b 
---
Me 
Me 
Me co2Et Me eo, Et 
(a) i-Bu2AIH, toluene, -78 'C; (b)NH20H.HCI, NaOAc, EtOH-H20, 60 'C; (c) 1-BuOCI, CHCI,, 0 'C; 
(d) Et3N, CHCI3, relux 
Scheme 13 
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With the isoxazole synthesised, the ester and amine functionalities could be 
deprotected, in turn, and coupled to amino acids. This showed the ability of such an 
isoxazole to be incorporated into a peptide chain. 
Over the past few years there have been many published examples of heterocyclic 
peptide mimetics including a variety of nitrogen containing heterocycles. 
In 2005, Gmeiner and Bitterman reported the synthesis of spirocyclic ~-lactams as 
potent ~-turn inducing peptide mimetics. 32 This account is of particular interest as the 
synthesis starts with (S)-proline, a proteinogenic amino acid and shows the utilisation of 
a single heteroatom ring system. 
The synthesis of the spirocyclic model begins with the synthesis of an enantiopure a-
vinylproline derivative (Scheme 14 ). 
a b (S)-Pro 
R=H 
:=Jr d,e R=CH, 
(a) CI3CCHO, CH3CN, rt, 2.5h; (b) I. LDA, THF, -78 °C, 2. HCOOCH3, -40 °C; (c) I. 
Methyltriphenylphosphonium bromide, KO'Bu, toluene, 80 °C, 2h, 2. rt, I h; (d) AcCI, MeOH, OCto rt, 7 
d; (e) DIPEA, Boc20, CH2CI2, rt, 2.5d; (f) NaOH, MeOH, H20, 50 °C, lh 
Scheme 14 
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By a simple amide bond formation and an intramolecular Mitsunobu reaction followed 
by aminolysis, the spirocyclic P-Iactam is formed (Scheme I 5). 
a b 
(a) HATU, DIPEA, NMP, GlyOMe.HCI, rt, 30 min; (b) I. 0 3, CH2Cl2, 
-78 °C, 2. NaBH(OAc)3, rt, 6-24 h; (c) DEAD, PPh3, THF, rt, 2.5-5 h; 
(d) CH3NH2, EtOH, 0 •c, 40 min. 
Scheme 15 
{\1-0H 
;x:X )<I 
c, d 
In a later paper published in 2007, Gmeiner reported the synthesis of another proline 
derived P-turn mimetic 25.33 
0 R' \_I ~>= 
HN 
I 25 
..rvV'V' HN O 
vvL 
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This spirobarbiturate structure was designed in such a way that the NH atoms of the 
spirobarbiturate ring could be exploited to incorporate different substituents which may 
serve as molecular probes exploring binding pockets of complementary target proteins. 
There are examples in the literature of more heteroatom-rich ring systems, such as 
oxadiazoles, as peptidomimetic building blocks. 
In 2007, Dolenc reported the synthesis of twelve new I ,2,4-oxadiazole-based 
compounds that incorporate a protected amine and a carboxyl or ester group, thus 
serving as potential peptide mimetic building blocks. 34 Again the synthesis starts with a 
proteinogenic amino acid which has retained its stereochemistry throughout the 
sequence (Scheme 16). 
a, b, c 
d 
1 /.N e B~HN/ \:Z. 
)-oH 
0 
g,h 
OH 
(a) (Boc)20, NaOH, dioxane/water, 0 'C; (b) ethyl chloroformate, Et3N, CH2CI,, -10 'C then NH3(g); (c) 
cyanuric chloride, DMF, rt; (d) NH20H x HCl, Et3N, EtOH, reflux, 20 h; (e) succinic acid anhydride, DMF, 
pyridine, 110 'C, 4 h; (f) glutaric acid anhydride, DMF, pyridine, 110 'C, 4 h; (g) ethyl malonyl chloride, 
Et3N, CH2Cl2, 0 'C; (h) toluene, 120 'C, 72 h. 
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Scheme 16 
There is no shortage of bicyclic ring examples of peptide mimetics in the literature. 
This may be due to the way bicyclic scaffolds can encourage any appropriate 
substituents to hydrogen bond thus mimicking structural features of ~-turns. 
In 2006, Lubell reported the synthesis of enantiopure C6-functionalized pyrolizidinone 
amino acids as potential dipeptide mimetics (Fig 16). 35 
Fig 16 
Upon synthesis of the bicyclic structure, the hydroxyl group can be manipulated to be in 
the R or S configuration depending upon the stereochemistry of the acetyl protected 
oxygen in the starting material. 
The synthesis was carried out in four steps from an a-acetoxy ketone (Scheme 17). 
Page [39 
NHPhF 0 
Pd/C, 8 atm, H2 
+ HCI, EtOH/THF OAo NHPhF 
HO,C 
I. Et3N, MeOH, A 
2. (Boc)20, TEA, CH2Cl2 AcCI 
MeOH. RT 
Scheme 17 
Here the 6R stereoisomer was formed by starting with the 5R a-acetoxy ketone; starting 
with the 5S a-acetoxy ketone would therefore yield the 6S bicycle. 
There are examples in the literature of bicyclic peptide mimetics constructed from 
larger heterocyclic ring systems. 
Peptide mimetics based around 2-pyridone scaffolds have proven to be useful as they 
inhibit the hepatitis C virus (HCV) NS3 serine protease. They have been shown to act 
as inhibitors of human rhinovirus (HR V) 3C protease. In general, ring fused 2-pyridone 
scaffolds are also present in compounds with many biological applications such as anti-
cancer agents, ACE inhibitors and inhibitors of A~- peptide aggregation. 
Almqvist, Aberg, and Sellstedt contributed in this area by reporting the design and 
synthesis of peptide mimetics based upon the substituted bicyclic 2-pyridones 26.36 
5NHCI 
Dioxane 
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~.~ 
co,H 0 26 
Hruby et al. reported the synthesis of a pyrimidine/piperazine fused bicycle 27 in 
2008.37 
27 
The synthesis was carried out starting with a mono protected diamine via an acid 
catalysed cyclisation to give the bicyclic product as one diastereoisomer (Scheme 18). 
f l 
m 
a 
e 
-~) 
'11 I 
Cb• 
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b-d 
g 
(a) Boc-L-Phe-OH, BOP, HOBt, NMM, DMF; (b) TFA, CH2Cl2; (c) 2,2-diethoxyacetaldehyde, THF; (d) 
NaBH(OAc)3, AcOH, THF; (e) Cbz-Cl, DIEA, CH2Cl2 ; (f) formic acid; (g) H2, Pd/C, MeOH 
Scheme 18 
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1.5 Pyrazolines 
2-Pyrazolines, or 4,5-dihydropyrazoles, are five membered heterocycles containing two 
adjacent nitrogen atoms with the general structure shown (Fig 17). 
4 
Fig 17 Basic structure of pyrazoline 
There are three tautomeric pyrazoline structures, shown below, but the 2-pyrazolines 
are by far the most common (Fig 18). 
0 
Fig 18 The Tautomeric Pyrazoline Structures 
The first reported synthesis of a pyrazoline was by Knorr and Blank in 1885 where they 
described the slow reduction of 1,3-diphenyl-5-methylpyrazole with sodium and 
ethanoi.38 In 1887 Fisher and Knoevenagel reported the first synthesis of a pyrazoline 
from aryl hydrazines by the reaction of phenylhydrazine and acrolein.39 It was then 
Curtius and Wirsing who first synthesized pyrazoline itself from the reaction of acrolein 
with hydrazine.40 
The standard syntheses of pyrazolines presently either involve the conjugate addition 
and subsequent _cyclisation of hydrazines with u,j3-unsaturated carbonyl compounds 
(Scheme 19), or proceed via a 1,3-dipolar cycloaddition reaction of nitrile imines with 
olefins that preferably possess electron-withdrawing groups (Scheme 20).41 
p~ 
Scheme 19 
Scheme20 
H 
N-NH2 
-H,O 
Ph 
N_/ 
R~ 
EWG 
Nitrile oxide and nitrone 1,3-dipolar cycloadditions have been exploited in the 
construction of enantiopure five membered heterocycles. Despite the utility of 
enantiopure pyrazolines in organic synthesis and some interesting applications of 
related products, the stereoselective synthesis of pyrazolines has only become useful in 
the last few years. A 1998 review by Gothelf and Jorgensen stated that "only very few 
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studies have been perfonned in the field of asymmetric 1,3-dipolar cycloadditions 
involving nitrile imines". 1 In 2005, Molteni published a review on stereoselective 
cycloadditions of nitrile imines as a source ofenantiopure heterocycles.42 
The behaviour ofN-4-methylphenyl-C-methoxycarbonyl nitrile imines towards a series 
of enantiopure acrylamides was investigated. It was found that the diastereoisomeric 
ratio ranged from 58:42 to 83:17 depending upon the chiral auxiliary connected to the 
dipolarophile. It was found that bulkier acrylamides gave better results as a possible 
outcome of lower confonnational flexibility. It was also found that the base, whether 
chiral or achiral, and the presence of salts such as LiCl as potential complexing agents 
had little or no influence on the diastereoselectivity (Scheme 21 ). 
co2Me 
CIYC02Me Me02 
Meo,c 
11 
0 
"+?y" base R~ N N<D I ~a NH I I 0 pTol 0 pTol pTol 
R= OC02Me N- .--(eo, en l_?-
Scheme 21 
Cycloaddition of the nitrile imine 28 with 29 gave a 75:25 mixture of diastereoisomers 
in a yield of 60%.44 In tenns of regioselectivity, the fonnation of just the 5-substituted 
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4,5-dihydropyrazoles is in agreement with the HOMO-dipole (LUMO-dipolarophile) 
control which is typical for cycloaddition of nitrile imines with dipolarophiles that bear 
electron-withdrawing groups (Scheme 22). 
0 Ph3C 0 0 
El e ~0 Ph3C N-N-CPh3 + THF,-40'C 0 0 
28 29 0 
Scheme22 
Pyrazolines, as with other nitrogen containing heterocycles are of great interest to 
medicinal and organic chemists due to their proven biological activity. In the literature 
there are reported examples of pyrazoline derived compounds that have shown anti-
diabetic,43 antidepressant44 and anti-inflammatory activity.45 There are also examples 
reported that have shown ability to inhibit enzymes related to Alzheimer's and 
Parkinson's diseases.46 
In a 2007 paper by Conti, the synthesis of 1,3,5-trisubstituted pyrazolines was described 
as part of a project aimed at the discovery of new NMDA (N-methyl-D-aspartate) 
antagonists.47 1,3,5-Trisubstituted pyrazolines and pyrazoles are of great interest as 
synthetic targets as they form the basis of numerous drugs including Viagra and 
Celebrex. The synthesis of the 1,3,5-trisubstituted pyrazoline, 5-substituted-3-
dimethoxyphosphono-2-pyrazoline 30, was accomplished by a 1,3-dipolar 
cycloaddition from a nitrile imine. The presence of the phosphonate moiety has been 
shown to be responsible for an increase in potency (Scheme 23). 
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a b,c 
/NYPo,Me2 HN "-'::: 6• 
j d 
PO, Me, 
e 11 
+ N 
I 
-N 
I Ph 
R =Ph, C02Me, C4H9, C19H19 
(a) (COCI},, DMSO, TEA, ·60 oc; (b) PhNHNH2, -40 oc, CH2Cl2; (c) NBS/AcOEt, A; (d) NaHC03/Ac0Et; (e) 
RCHCH,. 
Scheme23 
There are examples of pyrazoline-containing natural products reported in the literature. 
In 2005, Kelly and eo-workers reported the total synthesis of nigellicine 31, a natural 
product that was first isolated in 1985 from the seeds of Nigella sativa.48 
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Pyrazole ring structures are also of great interest and there is evidence of their synthesis 
via a I ,3-dipolar cycloaddition route in the literature. 
A paper by Oh describes the synthesis of celecoxib 34 by I ,3-dipolar cycloaddition.11 
Celecoxib is the active molecule in the widely prescribed drug Celebrex, a COX-2 
inhibitor. A common approach for the synthesis of celecoxib is to react 4-
sulfamidophenylhydrazine 32 with diketone 33 (Scheme 24). 
Mo 
0 0 
• 
~ CF, 
Mo # 
S02NH2 
33 
32 
34 
34a 
Scheme24 
In this example, and others, a regioisomeric mix of both pyrazoles is often produced 
therefore further recrystallization techniques are required to obtain the correct 
regioisomer. The example described by Oh utilises the I ,3-dipolar cycloaddition 
reaction to give a totally regioisomeric product. 
Due to the extensive number of publications that show the presence of pyrazoles and 
pyrazolines in drug targets and natural products, along with great interest from 
biological chemists, it was felt that this type ofheterocycle was worthy of further 
research, in particular in connection with heterocyclic peptide mimetics.49 
CF, 
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2.0 Aim of the Project 
The aim of this project is to incorporate all of the topics covered in the introduction 
leading to the synthesis of pyrazolines as potential peptide mimetics with the general 
structure 35, as an extension of work carried out previously in the group on substituted 
isoxazoles and azomethine imines.31•50 
R' 35 
The imine bond potentially acts as a carbonyl mimic therefore the peptide bond is 
replaced and the peptide chain is allowed to carry on through ring structure therefore 
mimicking the dipeptide structure 36. So not only are we creating a peptide mimetic but 
also, due to the presence of the protected amine and acid functionalities, we aim to 
synthesise novel non-proteinogenic amino acids. 
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The initial aim is to synthesize these types of pyrazolines from N-protected 
proteinogenic amino acids via routes involving either a hydrazone 37 or a hydrazide 38. 
37 38 
As discussed previously, pyrazolines can be formed by I ,3-dipolar cycloaddition. In 
order to do this a dipole must be generated in the form of a nitrile imine 40. This is 
done by the treatment of a hydrazonyl chloride 39 with base (Scheme 25). 
Base't 
'S!.-R' 
N/ 
R~ ~ J. 'c1 
NHP' 39 
Scheme25 
-~'-R' 
R~ )('t I. "c1 
NHP1 
The dipole that is formed in situ can then be subject to a suitable dipolarophile and by 
the mechanism shown the desired heterocycle is formed (Scheme 26). 
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Scheme26 
In more specific terms, the aim of this thesis is to investigate the scope of the I ,3-
dipolar cycloaddition reaction leading to the synthesis of compound 35 and to 
investigate the potential in variation of the group R2 situated on N-1 of the heterocyclic 
ring. 
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3.0 Results and Discussion 
3.1 Synthesis via a Hydrazone Route 
We initially had two strategies for the synthesis of the pyrazolines, the first of these 
proceeding via a hydrazone route. The method employed for the synthesis of the 
pyrazoline is a I ,3-dipolar cyclo!iddition. This type of cycloaddition relies on the 
reaction of a suitable dipole, here in the form of a nitrile imine, with a dipolarophile. 
Nitrile imines are formed in situ by the reaction of hydrazonyl chlorides (Scheme 27) 
with base. 
> 
NHR2 R~ r 1 l. "c1 
NHP1 
> 
il 
R
1YC02H 
<<:=:  
NH2 
R
1YC02Me R1YC02Me ~ <== 
NH2 NHP1 
Scheme27 
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As the retrosynthetic analysis shows, our first task was to synthesise an N-protected 
amino acid ester. We chose L-alanine 41 as our starting amino acid as the presence of 
the methyl group may have given us early indications of any steric effects. L-Alanine 
was esterified using acetyl chloride in dry methanol, a procedure already established 
within the group to give L-alanine methyl ester 42 in 96% yield (Scheme 28).51 
41 
Scheme28 
MeOH,b., 24h 
96% 
42 
The next step was amine protection. We decided to try two common N-protecting 
groups in order to establish whether there could be preference of one over the other 
further into the synthesis. tert-Butyloxycarbonyl (Boc) and benzyloxycarbonyl (Cbz) 
protecting groups were employed as these types of N-protection had also been carried 
out in the group previously.51 This gave the Boc 43 and Cbz 44 protected amino acid 
esters in yields of96% and 53%, respectively (Schemes 29 & 30). 
MeyC02Me 
NH2 
Scheme29 
Et,N, DCM, 19 h 
96% 
MeyC02Me 
NHBoc 
43 
Scheme30 
aq .KHC03, EtOAc 
53% 
Page 153 
44 
Both the Boc 43 and Cbz 44 L-alanine methyl esters were reduced to their respective 
aldehydes 45 and 46 in 93% yield using DIBAL-H in dry toluene at -78 oc (Schemes 
31 & 32). 
Scheme 31 
Scheme32 
"'Yco,"' 
NHBoc 
DIBAL-H 
Toluene, -78 °C 
93% 
DIBAL-H 
Toluene, -78 oc 
93% 
"'Yc"o 
NHBoc 
45 
"'Yc"o 
NHCbz 
46 
As these first few synthetic steps were performed quite smoothly we were soon ready to 
attempt the synthesis of the phenylhydrazones. This was done using a common method 
used as a test for the presence of carbonyl compounds. 52 The crude aldehydes were 
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dissolved in a little ethanol and added to a solution of phenylhydrazine hydrochloride 
and sodium acetate in water. After heating at approximately 70 oc for 15 minutes the 
Boc-protected phenylhydrazone precipitated from solution; this happened more rapidly 
on cooling in an ice bath. The solid produced was filtered and dried to give [!-methyl-
2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 47 in a yield of81% (Scheme 
33). 
45 
Scheme 33 
PhNHNH2.HCI, NaOAc 
EtOH/H20, 70°C, lSmin 
81% 
··J 
_......-NHPh 
NHBoc 
47 
The Cbz-protected phenylhydrazone was not able to be isolated in the same way as it 
formed as an oil in the reaction solution. Attempts were made to extract and purity this 
oil but they were unsuccessful so, due to its ease of formation and high purity, we 
decided to carry the synthesis forward using the Bee-protected hydrazone 47. 
Formation of isoxazoles had been reported and carried out using a I ,3-dipolar 
cycloaddition previously in the group. 51 These reaction conditions were applied to the 
Bee-protected phenylhydrazone with the aim of forming the desired pyrazoline in one 
pot. These reactions are summarised in Table 2. 
The hydrazone 47 was C-chlorinated using N-chlorosuccinimide (NCS) at 0 oc before 
heating to reflux for I 7h. After this period the dipolarophile was added in the form of 
ethyl acrylate followed by Et3N over a period of 3h and the reaction mixture was left to 
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reflux for a further 6h (Entry 1). Previous members of the group had found that, in the 
isoxazole series from chlorinated oximes, better yields could be achieved by slower 
addition of the base. We tried adding Et3N over longer periods of time (Entries 2-3) but 
still only a complex mixture (CM) was seen. We decided to try two other dipolarophiles 
with stronger electron-withdrawing groups than ethyl acrylate. The chlorination and 
cycloaddition was carried out as before except N-phenylmaleimide and diethyl 
fumarate were employed as dipolarophiles (Entries 4-5) but analysis showed once again 
that the reaction had not worked. 
Entry Solvent Dipolarophile Base Addition Time Result 
I CHCb Ethyl Acrylate Et3N 3h CM 
2 CHCl3 Ethyl Acrylate Et3N 4h CM 
3 CHCb Ethyl Acrylate Et3N 4h CM 
4 CHCb ~-Phenylmaleimide Et3N 3h CM 
5 CHCb Diethyl Fumarate Et3N 3h CM 
Table 2 Summary of Attempted 1,3-Dipolar Cycloaddition Reactions 
After this disappointment we went back to the literature to find work by Torssell and 
his eo-workers where they had reported the synthesis of pyrazolines in one pot from 
hydrazones. 53 
We applied this methodology to the Hoc-protected phenylhydrazone whereby C-
chlorination was carried out using NCS for lh at 60 oc before addition of ethyl acrylate 
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and KHC03 as the base. The reaction mixture was stirred at 70 oc for 20h and 
purification gave 5-(1-tert-butoxycarbonylamino-ethyl)-2-phenyl-3,4-dihydro-2H-
pyrazole-3-carboxylic acid ethyl ester 48 in a yield of 41% as a I: I mixture of 
diastereoisomers, as confirmed by chiral phase HPLC (Scheme 34). Et3N was tried as 
an alternative base to give 48 in a comparable yield of 41%, again as a I: I 
diastereomeric mixture. 
MeOL r:HPh __ .:..;N.::CS::___+ J .... EtOAc, 60°C, lh 
NHBoc 
47 
Scheme34 
MeOL r NHPh /""--eo, eo 
l "c' KHCo,, 70°C, 20h 
NHBoc 41% 
/Ph 
Me ..... J \_ T "-../' --co2Et 
NHBoc 
48 
Both reactions were regioselective giving us the ethyl ester in the required position. 
This was confirmed by obtaining a crystal structure of the pyrazoline (Fig 19) which 
shows that only one diastereoisomer had crystallised out. This shows an S configuration 
at the chiral centre ofC(l3) and an R configuration at the newly formed chrial centre of 
C(l). Unfortunately on further attempts, we were unable to form a crystallised product 
that could be separated from the diastereomeric mixture. 
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Fig 19 Crystal Structure of 5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-
pyrazole-3-carboxylic acid ethyl ester (Appendix I) 
After establishing this methodology to synthesise the pyrazolines we decided to look at 
modified dipoles which would give us pyrazolines with different groups at N-1 of the 
heterocyclic ring. 
We thought that it would be useful to prepare pyrazolines whereby the N-1 atom of the 
pyrazoline heterocycle was protected by amine protecting groups with a view to 
cleaving these off at a later stage and replacing them with different alkyl chains or 
groups with interesting functionality. N-(2-tert-
Butoxycarbonylaminopropylidene)hydrazinecarboxylic acid tert-butyl ester 49 and N-
(2-tert-Butoxycarbonylaminopropylidene)hydrazinecarboxylic acid benzyl ester 50 
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were prepared from N-protected amino acid aldehyde 45 using the required protected 
hydrazines in toluene over a period of 24h in yields of 27% and 48%, respectively 
(Schemes 35 & 36). 
Scheme35 
Scheme36 
BocNHNH2 
Toluene, 24h, RT 
27% 
CbzNHNH2 
Toluene, 24h, RT 
48% 
/NHBoc 
··yl" 
NHBoc 
49 
/NHCbz 
··yl" 
NHBoc 
50 
We attempted to chlorinate and cycloadd to these hydrazones as before using NCS as 
the chlorinating reagent and ethyl acrylate as the dipolarophile in the presence of 
KHC03 as the base. Table 3 gives a summary of these reactions. 
Entry Hydrazone R %Yield Cycloaddition Observation 
I 16 Boc 27 C-Chlorinated Product 
2 17 Cbz 48 C-Chlorinated Product 
Table 3 Summary of Attempted Cycloaddtion Reactions with 16 and 17 
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For both of the hydrazones, only the hydrazonyl chloride derivatives of these 
compounds was recovered. This was confirmed by the loss of the appropriate signal in 
the 1H NMR spectra. For the Boc- and Cbz -protected hydrazones we were unsure as to 
why these reactions would not work. We had hoped that these electron-withdrawing 
groups would render the NH proton more acidic and enhance the dipole formation but 
this did not appear to be the case. 
Also, Molteni published work in which an investigation had been carried out into the 
effects of functional groups situated para on the phenyl ring of phenylhydrazones 
(Scheme 3 7). 54 
+ ~CO, Et Base 
p 
N-N MoO,C~CO,Et 
Scheme37 
The results (Table 4) show that for the more electron-withdrawing para-substituents of 
the phenyl ring, much longer reaction times are needed resulting in much lower yields. 
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R Time/Min %Yield 
H 10 95 
Me 10 95 
M eO 10 93 
Br 70 68 
N02 100 3 
Table 4 
These findings lead us to believe that, due to the electron-withdrawing nature of the 
carbonyl-containing Boc and Cbz groups, the 1,3-dipolar cycloaddition would not. take 
place as the nitrile imine has reduced reactivity. However if we are seeing the C-
chlorinated compounds as products then this could suggest that the dipoles are never 
actually formed. 
Attempts were made to prepare pyrazolines with a less electron-deficient dipolarophile 
to provide a substituent on the pyrazoline that we could then oxidise to the carboxylic 
acid. Both 49 and 50 were chlorinated as before with NCS before addition of allyl 
alcohol, as a more electron-rich dipolarophile, but neither of these reactions gave 
cycloaddition products. 
This led us to look at different protocols for preparing the pyrazolines that we had 
already managed to synthesise. Many of the methods that we came across required the 
isolation of the hydrazonyl chloride before cycloaddition. In order to do this we used a 
method previously reported by Pate! in which the Corey-Kim reagent, an N-
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chlorosuccinimide-dimethyl sulfide complex previously used for the oxidation of 
alcohols to carbonyl compounds, was employed. 55•56 
The Corey-Kim reagent was prepared in situ according to the reported procedure by 
addition of dimethyl sulfide (DMS) to N-chlorosuccinimide at 0 °C. Treatment of this 
complex with the Hoc-protected phenylhydrazone 47 at -78 °C, with warming to room 
temperature over a period of 3h resulted in the formation of the desired hydrazonyl 
chloride in 55% yield. The mechanism suggested by Pate! in his paper is shown below 
(Scheme 3 8). 
Scheme38 
The first step is assumed to be loss of a proton from the nitrogen atom. The Corey-Kim 
reagent then undergoes nucleophilic attack by the nitrogen atom of the hydrazone 
resulting in the loss of succinimide. The double bond of the hydrazone rearranges 
forcing removal of dimethyl sulfide and resulting in the generation of a carbocation. 
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This then undergoes attack by the counteranion, er, to give 51, which can tautomerise 
to give the hydrazonyl chloride 52. 
Confirmation of the formation of the hydrazonyl chloride was given by 1H NMR 
analysis where the disappearance of the appropriate proton signal is observed. By 
carrying out this methodology we were able to isolate the hydrazonyl chloride and 
attempt more cycloadditions. 
A paper by Molteni, who has carried out work on a large number of reactions involving 
the synthesis of pyrazolines from nitrile imines, suggested the use of AcOAg as the 
base and used much milder conditions to those we had used previously.57 The 
hydrazonyl chloride 52 produced by the Corey-Kim route was reacted with ethyl 
acrylate in the presence of AcOAg at room temperature (Scheme 39). 
Me40. rNHPh 
~ 'c1 
NHBoc 
52 
Scheme39 
AcOAg 
toluene, 2-20h, RT 
15-25% 
/Ph 
Me' J \_ T ~ --co2Et 
NHBoc 
48 
The reaction time was varied from 2 to 20 h with the pyrazoline 48 only being formed 
in 15% yield at best. We tried adding another 1.5 eq of AcOAg after a reaction time of 
I h before leaving the reaction for a further 19 h but in this case a yield of only 25% 
could be achieved after purification. Again regioselectivity was maintained but the 
product was still formed as a mixture of diastereoisomers. 
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In another of the papers by Molteni, I ,3-dipolar cycloadditions of nitrile imines were 
carried out in aqueous media in the presence of tetrahexylammonium chloride (THAC) 
as a catalyst. 54 We carried out this reaction on our Boc-protected hydrazonyl chloride, 
prepared by the Corey-Kim procedure, in O.IM aqueous sodium hydrogen carbonate 
with a catalytic amount of THAC and ethyl acrylate as the dipolarophile. The reaction 
mixture was shaken for 2h and an orange solid was formed that could be collected by 
suction filtration to give 48 in a yield of 57% (Scheme 40). 
Me.. ~NHPh 
~ "c1 
NHBoc 52 
Scheme 40 
/"-co2Et 
O.lM aq. base, THAC, 2h, RT 
57% 
C02Et 
NHBoc 48 
This method meant that all impurities were filtered off with the aqueous medium 
therefore no further purification ofthe product was needed. It is thought that due to the 
hydrophobic nature of the organic reagents they are forced into close association 
whereas the catalyst acts as a phase transfer catalyst that carries the basic agent from the 
aqueous medium to the organic aggregate. 
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3.2 Synthesis via Hydrazide Route 
A retrosynthetic analysis for the second approach to the pyrazolines is shown in 
Scheme 48. As seen for the hydrazone route, the pyrazoline is to be formed by the 1,3-
dipolar cycloaddition of a nitrile imine with a suitable dipolarophile, and the nitrile 
imine is to be formed, as before, by the treatment of a suitable hydrazonyl chloride with 
base. The difference is in the generation of the hydrazonyl chloride, this time from an 
acyl hydrazide (Scheme 41). 
Scheme41 
NHR2 
> ·R~ JC I I. "c1 
NHP1 
< 
> 
NHR2 
.ye 
NHP1 
ll 
The first task at hand was to prepare N-protected amino acids. The amino acid of choice 
was again L-alanine 41 with di-tert-butyl dicarbonate and benzyl chloroformate being 
used, to add N-terminal protecting groups. These reactions were carried out as 
performed previously in the group to give N-tert-butyloxycarbonyl-L-alanine 53 and N-
benzyloxycarbonyl-L-alanine 54 (Schemes 42 & 43).58 
Scheme42 41 
Scheme43 
Et3N, CH2CI2, 19h 
69% 
aq.KHC03, EtOAc, 19h 
96% 
··y·" 
NHBoc 
53 
"'Yco,H 
NHCbz 
54 
After this we were ready to prepare the desired hydrazides. Originally this was done 
using phenylhydrazine hydrochloride in the presence of dicyclohexylcarbodiimide 
(DC C) as the peptide coupling agent along with I -hydroxybenzotriazole (HOBt) as the 
carboxyl activating agent (Schemes 44 & 45). 
Scheme44 
Scheme45 
OCC, HOBt, PhNHNH2.HO 
CH2CI2, 0°C-+RT, 24h 
DCC, HOBt, PhNHNH2.HO 
CH2CI2, 0°C-+RT, 24h 
~ye:~' 
NHCbz 
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This was an extremely capricious reaction and was difficult to repeat to the desired 
purity, therefore an alternative method was sought. Zhang and his eo-workers carried 
out an investigation into the preparation of carboxylic acid hydrazides.59 He found that 
the order of addition of the reagents had an effect on the outcome of the reaction. A 
stepwise reaction in which the acid is first converted to an activated intermediate 
followed by reaction with the chosen hydrazine gave the best results. This stepwise 
method minimizes the number of side reactions as it avoids the coexistence of the 
hydrazine with the peptide coupling agent. We applied this methodology to our work 
whereby HOBt was first of all added to a solution of the N-protected alanine in 
dimethylforrnamide. This time I -(3-dimethylaminopropyl)-3-ethylcarbodiimide 
hydrochloride (EDCI) was used as the coupling agent as it is easier to handle than DCC 
and the byproducts are easier to remove from the product. This was added in one 
portion after the addition ofHOBt. After 2 hours the reaction mixture was poured into a 
solution of phenylhydrazine in dimethylforrnamide whilst maintaining a temperature of 
0-10 oc (Schemes 46 & 47). 
Scheme 46 
1) HOB! 
2) EDCI. 2h 
3) PhNHNH,, CH,CN 
50% 
/NHPh 
••Ylo 
NHCbz 
55 
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1) HOB! 
2) EDCI, 2h 
3) PhNHNH2, CH,CN 
56% 
/NHPh 
••Ylo 
NHBoc 
Scheme47 56 
By forming the intermediates in this stepwise manner and carrying out a reverse mode 
of addition, the formation of side products is suppressed and the desired hydrazides, 55 
and 56 were formed in yields of 50% and 56% respectively. 
The synthesis of these N-protected phenylhydrazides meant that we were able to 
attempt the chlorination of these products followed by cycloaddition. 
A number of reagents can be used for the chlorination of amide bonds or hydrazides, 
such as PCls, POCh, and CCI4 in the presence of triphenylphosphine. Some of these 
methods have been found to be quite harsh and a drawback is that the excess of 
chlorinating agent and reagent-derived byproducts have to be removed. Nevertheless 
we decided to try some of these more classical methods as a means of obtaining the 
desired hydrazonyl chlorides. The results of these experiments are summarised in Table 
5. 
Page 168 
Entry p' Chlorinating Reagent Solvent Temp Hours Base Hours Result 
l Boc PCI, Toluene <l 3 . . CM 
2 Cbz PC I, CC!, <l 5 KHCO, 20' CM 
3 Cbz CCI.,JI'Ph3 CH3CN RT 7 KHCO, 20 CM 
4 Cbz CCI.,JI'Ph3 EtOAc RT 5 KHCO, 20' ? 
5 Cbz CCI.,JI'Ph3 EtOAc RT 5 Et3N 20' ? 
6 Boc PC!, CCI4 <l 5 . . CM 
7 Cbz PC!, CCI4 <l 5 . . CM 
8 Boc CCI.,JI'Ph3 CH3CN RT 17h . . . 
"temperature changed to 70° C 
Table 5 Summary of conditions used for chlorination of 56 
Initially PCI5 was used as the chlorinating reagent (Entry I) whereby the Boc-protected 
phenylhydrazide was heated to reflux in toluene. This led to a complex mixture (CM) in 
which nothing could be identified or isolated. We decided that as chlorination and 
cycloaddition via the hydrazone route was carried out in one pot, we would try this for 
the hydrazide route. Therefore we tried chlorinating again with PCI5 (Entry 2) and 
CCI,JPPh3 (Entry 3) for the period of time indicated before adding the base and ethyl 
acrylate again as the dipolarophile. The reaction mixtures were left for a further 20h, as 
done for the hydrazone route, at the temperatures indicated but again these led to 
complex mixtures. We decided that as ethyl acetate was the solvent of choice for the 
hydrazone route we would attempt the chlorination and cycloaddition in this solvent 
using the bases indicated (Entries 4-5). On analysis no cycloaddition product was seen. 
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We then decided that to be certain that the chlorination of the hydrazides had worked, 
we would try to isolate the hydrazonyl chloride (Entries 6-8) before carrying out the 
cycloaddition reaction. Again PCls was used as the chlorinating reagent but as before a 
complex mixture was seen in both cases. CCl4 in the presence of PPh3 was tried again 
but left to react at room temperature for a much longer period of time than before. It 
appeared that as we thought, the chlorination of the Boc-protected hydrazide had taken 
place to give 57, and this was also seen when performed with the Cbz-protected 
hydrazide to give 58 (Schemes 48 & 49). 
/NHPh /NHPh 
HN 1. PPh3 N -~, 2. CCI4 y CH3CN, RT, 17h Cl 
NHBoc NHBoc 
57 
Scheme48 /NHPh /NHPh 
HN 1. PPh3 N ~yl, 2. CCI4 y CH3CN, RT, 17h Cl 
NHCbz NHCbz 
58 
Scheme49 
Having isolated the Boc- and Cbz- protected phenylhydrazonyl chlorides, it was 
decided to carry these through to the cycloaddition in crude form as problems had been 
encountered with their purification with the hydrazone route. A mechanism for C-
chlorination is shown (Scheme 50). 
~CI3 [ VNHPh J:;l R~O Ph3P, roo- -C:'N/NHPh CI-CCI3 4 ~ '-.___./ Ao <!> j Ph,PV 
Ph3P=O /NHPh 
CJ/NHPh q 
+ R~e.Ph, ;}0-e.Ph, /NHPh N 
R)lCI Cl 
Scheme 50 
The cycloaddition was carried out for the Boc and Cbz phenylhydrazonyl chlorides, as 
was done for the hydrazone route, whereby KHC03 was added to a solution of the 
hydrazonyl chloride in the presence of ethyl acrylate as the dipolarophile. 
After purification 5-(l-tert-butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-
pyrazole-3-carboxylic acid ethyl ester 48 was isolated in 31% yield as a 1: I mixture of 
diastereoisomers. 
No cycloaddition product was obtained from the Cbz protected hydrazonyl chloride. 
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3.3 Conclusion 
In conclusion, we have been able to synthesise our target molecule via the two routes 
that we proposed, a hydrazone 47 and a hydrazide 56 route. 
Ph Ph 
I I 
/NH /NH 
N HN 
··y, ~~ 
NHBoc 
47 
NHBoc 
56 
We have looked at different amine protecting groups to see if there was a preference as 
to which one gave us the best yields. It was found that the Boc-protected amino acids 
gave the best results. It is thought that the Cbz-protected hydrazones and hydrazides do 
not undergo cycloaddtion reactions as the conditions for chlorination involve the 
presence of the er ion. It is known that Cbz is removed from amine groups with the use 
ofBr", therefore it is logical to think that the chloride ion may work in the same way. 
We have been able to use a number of methodologies to synthesise the target molecules 
whereby the chlorination step and I ,3-dipolar cycloaddition reactions can be carried out 
in "one pot" or in a stepwise manner. We have also trialled different bases to see if they 
can have an influence on the yield of the cycloaddition reactions. 
Taking into account factors such as ease and time of reaction, number of steps and 
yield, the hydrazone route has proven to be the best. For the purpose of this thesis, any 
further cycloadditions will be undertaken via the hydrazone route. 
Pagel72 
3.4 Diastereoselective Cycloaddition Reactions 
As mentioned earlier, it had been realised that on cycloaddition of the hydrazonyl 
chloride with ethyl acrylate, the formation of the new chiral centre led to the product 48 
being an inseparable mixture of diastereoisomers in a 1: I ratio. This was confirmed 
earlier by chiral phase HPLC, although normal HPLC would have shown this. It can 
also be identified in the 1 H NMR spectra of pyrazoline 48 as two overlapping doublets 
of doublets for the proton on the ethyl ester substituted carbon can be seen representing 
each diastereoisomer. 
co,Et 
NHBoc 
48 
This was the case for all of the methods carried out to form the pyrazoline 48. It was 
decided that we needed to find modifications to try and influence the 
diastereoselectivity of the reaction. 
The first method that was tried was the inclusion of a chiral auxiliary on the 
dipolarophile. Molteni reported the 1 ,3-dipolar cycloaddition reactions of hydrazonyl 
chlorides with proline acrylamides as the proline could easily be removed to leave the 
free carboxylic acid.60 Molteni reported yields of up to 70% with the proline 
acrylamide as a chiral auxiliary but the best diastereoselectivity ratio achieved was 
67:33. In our case this would give a pyrazoline with an amino acid already coupled at 
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the acid terminus of the molecule. Before carrying out the synthesis of the proline 
acrylamide, a test reaction was carried out using N,N-dimethylacrylamide as the 
dipolarophile (Scheme 51). 
/NHPh 
YN' H NCS 
NHBoc 
Scheme 51 
EtOAc, 1 h 
6Q•C 
NHBoc 
59 
The reaction was carried out under the preferred cycloaddition conditions of in situ 
chlorination with N-chlorosuccinimide and cycloaddition with KHC03 as the base. This 
gave the pyrazoline 59 in a yield of25% and a 1:1 mixture of diastereoisomers. As this 
reaction was a success, synthesis of the proline acrylamide was carried out. 
L-Proline was esterified with methanol in the presence of thionyl chloride to give the 
methyl ester 60 in I 00% yield. This was subsequently converted to the acrylamide 61 
by a literature procedure to give the desired product in 43% yield (Scheme 52).61 
o_e[? 
co2Me 60 
Scheme 52 
Et,N, DMAP 
Acryloyl Chloride 
DCM, 19.5 h 
o•c-RT 
100% 
61 
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With the acrylamide in hand, chlorination and cycloaddition of the hydrazone 47 was 
carried out to give the pyrazoline 62 in 15% yield (Scheme 53). Although this 
cycloaddition was achieved, the inclusion of L-proline on the dipolarophile did not 
influence the diastereoselectivity of the reaction as the products were again a 1: I 
mixture of diastereoisomers. 
Scheme 53 
NCS 
EtOAC, 1 h, 
60 ° c 
NHPh 
Me0N/ CH:;:~~7h~M~e 
Cl 70' C 
15% 
NHBoc NHBoc 
It was thought that by using a different starting amino acid with a bigger side chain, the 
diastereoselectivity of the reaction could be influenced from the amine side of the 
molecule. Thus the amine group of L-valine methyl ester 63 was protected using di-
tertiary-butyl dicarbonate in a yield of 78 %. The Boc-protected amine 64 was then 
reduced to the aldehyde 65 using DIBAL at -78 oc in a yield of 76 %. This was used 
immediately and converted to the phenylhydrazone 66 using phenylhydrazine 
hydrochloride and sodium acetate. The hydrazone was subject to the normal 
chlorination and KHC03 cycloaddition conditions to give the pyrazoline 67 in 20 % 
yield but yet again as an insepearble 1: I mixture of diastereoisomers (Scheme 54). 
. eo, Me _Boc_oc_;o2:...~c.:..: -:;R::..'T:-.-Jyco,Me To~:::~-:8 oc 
- 76% 78% 
~H,~I NHBoc 
63 64 
NCS 
EtOAc, 1 h, 60 °C 
NHBoc 
KHC03 j CH2=CHC02Et 
EtOAc, 20 h 
70 °C 
20% 
/Ph 
N-N 
f 
C02 Et 
NHBoc 67 
Scheme 54 
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1 ~CHO /1 65 
NHBoc 
NH2NH.Ph.HO 
NaOAc 
aq.EtOH, 15 mln 
60 °C 
96% 
H 
.NHBoc 66 
One way of avoiding this problem was to start with an amino acid that had no chiral 
centre at all, the only one of these being glycine (Scheme 55). Again the amine group of 
glycine methyl ester hydrochloride 68 was protected with di-tertiary-butyl dicarbonate 
to give the Boc-protected amino acid 69 in 81% yield. This was then reduced to give 
the aldehyde 70 which was used directly as before to form the phenylhydrazone 71. 
Chlorination and cycloaddition with ethyl acrylate was carried out to give the 
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pyrazoline 72 in a poor 8% yield. As there is only one chiral centre in the molecule this 
was now a mixture of enantiomers. 
(
C02Me __ ~ ___ 2o_,_E_~-N~~ 
DCM, 17 h, 
0 °C- RT ~H3~I 81% 
68 
/NHPh 
f" 
NHBoc 
KHC03 
EtOAc, 20 h 
70 °C 
8% 
NHBoc 72 
Scheme 55 
(
C02Me DIBAL-H 
Toluene, -78 °C 
NHBoc 98o/o 
69 
NCS 
EtOAc, 1 h, 60 °C 
(CHO 
NHBoc 70 
NH,NHPh.HO 
NaOAc 
aq.EtOH, 70°C 
81% 
As changing the starting amino acid proved unsuccessful in influencing 
diastereoselectivity, it was decided that attention would be turned back to the 
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dipolarophile. A variety of ester activated dipolarophiles were tried (Scheme 56) and 
the results are summarised in the table below (Table 6). 
/NHPh 
YNI H NCS 
NHBoc 
Scheme 56 
Entry 
73 
74 
75 
Table 6 
EtOAc, 1 h 
60 °C 
R' R" 
COz'Bu H 
COz'Bu Me 
COzMe H 
/NHPh R3=R2R1 
YNI KHC03 EtOAc, 20 h Cl 70 oc 
NHBoc 
NHBoc Ra 
R' %Yield Ratio of Diastereoisomers 
H 27 1:1 
H 25 1:1 
COzMe 12 1:1 
Tertiary-butyl acrylate and tertiary-butyl methacrylate were tried as it was thought that 
the size of the butyl group may lead to preferential cycloaddition from one face but this 
was not the case as a I: I mixture of diastereoisomers was seen in both cases. Dimethyl 
fumarate was chosen for similar reasons to see if one approach for cycloaddition would 
be preferred over the other but again the product was a I: I mixture of diastereoisomers. 
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3.5 Conclusion 
In conclusion, we have looked at a number of factors to influence the 
diastereoselectivity of the reaction including the use of different starting amino acids 
and the use of different dipolarophiles. We have also looked at using a chiral 
dipolarophile as this would give us a product that was already coupled to an amino acid. 
In all cases the pyrazolines were isolated, thus extending the set of pyrazolines 
prepared. However they were still isolated as I: I mixtures of diasterereoisomers except 
for the glycine based compound. 
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3.6 Synthesis of Pyrazoles 
It had been queried earlier that the presence of diastereoisomers may have been due to 
the amino acid aldehydes racemising over a period of time. 62 It was felt that the 
integrity of this chiral centre needed to be proven in order to confirm the origin of the 
diastereoselectivity. 
This was done by carrying out the cycloaddition step with the alkyne methyl propiolate 
as the dipolarophile. This meant that no new chiral centre would be formed in the 
molecule and the reaction should lead to only one enantiomer. The chlorination and 
cycloaddition were carried out as normal, using the NCS and KHC03 methods 
respectively, to give the pyrazole 76 in 25% yield (Scheme 57). 
/NHPh 
YNI H NCS 
NHBoc 
Scheme 57 
EtOAc, lh 
60 oc 
NHPh 
YN/ :~:~0c:
2Me 
Cl 70 °C 25% 
NHBoc 
co2Me 
NHBoc 76 
As this yield was slightly disappointing the cycloaddition was repeated under aqueous 
media conditions as this had proven to be better yielding in the past. The hydrazonyl 
chloride 52 was synthesised and isolated as previously before using the Corey - Kim 
reagent.55 Reaction with methyl propiolate in O.IM NaHC03 in the presence of 
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tetrahexylammonium chloride gave the pyrazole 76. Under these conditions the 
pyrazole 76 was formed in a better yield of 40% (Scheme 58). 
NHPh 
N/ CHCHC02Me I THAC 
0.1 M NaHC03 
Cl 20 h, RT 
40% 
NHBoc 52 
Scheme 58 
3.6.1 HPLC Analysis 
NHBoc 
/Ph 
N-N 
~ p C02Me 
76 
The pyrazole 76 was analysed using HPLC with a chiral column. It was apparent that 
there was one large peak present with what appeared to be a small shoulder at the base. 
On further manipulation of the chromatography the separation was improved to show 
two peaks. It was thought that one of these peaks was a major enantiomer with a small 
presence of the other enantiomer (Fig 20- Appendix II)). 
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In order to further confirm that this was case the whole synthesis was carried out using 
a racemic mixture of D and L-alanine methyl ester hydrochloride 77 (Scheme 59). 
Initially the amine was group was protected again using di-tertiary-butyl dicarbonate to 
give the desired product 78 in 90% yield. This was then reduced using DIBAL at -78° C 
to give the aldehyde 79 in 95%. The aldehyde was used immediately to synthesise the 
phenylhydrazone 80 in 88% yield which was then subject to the usual chlorination and 
cycloaddition conditions to give the enantiomeric mixture ofpyrazoles 81 in 30% yield. 
Y C02Me ___ N_cs __ _ EtOAc, 1 h, 60 oc 
~H3~1 90% 
77 
/NHPh 
yl" 
NHBoc 
KHC03 
EtOAc, 20 h 
70 °C 
30% 
NHBoc 
Scheme 59 
CHCHC02Me 
C02Me 
YC02Me 
NHBoc 
78 
NCS 
EtOAc, 1 h, 60 °C 
EtOAc, 20 h 
70 °C 
95% 
YCHO 
NHBoc 79 
NH2NHPh.HO 
NaOAc 
aq.EtOH, 70 °C 
88% 
/NHPh y, 
NHBoc 80 
This enantiomer mixture was then subject to chiral HPLC chromatography (Fig 21). 
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By overlaying the chromatograms it was shown that the initial trace was indeed from 
the L-series showing one major enantiomer with a smaii presence of the minor 
enantiomer (Fig 22). 
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Thus it appears that the amino acid derived chiral centre is very largely preserved 
during the synthetic sequence, with epimerisation limited to< 1 %. 
The pyrazole 76 was then subject to deprotections and peptide couplings. 
3.7 Peptide Couplings 
Firstly the methyl ester was hydrolysed using conditions reported by Molteni.64 The 
pyrazole was dissolved in aqueous tetrahydrofuran and 2M NaOH and left for 3h at 
room temperature. After work up, the free acid 82 was seen in almost quantitative yield. 
This was pure enough to be used directly for coupling to another amino acid. It was 
decided that glycine methyl ester hydrochloride would be used as the peptide coupling 
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could be carried out without the use of any racemisation suppression agent and there 
would be no introduction of another chiral centre to the molecule. The peptide coupling 
was carried out using EDCI as the coupling agent in anhydrous diethyl ether to give the 
product 83 in a yield of 46%, coupled at the acid terminus (Scheme 60). 
C02 Me 
NHBoc 76 
Scheme60 
2M NaOH 
aq.IHF, 3 h, RT 
then W 
97% 
NHBoc 1) EDCI 
82 
C02H 
2) Gly- OMe 
3) Et,N 
Et02, 17 h 
0 oc- RT 
46% 
It was also possible to deprotect the amine terminus of the pyrazole 76. Trifluoroacetic 
acid was used to remove the Boc-group and gave the amine as a trifluoroacetate salt 
which was converted to the hydrochloride salt 84 by treatment with 2M hydrochloric 
acid in a yield of 65%. This hydrochloride salt was treated with triethylamine to yield 
the free amine. 65 The peptide coupling was then carried out using Boc-glycine 85 with 
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EDCI again used as the coupling agent (Scheme 61) to afford 86, albeit in an 
unoptimised yield of 13%. 
C02 Me 
NHBoc 
1FA, 2M HO 
DCM, 3 h, RT 
65% 
-~H3CI 
C02Me 
1) Et3N 
2)Boc- Gly 
3)EDCI 
DCM, 19 h 
RT 
13% 
84 
C02 Me 
~ 86 
NHBoc 
Scheme61 
The next logical step to follow this synthesis was to hydrolyse ester 86 and carry out a 
further coupling reaction to obtain the fully coupled peptide mimetic. 
The pyrazole 86 was treated with 2M NaOH at room temperature (Scheme 62) as 
before. 
co,Me 
')'' 
BocHN 
86 
Scheme62 
2M NaOH 
aq. THF, 3 h, RT 
70% 
')" 
BocHN 
The hydrolysis step afforded the product 87 in a yield of70%. 
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co2H 
87 
The pyrazole acid 87 was next subject to the peptide coupling conditions with glycine 
methyl ester (Scheme 63). 
co,H 
)" 
BocHN 
87 
Scheme63 
1) EDO 
2) Gly-OMe 
3) Et,N 
Et0,,17H 
0 °C- RT 
D% ')" 
BocHN 
0 
88 
This gave the target peptide mimetic 88 coupled at both the amine and acid terminii in a 
yield of33%. 
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3.7.1 NMR Studies 
Whilst we have been able to synthesise the target molecule 88 we need to prove that 
this molecule could potentially act as a peptide mimetic. 
In order to do this we need to look at characteristics of peptide chains and see if 88 
shows any of these characteristics. One of the most notable characteristics of the 
peptide chain is the way that the chain is forced to bend and turn due to the interacting 
hydrogen bonds (Fig 23). 
Fig 23 Hydrogen Bonding Interactions in a P-Turn Structure 
For our molecule to be considered as a peptide turn mimetic, it would have to bend and 
incorporate hydrogen bonding interactions as shown (Fig 24). 
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Fig 24 Possible Hydrogen Bonding in 88 
. One method of confinning the structure and the presence of any hydrogen bonding 
interactions is X-ray crystallography but this relies on the product being crystalline and 
growing crystals for analysis, and only applies to the solid state. 
Another method for identification of potential hydrogen bonding uses 1 H NMR 
spectroscopy. Samuel Gellman has made a great contribution in the area of using 
spectroscopic techniques, such as NMR, to detennine the degree of hydrogen bonding 
in molecules.66 This technique is can be used to investigate the solution confonnation of 
our peptide mimetic. 
The rate at which an amide proton exchanges between its various hydrogen bonded and 
non-hydrogen bonded states is rapid on the NMR timescale, therefore the lone signal 
observed represents the weighted average of signals for that particular proton in its 
different environments. NMR studies documented in the literature have shown that an 
intramolecularly hydrogen bonded NH proton displays a chemical shift of around 7-8 
ppm whereas a free NH proton is around 6 ppm. The NH monitored in our pyrazole 
occurs at approximately 7 ppm which is within the shift range for intramolecular 
hydrogen bonding. 
VT 1H NMR experiments were run on the peptide mimetic 88. Recordings were taken 
at five degree intervals over the range 273-333 K in CDCh. The spectra were run at 
fairly low concentrations (5nM) to minimise any possible intermolecular amide-amide 
hydrogen bonding. 
The change in amide proton chemical shift is shown plotted as a function of 
temperature (Fig 25). 
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Fig 25 Amide NH Proton Shifts as a Function of Temperature 
In the literature it has been suggested if there is a change in temperature, this should 
have little effect on the chemical shifts of protons that are involved in an intramolecular 
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hydrogen bond. It is found that those hydrogens that are exposed to the solvent tend to 
exhibit a larger temperature coefficient (> 4 ppb/K) than those that are intramoleculary 
hydrogen bonded(< 3 ppb/K). 
The proton studied lies within the relevant chemical shift range suggested for a 
intramolecularly hydrogen bonded proton but the chemical shift changes quite 
significantly with temperature i.e. the temperature coefficient (~o/ ~ T) calculated from 
the data plotted is -5.9 ppb/K. This value is outside the range of values suggested for a 
proton that is intramolecularly hydrogen bonding. 
3.8 Conclusion 
In conclusion, the target molecule has been synthesised as a pyrazole 76 instead of a 
pyrazoline. 
NHBoc 
The pyrazole 76 has been subject to amine and ester deprotections. We have then been 
able to carry out peptide couplings at both terminii to give the individually coupled 
product as well as the fully coupled product 88. 
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0 
)'" 
BocHN 
88 
We have carried out variable temperature 1H NMR studies to show if the molecule 
adopts a ~turn-like confonnation through intramolecular hydrogen bonding. The 
studies have shown that this is unlikely but without further proof this idea cannot be 
discounted. 
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3.9 Reversed Functionality 
It was proposed that the pyrazolines could be synthesised with "reversed functionality" 
where the acid and the amine functionalities would be on opposite carbons to the 
heterocycles prepared so far. The retrosynthetic analysis for this strategy is shown 
below (Scheme 64). 
R2HN'\_ H N=< 
co,P' 
Scheme64 
The first synthetic steps leading to the synthesis of a suitable benzyl hydrazone have 
recently been reported in the literature (Scheme 65).53 
EtOYC02Et ___ P_c_ls _ __,~ 
19 h, 0 oc- 80 °C 
OEt 
89 
Scheme 65 
90 
NH2NHBn.2HCI 
H20, 1 h, 0°C - RT 
77% 
/NHBn 
""~" 
91 
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The synthesis was repeated to give the benzylhydrazone 91 in a yield of 77%. The same 
conditions were used in an attempt to synthesise the phenylhydrazone but they just gave 
starting material in the form of the chlorinated product 90. As an alternative ethyl 
glyoxylate 92 was treated with phenylhydrazine hydrochloride and sodium acetate in 
aqueous ethanol as done previously to give the phenylhydrazone 93 in a yield of 56% 
that required no further purification (Scheme 66). 
/NHPh 
NH2NHPh.HCI, NaOAc ~~ 
aq.EtOH, 15 min, 70 oc ~ 
. SG% EI02C H 
93 
Scheme66 
It was now possible to start carrying out cycloaddition reactions. 
With the knowledge of previous cycloaddition reactions involving hydrazones with 
chiral centres and also reactions involving the formation of new chiral centres is was 
decided that, initially, cycloaddition reactions would be carried out with alkynes. In the 
first instance, the dipolarophile of choice was to be derived from glycine. It is possible 
to synthesise amino-acid based alkynes via the Corey - Fuchs synthesis67 but as it had 
been decided that glycine would be trialled initially, the required functionality could be 
achieved by using propargylamine as the dipolarophile. In order to make direct 
comparison with previous work, the amine group of propargylamine was protected with 
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di-tertiary-butyl dicarbonate and the phenylhydrazone was used as the source of the 
dipole. The chlorination and cycloaddition steps were carried out using the preferred 
conditions but although chlorination appeared to have taken place the cycloaddition 
reaction did not. After this, a series of cycloaddition reactions were investigated using 
different dipoles and dipolarophiles (Scheme 67). 
Scheme 67 
These are summarised in the table below (Table 7). 
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Propargyl or 
Chlorination Cycloaddition Desired % 
Entry SM R' R' Allyl 
Conditions · Conditions Product Yield 
Dipolarophile 
1 93 Ph NHBoc Propargyl NCS, 60 oc KHC03 94 0 
2 93 Ph OH Allyl NCS,60 oc KHCO, 95 0 
3 93 Ph OH Propargyl NCS, 60 °C KHC03 96 0 
4 93 Ph NH, Allyl NCS, 60 oc KHC03 97 0 
5 93 Ph OH Propargyl NCS, 60 °C KHC03, lJ. 98 0 
6 93 Ph NH, Allyl NCS, 60 oc KHC03, lJ. 99 0 
7 93 Ph OH Allyl NCS/DMS AgOAc,RT 100 0 
8 93 Ph NHTs Propargyl NCS, 60 oc Et3N, lJ. 101 0 
9 91 Bn C02Et Allyl NCS, 60 oc KHC03 102 78 
10 91 Bn Ph Allyl NCS, 60°C KHC03 103 29 
11 91 Bn NH, Allyl NCS,60 oc KHC03 104 47 
Table 7 Cycloaddition of 93 and 91 with various dipolarophiles 
To summarise, none of the reactions carried out using the phenylhydrazone were 
successful. As outlined above the cycloaddition was first attempted using Boc-protected 
propargylamine 105 as the dipolarophile (Entry 1). This was prepared under standard 
Boc-protection conditions in dichloromethane to give prop-2-ynylcarbamic acid tert-
butyl ester 105 in a yield of 96% (Scheme 68). 
Scheme68 
Boc20, Et3N 
DCM, 17 h 
o•c-RT 
96% 
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BocHN~ 
105 
As the Boc-protected propargylamine did not work we decided to try both propargyl 
and allyl alcohol (Entries 2 and 3) as the alcohol group could potentially be converted 
to give the amine functionality, but neither of these cycloadditions worked. Unprotected 
allylamine was tried to see if the presence of the Boc-protecting group was influencing 
the reactivity of the dipolarophile but again this reaction was unsuccessful (Entry 4). 
We decided to try the chlorinations and cycloadditions again with propargyl alcohol 
and allylamine but this time the reactions were carried out in toluene and heated to 
reflux for the cycloaddition steps (Entries S and 6). NMR analysis showed that these 
conditions did not produce my pyrazole. 
The phenylhydrazone was converted to the hydrazonyl chloride using the Corey- Kim 
conditions. 63 This was isolated and the cycloaddition step was carried out with silver 
acetate as the base and in toluene at room temperature (Entry 7). These conditions had 
proven to be successful in publications by Molteni and in previous . cycloadditions 
reported in this thesis but again these conditions did not work. 
Propargylamine was protected using p-toluenesulfonyl chloride as it was thought that 
this would make the alkyne bond less electron-rich and aid in the cycloaddition 
reaction. N-Propargyl-p-toluenesulfonamide lOSa was obtained in a yield of 77% 
(Scheme 69). The cycloaddition reaction was carried out using this dipolarophile but 
again this proved unsuccessful (Entry 8). 
Scheme69 
TsCI, Et3N 
DCM, 12 h, RT 
77% 
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We next decided to turn our attention to the benzylhydrazone of ethyl glyoxylate as it 
had been shown in the literature that cycloaddition reactions had been carried out with 
this compound for the formation ofpyrazolines.53 Initially it was decided that a couple 
of these literature procedures would be repeated to check that pyrazolines could be 
formed using this type of dipole. The benzylhydrazone of ethyl glyoxylate was subject 
to chlorination using NCS as normal and then the cycloaddition step was carried out 
using ethyl acrylate and styrene as dipolarophiles. The cycloadditions with ethyl 
acrylate and styrene gave pyrazolines 102 and 103 as reported in the literature in yields 
of78 and 29 %, respectively (Entries 9 and 10). 
Bn 
I N-N 
Et02C~Ph 
103 
In the literature, the cycloaddition reaction was also carried out using allyl alcohol.53 
The paper states that the product was extremely difficult to purify and was therefore 
directly converted to the acid. It was thought that the alcohol could be converted to the 
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amine. Direct transformations from the crude alcohol product of allyl alcohol 
cycloaddition to the amine were attempted with no success. We tried to purify the 
presumed alcohol funtionalised product to prove that this was produced in the synthesis 
but this proved tricky as reported. 
As the reported reactions with ethyl acrylate and styrene had worked, the cycloaddition 
step was carried out with allylamine as the dipolarophile (Entry 11) to give what was 
assumed to be the pyrazoline 104 in 47% yield (Scheme 70). 
/NHBn /NHBn 
Bn 
NCS CH,=CHCH,NH, I N 
Et02CAH 
N N-N 
EtOAc, lh 
Et02CACI 
KHC03, EtOAc, r 60 •c 2oh, 70 •c 
47% 
EI02C 
104 
Scheme70 
With this desired cycloaddition product assumed to be in hand it was thought that we 
could go ahead and attempt peptide couplings with another amino acid at the amine 
terminus. The coupling was initially carried out using Hoc-glycine as before but proved 
to be unsuccessful. On further analysis of the 1H NMR spectra of the presumed 
cycloadduct it was found that the desired pyrazoline product had not been formed, due 
to the absence of the characteristic doublet of doublet signal seen in the spectra of 
previous structures. 
A paper by Molteni in 2004 discussed potential by-products of a 1 ,3-dipolar 
cycloaddition with a hydrazonyl chloride acting as the dipole precursor and allyl 
NH2 
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alcohol as the dipolarophile. The four possible products of this reaction (106 - 109), 
promoted by the silver ion, are shown below (Scheme 71 ). 68 
CO, Me Ar-~-N=< 
Cl 
l 
C02 Me A _,.Ar 
N N 
I I 
_.,...NVN 
Ar I 106 
CO,Mo 
Scheme71 
I 
C02 Me Ar-N-~-( Ao 
0 
107 
+ ~OH 
Base, Ag+ 
Toluene 
I 
H C~Me Ar-N-N=<--····-
~OH 
108 
1 
A\ 
N-N 
~CO,Me 
HO 
109 
We were initially convinced that the desired pyrazoline 104 had been obtained as mass 
spectrometric analysis was able to give us an accurate mass that matched that of the 
pyrazoline 104. However the possible by-product 108 reported by Molteni from allyl 
alcohol has the same molecular mass as the pyrazoline 109, therefore suggesting that 
synthesis of a by-product was likely in our allylamine reaction. 
The rationale for the formation of the by-product 108 is that it is highly likely that the 
formation of the required nitrile imine is promoted by the high affinity of the silver ion 
for er and proceeds via the nitrilium cation 110. Normally this cation goes on to lose a 
proton and form the correct nitrile imine for dipolar cycloaddition to give the correct 
pyrazoline. However, it is possible that allyl alcohol capture gives rise to carbocation 
111 which then evolves to give 108 (Scheme 72). 
H =<C02Me Ag• 
Ar-N-N 
Cl 
[ Ar-~-~:=;--co2Me ] 
110 j 
H Ar-N-N 
~OH 
C02Me 
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[ Ar-~-~:=;--co2Me] 
This rationale can be applied to our synthesis to determine the possible by-product 
(Scheme 73). 
H =<C02Et [ H @ l Bn-N-N -----1~ Bn-N-N:=:--C02Et 
Cl j 
Scheme73 
H Bn-N-N 
H Bn-N-N 
~NH, 
eo, Et 
j w 
eo, Et 
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NH, 
NH, 
Although this rationale is in agreement with literature reports, the argument reported by 
Molteni depends on the affinity of the er ion to the Ag +ion to form the nitrilium cation 
which captures the allyl alcohol. This in turn goes on to form the by-product via a 
secondary carbocation intermediate. 
In our example there are no ions present that would encourage the loss of the er ion 
and encourage the formation of the by-product so it remains uncertain as to the 
structure of the product of our allylamine reaction. 
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3.10 Conclusion 
In conclusion, we have been able to synthesise a number ofpyrazolines with "reversed" 
functionality. However, none of the products formed have proven to be suitable 
candidates for peptide mimetics. It appears that the reactive nature of the dipole can 
give rise to potential side reactions and by-products. 
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3.11 Debenzylation Reactions 
As we had the ethyl acrylate cyclisadon product in hand it was thought that if the 
benzyl group of N-1 could be removed then this may give an opportunity to put 
different functional groups onto the ring at this position, or even extend the peptide 
mimetic chain from this N-terminus (Scheme 74). 
/Bn 
N-N 
Et02C~C02Et 
Scheme74 
-Bn N-NH 
Et02C~C02Et 
)-R 
N-N 
Et02C~C02Et 
There are many examples in the literature for the removal of benzyl groups from 
amines even though this can be a notoriously tricky reaction. The first conditions that 
we tried were those reported by Rewolinski involving treatment wth base followed by 
exposure to oxygen.69 This method was of particular interest as the reaction conditions 
were applied to N-heterocylic compounds such as 112, 113 and 114. 
Bn 
I 
CC> 
112 
# 
113 
OBn 
114 
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The proposed mechanism for this type of debenzylation is shown (Scheme 75). 
e 
/ 
CO H j CO H j 
Aqu. workup 
e 
CO Me,S02 + 
+ PhCHO 
Scheme75 
The pyrazoline 102 was dissolved in DMSO and potassium tertiary butoxide was added 
whilst stirring at room temperature. Oxygen was bubbled through the reaction solution 
for I 0 minutes before quenching with saturated ammonium chloride (Scheme 76). 
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Bn 
/ KO'Bu, 0 2 N-N X 
11 \ DMSO, RT, 10 min Et02C~C02Et 
• ;; N\ 
Et02C~C02Et 
102 
Scheme76 
After work up and analysis it was found that these conditions proved far too harsh and 
the ring appeared to decompose as the 1H NMR spectra showed no sign of ring protons 
being present. It is suggested in an earlier publication by Kawakami and Suzuki that 
heterocycles which incorporate either nitro or ester groups in the molecule were not 
tolerant of the reaction conditions.70 In these cases the starting materials appear to 
decompose to a complex mixture of products as soon as they come into contact with the 
KO'Bu!DMSO mixture, prior to the addition of oxygen, thus confirming our findings. 
A publication by Davies and eo-workers reported the use of cerium ammonium nitrate 
(CAN) for the removal of benzyl groups.71 An example of this application is shown 
(Scheme 77). 
Scheme77 
Ph 
lN/"-.._Ph 
Ph) 
CAN 
MeCN-H20 (5:1), RT 
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These conditions were tried with the styrene cyclisation product 103 as it was thought 
that there was potentially less functionality for the reagent to react with. The pyrazoline 
was stirred for 3 hours with CAN at room temperature in aqueous acetonitrile. A yellow 
oil was produced that solidified after a period of time (Scheme 78). 
Bn 
I CAN 
N-N 
Et02C I! \ MeCN-H,O ;), RT, 3h ~Ph 
103 
Scheme78 
1 H NMR analysis showed that the pyrazoline ring was still intact and also both phenyl 
rings were still present. The signals for the protons at C-2.and C-3 had disappeared. It 
was thought that the actual product was the pyrazole due to the appearance of a single 
aromatic proton peak in the appropriate region of the 1 H NMR spectrum. Also a mass 
spectrum of the product was obtained along with an accurate mass which gave the 
correct mass for the proposed pyrazole 103a (Scheme 79). 
Bn 
I 
N-N 
Et02C---ZAPh 
103 
Scheme79 
Bn 
CAN I 
N-N 
MeCN-H20 (5:1), RT, 3h . I! \ 
E!02C~Ph 
103a 
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Although this was thought to be a potentially useful reaction, without the removal of the 
benzyl group this molecule could not be utilised as a peptide mimetic. With that in 
mind we concentrated our efforts on finding ways to remove the benzyl group and leave 
the free amine. 
The use of palladium catalyst and hydrogen as de-benzylating agents has been widely 
reported in the literature. This gave us reason to utilise this method in order to de-
benzylate 103. 
The pyrazoline 103 was dissolved in methanol and treated with Pd(OH)2 at room 
temperature under a hydrogen atmosphere (Scheme 80). 
Bn 
I N-N Et02C~Ph 
103 
Scheme SO 
Pd(OHJ, H2 
X • ;; N\ 
Et02C~Ph MeOH, 19h, RT 
After 19h the reaction mixture was filtered through a pad ofCelite. The resulting filtrate 
was concentrated under reduced pressure but the product obtained was confirmed by 1 H 
NMR spectroscopy to be the starting p)Tazoline. 
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Another reported procedure involving the use of palladium reagents as a means of de-
benzylation is catalytic transfer hydrogenation. 72 
The pyrazoline 103 was stirred in absolute ethanol and acetic acid. The reaction mixture 
was treated with IOO/o Pd-C followed by I,4-cyclohexadiene under a nitrogen 
atmosphere (Scheme 8 I). 
Bn 
I N-N EtOzC~Ph 
103 
Scheme 81 
10% Pd-C 
1,4-cyclohexadiene 
X 
Et0H/CH3COOH, N,, 
17h, RT 
• ; N\ 
Et02C~Ph 
After I 7h the reaction mixture was again filtered through a pad of celite and the 
resulting filtrate was concentrated under reduced pressure to give an orange oil that was 
was confirmed by 1H NMR spectroscopy to be the starting material. 
3.12 Conclusion 
In conclusion, a number of known de-benzylation methodologies have been applied to 
the synthesised pyrazolines. None have these have led to the desired de-benzylated 
product. This may be due to the number and type of functionalities that are incorporated 
into the heterocyclic structures. It is neccessary to find a method that will work in a 
chemoselective manner and just complete the removal of theN-benzyl group. 
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3.13 Attempted Synthesis with P-alanine 
As we had successfully carried out the synthesis of novel pyrazoles and pyrazolines 
with a number of proteinogenic amino acids, we felt that it was necessary to look at 
non-proteinogenic amino acids. 
It was decided that we would attempt to carry out the complete synthesis of a pyrazole 
with P-alanine as the starting amino acid to see if an extra carbon in the side chain 
would have an influence on the 1,3-dipolar cycloaddition reaction. Also it was thought 
that this extra carbon in the side chain may provide extra flexibility and encourage 
hydrogen bonding. 
We already had P-alanine ethyl ester hydrochloride 115 to hand in the group so the first 
reaction to carry out was Hoc-protection of the amine terminus. This was carried out as 
already reported in dichloromethane for 17h (Scheme 82). 
Scheme82 
Boc20, Et3N 
DCM, 17h 
0°C-RT 
66% 
After workup, the Hoc-protected p-alanine ethyl ester 116 was given in a yield of 66 %. 
The next step was the formation of the aldehyde using DIHAL. This was done using the 
same procedure as carried out for the other amino acids in anhydrous toluene (Scheme 
83). 
Scheme83 
D!BAL-H 
Toluene, -78 •c 
100% 
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fcHO 
NHBoc 117 
Here the Boc-protected aldehyde 117 was given in a I 00% yield and was used for the 
next step without further purification. 
The final step to carry out before attempting the cycloaddition reaction was the 
formation of the hydrazone analogue. Again this was carried out using the same method 
as described before in aqueous ethanol (Scheme 84). 
rCHO 
NHBoc 
Scheme 91 
NH2NHPh.HO 
NaOAc 
aq. EtOH, 70 •c 
47% 
~NHPh 
N 
BocHN~H 
118 
The resulting hydrazone 118 formed as a precipitate in solution. After filtration and 
drying the product was afforded in a yield of 4 7 %. 
As the first three steps were performed in a straightforward manner, we were able to 
begin the 1,3-dipolar cycloaddition reaction of118 with methyl propiolate in an attempt 
to synthesise 119. 
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Ph 
I 
N-N 
BocHN 
r# 
119 
The synthesis of 119 was attempted under the usual chlorination and cycloaddition 
conditions using NCS as the chlorinating agent and KHC03 as the base. Upon 
completion of the reaction and purification of the product it was found that the pyrazole 
had not been synthesised and only the starting material remained. The reaction was 
repeated a couple oftimes to see if there had been some error in work up or purification 
but on analysis of all of the isolated products, none of them were proven to be the 
desired pyrazole. 
Therefore it was decided that more work was needed in this area to find suitable 
methodology to complete the I ,3-dipolar cycloaddition and then to carry out further 
manipulations. 
3.14 Conclusion 
In conclusion, we have been able to successfully synthesise the required precursors for 
I ,3-dipolar cycloaddition from ~-alanine ethyl ester hydrochloride. On attempting the 
cycloaddition reaction using tried and tested methodology, we were not able to obtain 
the desired pyrazole. Further work is needed on the cycloaddition reaction to find 
suitable conditions to obtain the required product. 
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3.15 Final Conclusion 
We have succeeded in completing the synthesis of our target pyrazoline 48 by a number 
of methods using different bases and different strategies. 
C02Et 
NHBoc 48 
It has been shown that the reaction is regioselective but is not diastereoselective as 48 
was always obtained as a I: I mixture of diastereoisomers. 
In order to overcome this problem we have looked at different amino acid-derived 
dipoles and varied dipolarophiles that may have an influence on the diastereoselectivity 
but none of these proved to be successful. As questions were asked about the integrity 
of the chiral centre provided by the starting amino acid we turned our attention to 
proving that this was not the case and prepared pyrazole 76 as essentially the one 
enantiomer. 
C02 Me 
NHBoc 
Pagel113 
We have been able to subject 76 to further manipulations in order to achieve the fully 
coupled peptide mimetic 88. 
)"" 
BocHN 
88 
We have carried out variable temperature NMR studies to ascertain whether this 
structure adopts the same folding structure as peptides due to intramolecular hydrogen 
bonding although this has so far proven to be inconclusive. 
Attempts have been made to synthesise pyrazoles and pyrazolines with "reversed 
functionality" that could be subject to deprotection and coupling reactions in the same 
vein as 76. However we have not been able to complete the synthesis of a suitable 
target. We have taken some of the reversed functionality candidates and attempted to 
remove the benzyl group by a number of deprotection methods but none have these 
have given the deprotected product. 
Finally we have looked at carrying out a complete synthesis of the pyrazole 119 using a 
non-proteinogenic ~-amino acid as our starting point. 
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I 
N-N 
BocHN 
~# 
119 
Further work is needed in this area to find a suitable methodology to obtain the desired 
product. 
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4.0 Experimental 
4.1 General information 
Solvents and Reagents 
All solvents and reagents were purified by standard techniques as reported in Perrin. 
D.D.; Armarego, W. L. F., Purification of Laboratory Chemicals, 3'd edition. Pergamon 
Press, Oxford, 1998 or used as supplied from commercial sources as appropriate. 
Reagent chemicals were purchased from Aldrich Chemical Company Ltd., Lancaster 
Chemical Synthesis Ltd. and Acros (Fisher) Chemicals Ltd. Commercially available 
reagents were used as supplied, without further purification unless otherwise stated. 
Air- and moisture-sensitive reactions were carried out using glassware that had been 
dried overnight in an oven at 240 °C. 
Solvents where necessary, were dried and stored over 4A molecular sieves prior to use. 
Molecular sieves were activated at 240°C over a period of 3 days. Light petroleum (P.E. 
40-60) refers to the fraction of the light petroleum ether which boils between 40-60 °C. 
DCM refers to dichloromethane. 
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Chromatographic Procedures 
Analytical thin layer chromatography (TLC) was conducted using aluminium or glass 
backed plates coated with 0.25 mm silica containing fluorescer. Plates were visualised 
by quenching ofUV light (254 nm) as well as through staining with 1% vw/v potassium 
permanganate in aqueous alkaline solution followed by heat where appropriate. Flash 
chromatography was conducted using Merck Kieselgel (70-230 Mesh ASTM) as the 
stationary phase unless otherwise stated. Samples were applied as saturated solutions in 
the appropriate solvent. Pressure was applied to the column by use of hand bellows. 
High Performance Liquid Chromatography (HPLC) was carried out on a Chrom Elite 
Automated HPLC system with a chiral reverse phase column. Samples were run at 
0.5ml/min in a 99: 1 v/v solution of hexane : isopropyl alcohol. 
FT-IR 
Infra-red spectroscopy (IR) was conducted in the range of 4000-600 cm·1, using a 
Perkin-Elmer Fourier Transform Paragon 1000 spectrophotometer (with internal 
calibration). Samples were dissolved in an appropriate solvent and applied as a thin film 
to the NaCI plates. 
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Proton magnetic resonance spectra eH NMR) were recorded at 400 MHz on a Bruker 
DPX-400 spectrometer as solutions in CDCh unless otherwise specified. Chemical 
shifts (oH) are quoted as parts per million (ppm) and are referenced to tetramethylsilane 
(TMS) as the internal standard. The following abbreviations are used; singlet ( s ), 
doublet (d), triplet (t), quartet (q) multiplet (m) and broad (br). Assignment of 
individual proton signals was assisted by analysis of 1H COSY spectra and nOe data. 
Coupling constants (J values) are reported in hertz (Hz). Diastereoisomer ratios were 
calculated from the integration of suitable peaks in the 1 H NMR spectra. 
Carbon magnetic resonance spectra (13C NMR) were recorded at 100 MHz using a 
DPX-400 spectrometer as solutions in CDCh unless otherwise specified. Chemical 
shifts (oc) are quoted as parts per million (ppm) and are referenced to tetramethylsilane 
(TMS) as the internal standard. Assignment of individual carbon signals was assisted by 
DEPT and HMQC data. 
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Mass Spectra 
Mass spectra (high/low resolution) were recorded using a JEOL SX I 02 instrument, 
with modes of ionisation being indicated as electron impact (El) and fast atom 
bombardment (FAB) with only the molecular ion, molecular ion fragments and major 
peaks being reported. Analysis was performed by Mr J. Kershaw, Department of 
Chemistry, Loughborough University. 
Other Data 
Melting points where appropriate were determined using an electrical 9100 Thermal 
Melting point instrument and are uncorrected. Yields (unless otherwise stated) are 
quoted for isolated pure products. Combustion analysis data were recorded by Mr A. 
Daley, Department of Chemistry, Loughborough University. 
Page 1119 
4.2 Experimental Procedures 
L- Alanine methyl ester hydrochloride [42] 51 
To a suspension of L-alanine (17.60 g, 0.198 mol) in dry methanol (125 ml) at 0 °C, 
acetyl chloride (66.24 g, 60 ml, 0.84 mmol, 4.3 eq) was added dropwise over 1h with 
stirring. The reaction mixture was heated to reflux for 20h, after which the solvents 
were removed under reduced pressure to yield a viscous colourless oil. This formed a 
white solid after trituration (14.67 g, 93%) that was used without further purification; 
mp. 109-111 oc (lit. 35 109-111 °C); I a ]o = 6.4 ( c 0.1 0, M eO H); OH ( 400 MHz; CDCb), 
1.41 (3H, d, J 7.2, CH3CH), 3.75 (3H, s, OCHJ), 4.08 (IH, br s, CH3CH), 8.53 (3H, br 
s, NH/); Be (100 MHz; CDCb) 15.6 (CH3), 48.5 (CH), 52.7 (OCH3), 171.3 (C=O); 
Ymax (CHCb)/cm'1 3233 (NH), 2932 (aliphatic CH), 2865 (aliphatic CH), 1680 (C=O) 
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N-tert-Butyloxycarbonyi-L-alanine methyl ester [43]51 
"'Yco,•• 
NHBoc 
To L-alanine methyl ester hydrochloride (10.00 g, 71.67 mmol) in dichloromethane 
(360 ml) at 0 °C, di-tert-butyl dicarbonate (16.42 g, 75.25 mmol, 1.0 eq) was added. 
The mixture was stirred for 15min before triethylamine (14.49 g, 19.96 ml, 143.34 
mmol, 2 eq) was added and the reaction mixture stirred for 17h. The mixture was then 
washed with citric acid solution (2M, 2 x 150 ml) and saturated brine (2 x 150 ml), then 
dried over magnesium sui fate and concentrated under reduced pressure to yield a light 
yellow oil (14.0 g, 96%). [u]0 = -48.0 ( c 0.10, CHCh); oH(400 MHz; CDCh) 1.38 (3H, 
d, J 7, CH3CH), 1.45 (9H, s, (CH3)J), 3.75 (3H, s, OCH3), 4.33 (IH, m, CH3CH), 4.97 
(IH, br s, NH); oc (100 MHz; CDCh) 18.5 (CHJ), 28.3 (C(CHJ)J), 49.1 (CH), 52.3 
(OCH3), 155.1 (C=O), 173.9 (C=O); Ymax (CHCh)/cm'1 3265 (NH), 2957 (aliphatic 
CH), 2866 (aliphatic CH), 1750 (C=O), 1690 (C=O) 
N-Benzyloxycarbonyi-L-alanine methyl ester [44]51 
"'Yco,Mo 
NHCbz 
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To a biphasic mixture of L-alanine methyl ester hydrochloride (5.04 g, 36.13 mmol) 
and potassium hydrogen carbonate (14.41 g, 143.91 mmol, 4.0 eq) in water (!50 ml) 
and ethyl acetate (175 m!) at 0 oc was added dropwise over 30 min with vigorous 
stirring benzyl chloroforrnate (7.41 g, 6.2 m!, 43.44 mmol, 1.2 eq). The reaction 
mixture was left to stir at room temperature for 16h. The aqueous phase was acidified to 
pH I with concentrated hydrochloric acid, separated and further extracted with ethyl 
acetate (!50 m!). The organic phases were combined, washed with saturated brine (2 x 
200 ml), dried over magnesium sulfate and concentrated under reduced pressure to 
yield a colourless oil which was purified by chromatography on silica gel, eluting with 
light petroleum: ethyl acetate (3:1 v/v) to yield the title compound as a colourless oil 
(4.61 g, 53%). [u]0 = -34.3 ( c 1.1, MeOH); liH (400 MHz; CDCi)) 1.32 (3H, d, J 7, 
CH3CH), 3.65 (3H, s, OCH3), 4.31 (IH, m, CH3CH), 5.02 (2H, s, OCHzPh), 5.34 (IH, 
br s, NH), 7.31 (5H, s, Ph-H); lie (100 MHz; CDCh) 18.5 (CH3), 49.6 (CH), 52.4, 
(OCH3), 66.9 (CH2), 128.1 (Ph-CH), 128.3 (Ph-CH), 128.4 (Ph-CH), 136.3 (Ph-C), 
155.7 (C=O), 173.52 (C=O); Vmax (CHCb)/cm-1 3338 (NH), 2952 (aliphatic CH), 1749 
(C=O), 1699 (C=O) 
L-2-(N-tert-butyloxycarbonylamino)propanal [45]73 
••yco,Mo 
NHBoc 
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"'Yc"a 
NHBoc 
To 1-N-tert-butyloxycarbonylalanine methyl ester (2.64 g, 13.06 mmol) in dry toluene 
(60 ml) at -78 oc under nitrogen over 1h, DIBAL-H (I.OM in toluene, 44.28 ml, 44.28 
mmol, 2.5 eq) was added dropwise with stirring, with the aid of a syringe pump. After 
the addition the reaction mixture was stirred for a further 0.5h. Methanol (14 ml) was 
added, and the reaction mixture was poured into a solution of Rochelle salt (50 g) in 
water (200 ml), and stirred vigorously for 1.5h. The aqueous phase was separated and 
extracted with ethyl acetate (3 x I 00 ml). The organic layers were then combined and 
washed with saturated brine (3 x I 00 ml), dried over magnesium sui fate and 
concentrated under reduced pressure to yield a colourless oil (2.1 g, 93%) that was used 
without further purification. OH ( 400 MHz; CDCI)) 1.34 (3H, d, J 7, CH3CH), 1.45 (9H, 
s, C(CH3)3), 4.63 (IH, m, CH3CH), 5.10 (IH, br s, NH), 9.57 (IH, s, CHO); Be (100 
MHz; CDCI)) 14.7 (CH3), 28.3 (C(CH3)3), 55.5 (CH), 155.4 (C=O), 199.9 (CHO); Vmax 
(CHCb)/cm·1 3347 (NH), 2978, 2934 (aliphatic CH), 1682 (C=O). 
L-2-(N--benzyloxycarbonylamino)propanal [46]73 
••yco,Mo 
NHCbz 
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"'Y"o 
NHCbz 
To N-Benzyloxycarbonyl-L-alanine methyl ester (2.15 g, 9.05 mmol) in dry toluene (30 
m!) at -78 °C under nitrogen over Ih, DIBAL-H (!.OM in toluene, 22.14 ml, 22.14 
mmol, 2.4 eq) was added dropwise with stirring, with the aid of a syringe pump. After 
the addition the reaction mixture was stirred for a further 0.5h. Methanol (14 ml) was 
added, and the reaction mixture was poured into a solution of Rochelle salt (50g) in 
water (200 m!), and stirred vigorously for 1.5h. The aqueous phase was separated and 
extracted with ethyl acetate (3 x I 00 ml). The organic layers were then combined and 
washed with saturated brine (3 x I 00 m!), dried over magnesi urn sulfate and 
concentrated under reduced pressure to yield a colourless oil (1.7 g, 93%) that was used 
without further purification. oH (400 MHz; CDCI)) 1.36 (3H, d, J 7.6, CH3CH), 4.30 
(IH, br s, CH3CH), 5.12 (2H, s, OCH2Ph), 5.37 (IH, br s, NH), 7.17-7.35 (5H, m, Ph-
H), 9.54 (IH, s, CHO); llc(IOO MHz; CDCI)) 13.6 (CH3), 63.6 (CH), 69.6 (CHz), 127.3 
(Ph-CH), 127.4 (Ph-CH), 128.7 (Ph-CH), 140.9 (Ph-C), 157.5 (C=O), 200.6 (CHO); 
Vmax (CHCI))/cm·1 3335 (NH), 2974 (aliphatic CH), 1697 (C=O). 
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L-[1-Methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester [47) 
··Y 
~NHPh 
NHBoc 
To phenylhydrazine hydrochloride (3.28 g, 22.68 mmol, 1.5 eq) and sodium acetate 
(4.98 g, 60.71 mmol, 4 eq) in water, was added the crude L-2-(N-tert-
butyloxycarbonylamino)propanal (2.60 g, 15.01 mmol) in ethanol (5 ml). The solution 
was warmed to 70 oc for 1 Omin and cooled in an ice bath. The resulting precipitate was 
filtered and dried to give an orange solid (3.19 g, 81%) that was used without further 
purification; mp.118-120 °C; OH ( 400 MHz; CDCI)) 1.29 (3H, d, J 7, CH3CH), 1.40 (9H, 
s, C(CH3)3), 4.34 (IH, br s, CH3CH), 5.00 (IH, br s, NH), 6.77 (IH, t, J 6.8, Ph-H), 
6.92 (2H, d, J 6, Ph-H), 7.00, (IH, br s, CH=N), 7.18 (2H, t, J 7.2 Ph-H), 8.22 (IH, br s, 
NH); Be (100 MHz; CDCI)) 28.4 (C(CH3)3), 112.6 (PhC), 120.0 (PhC), 129.3 (PhC), 
144.9 (C=N), 155.3 (C=O); Ymax (CHCI))/cm·l 3383 (NH), 1691 (C=O), 1606 (C=N), 
1165 (C-0), 753 (PhCH); mlz (FAB) 263.1629 (M+ Ct4H21N302 requires 263.1634), 
263 (33), 208 (53), 147 (100), 93 (41), 57 (60) 
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L-N'-(2-tert-Butoxycarbonylaminopropylidene)hydrazinecarboxylic acid benzyl 
ester [SO) 
··Y 
sJ'NHCbz 
NHBoc 
A solution of L-2-(N-tert-butyloxycarbonylamino )propanal (2.4 g, 13.90 mmol) and 
benzyl carbazate (2.38 g, 14.06 mmol, 1.0 eq) was left to stand in toluene (20 m!) for 
20h. The product separated out as a white solid which was collected by suction 
filtration to yield the title compound (2.14 g, 48%) as a white solid; mp 101-103 °C; 
[a]0 = 13.2 ( c 1.14, CHCh); oH (400 MHz; CDCI3) 1.25 (3H, d, J 6.8, CH3CH), 1.37 
(9H, s, C(CH3)3), 4.03 (IH, br s, CH3CH), 5.14 (2H, s, CHzPh), 7.26-7.30 (5H, m, Ph-
H), 7.97 (IH, br s, NH); oc (100 MHz; CDCh) 18.91 (CH3), 28.4 (C(CH3)3), 47.44 
(CH), 67.4 (CH2-Ph), 128.2 (PhC), 128.4 (PhC), 128.6 (PhC), 135.8 (C=N), 136.0 
(C=O), 155.2 (C=O); Vmax (KBr)/cm"1 3329 (NH), 3264 (NH), 1712 (C=O), 1521 
(C=N), 1165 (C-0), 737 (PhCH); mlz (El) 322.1770 (M+ C16H23N304 requires 
322.1767), 307 (27), 154 (100), 137 (49), 136 (57), 91 (31). 
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L-N'-(2-tert-Butoxycarbonylaminopropylidene)hydrazinecarboxylic acid tert-
butyl ester [49] 
~NHBoc 
y~ 
NHBoc 
y 
NHBoc 
A solution of L-2-(N-tert-butyloxycarbonylamino )propanal (2.1 0 g, 12.16 mmol) and 
tert-butyl carbazate (1.61 g, 12.15 mmol, 1.0 eq) was left to stand in toluene (20 m!) for 
20h. No precipitate was seen so the reaction mixture was concentrated under reduced 
pressure to give a yellow oil, which was treated with methanol and water to give a 
white solid (0.94 g, 27%) that was collected by suction filtration; mp 118-120 °C; 
(Found C, 54.5; H, 8.3; N, 14.2. C13HzsN304 requires C, 54.3; H, 8.8; N, 14.6%); [n]o= 
-11.6 ( c 1.03, CHCh); OH (400 MHz; CDCh) 1.26 (3H, d, J 6.8, CH3CH), 1.37 (9H, s, 
C(CH3)3), 1.43 (9H, s, C(CH3)3), 4.30 (lH, br s, CH3CH), 5.19 (lH, br s,NH), 7.19 (lH, 
s, HC=N), 7.72 (lH, br s, NH); lic(IOO MHz; CDCh) 19.0 (CH3), 28.3 (C(CH3)3), 28.4 
(C(CH3)3), 47.37 (CH), 136.0, (C=N), 155.3 (C=O), 156.3 (C=O); Vmax (KBr)lcm·1 
3348 (NH), 1711 (C=O), 1535 (C=N), 1164 (C-0), 779 (PhCH); mlz (El) 288.1928 
(M'· C13HzsN304 requires 288.1923), 176 (38), 154 (100), 136 (27), 57 (22). 
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5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid ethyl ester [48] 
,ri'NHPh 
~J ____..· 
NHBoc 
,ri'NHPh 
Me' l r "cl 
NHBoc 
C02Et 
NHBoc 
To a solution of L-[1-Methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.24 g, 4.72 mmol) in ethyl acetate (15 ml) at 60 oc was added N-chlorosuccinimide 
(0.71 g, 5.35 mmol, 1.1 eq). The reaction mixture was left to stir for !h. Ethyl acrylate 
(0.918 g, 1.0 m!, 9.16 mmol, 1.9 eq), potassium hydrogen carbonate (2.41 g, 23.97 
mmol, 5.1 eq) and a few drops of water were added and the reaction mixture was left to 
stir at 70° C for 20h. The reaction mixture was filtered and the filtrate concentrated 
under reduced pressure to give a dark orange oil, which was purified by column 
chromatography on silica gel eluting with light petroleum : ethyl acetate (7:1 v/v) to 
yield the title compound (0.72 g, 41%) in an inseparable 1:1 mixture of 
diastereoisomers, as an orange solid; mp 93-95 °C; (Found C, 62.6; H, 7.2; N 11.8. 
Ct9H21N304 requires C, 63.1; H, 7.5; N, 11.6%); OH (400 MHz; CDCh) 1.16 (3H, t, J 
7.2, C02CH2CH3), 1.35 (3H, d, J 7, CH3CH), 1.38 (9H, s, C(CH3)3), 2.99 (IH, dd, J 7.2 
& 17.6, CH2), 3.24 (IH, dd, J 12.4 & 17.6, CH2), 4.14 (2H, q, J 7.2, CH2CH3), 4.43 
(IH, m, CH3CH), 4.54 (IH, dd, J 7.2 & 12.4 CHC02CH2CH3), 4.57 (IH, dd, J 7.2 & 
12.4, CHC02CH2CH3), 5.00 (IH, br s, NH), 6.78 (IH, t, J, Ph-H), 6.93 (2H, d, J 8.4, 
Ph-H), 7.18 (2H, t, J 7.6, Ph-H); Be (100 MHz; CDCh) 14.2 (CH3) 21.09 (CH3), 28.2 
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((CH3)JC), 40.15 (CHz), 46.08 (CH), 61.7 (CHz), 62.43 (CH), 113.0 (Ph-CH), 113.0 
(Ph-CH), 119.7 (Ph-CH), 119.8 (Ph-CH), 129.0 (Ph-CH), 129.1 (Ph-C), 145.3 (C=N), 
171.2 (C=O), 171.5 (C=O); Vmax (CHCI))/cm·1 3354 (NH), 1599 (C=N), 1708 (C=O), 
1168 (C-0), 750 (PhCH); mlz (El) M"362.2073 (C19Hz7N304 requires 362.2080), 171 
(12), 154 (24), 147 (19), 123 (21), Ill (28), 109 (35), 95 (54), 81 (54), 69 (85), 57 
(I 00), 55 (99). 
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Preparation of hydrazonyl chloride [52] by Corey-Kim Chlorination55 
.rJ'NHPh 
··~ 
NHBoc 
.rJ'NHPh 
Me' l r 'cl 
NHBoc 
To N-chlorosuccinimide (2.70 g, 20.27 mmol, 3.0 eq) in dichloromethane (30 ml) at 0 
°C was added dimethyl sulfide (3.3 g, 3.0 ml, 42.24 mmol, 6.3 eq) over 5min. After 
stirring for 15min the reaction mixture was further cooled to -78 °C. L-[1-Methyl-2-
(phenylhydrazono )ethyl]carbamic acid tert-butyi ester (I. 76 g, 6.67 m mol) in 
dichloromethane (20 ml) was added and the reaction mixture was stirred at this 
temperature for Ih, then slowly allowed to warm to room temperature over a period of 
3h. Cold water (70 ml) was added, and the organic layer was washed with cold water 
(70 m!), saturated brine solution (70 ml), saturated aqueous sodium sulphate (70 m!) 
and water (I 00 m!). The organic layer was dried over magnesium sui fate, filtered and 
concentrated under reduced pressure to give a dark orange oil (1.3g, 55%) that was used 
without further purification. oH (400 MHz; CDCi)) 1.39 (12H, s, CH3CH & (CH3)JC), 
4.59 (IH, m, CH3CH), 4.85 {IH, br s, NH), 6.79 (IH, t, J 7.4, Ph-H), 6.92 (2H, d, J 8.8, 
Ph-H), 7.16 (2H, t, J 7.6, Ph-H); oc (100 MHz; CDCI3) 19.6 (CH3), 28.4 (C(CH3)J), 
52.3 (CH), 113.2 (Ph-CH), 121.0 (Ph-CH), 129.3 (Ph-CH), 143.5 (Ph-C), 143.4 (C=N), 
154.8 (C=O); Vmax (CHC1))/cm·1 3372 (NH), 2359 (=NH), 1700 (C=O), 1602 (C=N), 
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1165 (C-0); mlz (FAB) M 297.1238 (C14H2oN30 2CI requires 297.1244}, 297 (42}, 241 
(71}, 181 (100), 154 (66}, 136 (48), 57 (83) 
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5-(1-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid ethyl ester ( 48) 
.r-1'" NHPh 
N 
I 
Cl 
NHBoc NHBoc 
A solution of the hydrazonyl chloride 52 (1.30 g, 3.65 mmol) and ethyl acrylate (0.46 g, 
0.5 ml, 4.58 mmol, 1.3 eq) in dry toluene (50 ml) under nitrogen was treated with silver 
acetate (1.22 g, 7.31 mmol, 2.0 eq) under stirring at room temperature for 21h.The 
undissolved material was filtered off and the solvent reduced under reduced pressure to 
give a brown oil. This was purified using column chromatography (3:2 ethyl acetate : 
light petroleum to yield an orange oil (0.20 g, 15%) as a mixture of inseperable 
diastereoisomers (I: I). 
NMR Data consistent with those of 48 listed earlier. 
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5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid ethyl ester [48) 
~NHPh 
N 
I 
Cl 
NHBoc NHBoc 
The hydrazonyl chloride 52 (1.30 g, 3.65 mmol), ethyl acrylate (1.0 ml) and 
tetrahexylammoniumchloride (0.14 g, 0.36 mmol, 0.1 eq) in sodium hydrogen 
carbonate soluntion (O.IM, 20 ml) was stirred for 20h. The reaction mixture was 
filtered by suction filtration, the solid material w11shed with water and dried to give an 
orange solid (0.69 g, 57%) that required no more purification. The product was an 
inseparable mixture of diastereoisomers (I: I). 
NMR Data consistent with those of 48 listed earlier. 
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N-tert-Butyloxycarbonyi-L-alanine [53] 58 
··yco,, 
NHBoc 
To a solution of L-alanine (6.45 g, 72.40 mmol) in 1,4-dioxane, water and 1M sodium 
hydroxide (280 ml) (2:1:1 v/v/v) at 0 oc was added di-tert-butyl dicarbonate (17.86 g, 
81.83 mmol, 1.1 eq). The solution was stirred for 90 min at 0 oc then allowed to warm 
to room temperature and stirred for a further 30 min. The reaction mixture was 
concentrated under reduced pressure to approx. 70 ml then cooled to 0 °C. Ethyl acetate 
(70ml) was added and the biphasic mixture acidified to pH 3 with a solution of 
potassium hydrogen sulfate (2M). The aqueous layer was separated, then extracted with 
ethyl acetate (2x50 ml). The organic layers were combined, dried over magnesium 
sulfate and concentrated under reduced pressure. The crude product was recrystallised 
from light petroleum and ethyl acetate to yield a white solid (9 .4 7 g, 69% ); mp 83-85 
°C (lit.74 79-83 °C); [u]o= -48.0 ( c 0.10, CHCI)); oH (400 MHz; CDCI)) 1.39 (12H, m, 
CH3CH & C(CH3)3), 4.11 (IH, br s, CHCH3), 4.97 (IH, br s, NH); oc (100 MHz; 
CDCI)) 18.3 (CH3), 28.3 (C(CH3)3), 49.1 (CH), 155.5 (C=O), 177.7 (C=O); Vmax 
(CHCh)/cm'1; 3321 (NH), 2979 (aliphatic CH), 1724 (C=O), 1700 (C=O), 1164 (C-O) 
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N-Benzyloxycarbonyl-L-alanine [54] 58 
To a solution of L-alanine (9.97 g, 111.97 mmol) and sodium hydroxide (9.1 g, 227.5 
mmol) in water (100 ml) was added benzyl chloroformate (19.40 g, 16.23 ml, 113.72 
mmol, 1.0 eq) dropwise at 0 •c with the simultaneous addition of sodium hydroxide in 
water over a period of I h. The mixture was stirred for a further 16h. After this period 
the solution was carefully acidified to pH I with concentrated hydrochloric acid. The 
suspension was then extracted with ethyl acetate (2 x 70ml), and the organic phase was 
dried over magnesium sulfate, filtered and concentrated under reduced pressure to yield 
the title compound as a white solid (24.1 g, 96% ); mp 83-85° C (lit. 74 82-84 •q; [a ]0 = -
14.2 ( c 2.0, CHCI)); oH (400 MHz; CDCI)) 1.25 (3H, d, J 7, CHCH3), 4.00 (IH, br s, 
CHCH3), 5.02 (2H, s, PhCHz), 7.36 (5H, s, Ph-H), 7.56 (IH, d, J 7, NH); oc (100 MHz; 
CDCI)) 18.4 (CH3), 49.5 (CH), 67.2 (CH2), 128.2 (Ph-CH), 128.3 (Ph-CH), 128.6 (Ph-
C), 135.7 (Ph-C), 155.9 (C=O), 177.8 (C=O); Vmax (CHCh)/cm"1; 3333 (NH), 1701 
(C=O), 1534 (C-0) 
N-Benzyloxycarbonyl-L-alanine N2-pbenylhydrazide [55)59 
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/NHPh 
HN 
0 
NHCbz 
To a solution of L-N-benzyloxycarbonylalanine (1.02 g, 4.57 mmol) in DMF (20 ml) 
was added 1-hydroxybenzotriazole hydrate (0.78 g, 5.77 mmol, 1.3 eq) followed by 
EDCI (1.00 g, 5.22 mmol, 1.1 eq). The reaction mixture was stirred for 2h at room 
temperature before being slowly added to a solution of phenylhydrazine (1.21 g, 1.1 m!, 
11.18 mmol, 2.4 eq) in DMF (20 m!) at 0 °C. After 0.5h, water (40 ml) was added and 
the organic phase was extracted with ethyl acetate (2 x 40 ml). The organic phases were 
combined, washed with saturated sodium hydrogen carbonate solution ( 40 ml), dried 
over magnesium sulfate, filtered and concentrated under reduced pressure to give an 
orange solid. This was recrystallised from dichloromethane/hexane to yield the title 
compound as a white solid (0.71 g, 50%); mp 152-154 oc (lit.75 154.5-155.5 °C); [a]0 = 
+4.2 ( c 0.17, MeOH); oH (400 MHz; CDCI)) 1.45 (3H, d, J 6.8, CH3CH), 4.36 (IH, m, 
CHCH3), 5.15 (2H, s, CH2Ph-H), 5.38 (IH, br s, NH), 6.09 (IH, br s, NH), 6.81 (2H, d, 
J 8, Ph-H), 6.92 (IH, t, J 7.6, Ph-H), 7.23 (2H, t, J 7.6, Ph-H), 7.37 (5H, br s, CH2Ph-
H), 8.21 (IH, br s, NH); oc (100 MHz; CDCI)) 18.0 (CH3), 49.2 (CH), 67.3 (CH2), 
112.9 (Ph-C), 113.5 (Ph-C), 121.3 (Ph-C), 128.2 (Ph-C), 128.4 (Ph-C), 128.6 (Ph-C), 
129.2 (Ph-C), 129.6 (Ph-C), 147.6 (C=O), 172.4 (C=O) 
N-tert-Butyloxycarbonyl-L-alanine N2 -phenylhydrazide [56] 59 
""Ye"'" 
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/NHPh 
HN 
NHBoc NHBoc 
To a solution of L-N-tert-butyloxycarbonylalanine (3.25 g, 17.15 mmol) in DMF (40 
ml) was added 1-hydroxybenzotriazole (3.08 g, 22.80 mmol, 1.3 eq) followed by EDCI 
(3.60 g, 18.78 mmol, 1.1 eq). The reaction mixture was stirred for 2h at room 
temperature before being slowly added to a solution of phenylhydrazine (3,12 g, 2.9 ml, 
29.47 mmol, 1.7 eq) in DMF (20 ml) at 0 °C. After 0.5h, water (40 ml) was added and 
the organic phase was extracted with ethyl acetate ( 40 ml). The organic phases were 
combined, washed with saturated sodium hydrogen carbonate ( 40 ml), dried over 
magnesium sulfate, filtered and concentrated under reduced pressure to give an orange 
solid. This was recrystallised from dichloromethanelhexane to yield the title compound 
as a white solid (2.7 g, 56%); mp 148-150 °C (lit.75 151-152 °C); [a]0 = -46.8 ( c 1.17, 
CHCI)); oH (400 MHz; CDCI)) 1.41 (3H, d, J 6.8, CH3CH), 1.48 (9H, s, C(CH3)J), 4.25 
(IH, br s, CH3CH),6.06 (IH, br s, NH), 6.82 (2H, d, J 7.6, Ph-H), 6.89 (IH, t ,J 7.6, Ph-
H), 7.22 (2H, t, J 7.2, Ph-H), 8.33 (IH, br s, NH); oc (100 MHz; CDCI)) 17.7 (CH3), 
28.3 (C(CH3)3), 48.6 (CH), 113.6 (Ph-C), 121.2 (Ph-C), 129.2 (Ph-C), 147.7 (Ph-C), 
155.8 (C=O), 172.7 (C=O) 
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5-(1-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid ethyl ester [48] 
NHPh .rJ' NHPh •Y(----~yla-~Me 
C02Et 
NHBoc NHBoc NHBoc 
To a solution ofN-tert-butyloxycarbonyl-L-alanine N2-phenylhydrazide (0.56 g, 2.02 
mmol) in dry acetonitrile (20 ml) under nitrogen was added triphenylphosphine (2.53 g, 
9.65 mmol, 4.8 eq) followed by carbon tetrachloride (1.594g, 1.0 ml, 10.36 mmol, 5.1 
eq). The reaction mixture was left to stir at room temperature for 17h. Saturated brine 
(20 ml) was added and the organic phase was separated, dried over magnesium sulfate, 
filtered and concentrated under reduced pressure to give an orange oil. This was 
dissolved in ethyl acetate (15 ml) along with ethyl acrylate (2.30g, 2.5 ml, 22.92 mmol, 
11.3 eq). Triethylamine (5.08g, 7.0 m!, 50.22 mmol, 24.9 eq) was added and the 
reaction mixture was stirred at 70 oc for 20h. After this period the reaction mixture was 
filtered and the filtrate concentrated under reduced pressure to give an orange oil which 
was purified by column chromatography on silica gel, eluting with light petroleum : 
ethyl acetate (7: I v/v) to yield the title compound as an orange solid (0.22g, 31 %). The 
products was given as an inseperable mixture of diastereoisomers (I: I). 
NMR Data consistent with those of 48 listed earlier. 
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[1-(5-Dimetbylcarbamoyl-1-pbenyl-4,5-dihydro-1H-pyrazol-3-yl)etbyl)carbamic 
acid tert-butyl ester [59) 
/NHPh yl, 0 
NHBoc 
NHBoc NMe2 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(2.64 g, 10.04 mmol) in ethyl acetate (25 ml) at 60 oc was added N-chlorosuccinimide 
(1.61 g, 12.06 mmol, 1.2 eq). The reaction mixture was left to stir for !h. N-
Dimethylacrylamide (1.92 g, 2.0 ml, 19.41 mmol, 1.9 eq), potassium hydrogen 
carbonate (5.06 g, 50.54 mmol, 5.0 eq) and a few drops of water were added and the 
reaction mixture was left to stir at 70 oc for 20h. The reaction mixture was filtered and 
the filtrate concentrated under reduced pressure to give an orange oil, which was 
purified by column chromatography on silica gel eluting with light petroleum : ethyl 
acetate (1:1 v/v) to yield the title compound (2.1 g, 58%) as an orange oily solid which 
was an inseperable mixture of diastereoisomers (I :I); OH ( 400 MHz; CDCh) 1.38 (12H, 
br s, CH3CH & C(CH3)3), 2.94 & 3.00 (6H, s, N(CH3)2), 4.42 (IH, br s, CHCH3), 4.71 
(IH, m, CH), 5.17 (IH, br s, NH), 6.75 (IH, q, J 5.2, Ph-H), 6.86 (IH, t, J 8, Ph-H), 
7.09 (IH, d, J 8.8, Ph-H), 7.15 (2H, t, J 8.4, Ph-H); oc(IOO MHz; CDCh) 19.1 (CH3); 
28.4 (C(CH3)J}, 35.6 (NCH3), 37.4 (NCHJ), 38.8 (CH2), 46.1 (CH), 62.1 (CH), 112.7 
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(Ph-C), 113.8 (Ph-C), 119.5 (Ph-C), 128.9 (Ph-C), 129.3 (Ph-C), 145.3 (C=N), 166.6 
(C=O), 170.5 (C=O); Vmax (CHCh)/cm·1 3305 (NH), 2976 (aliphatic CH), 1708 (ester 
C=O), 1655 (amide C=O), 1599 & 1503 (arene C~C), 1171 (ester C-0); mlz (EI) M 
360.2168 (C19H28N403 requires 360.2161), 302 (24), 257 (21), 243 (22), 232 (41), 205 
(26), 172 (29), 171 (I 00), 57 (31) 
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L- Proline methyl ester hydrochloride [60] 
To a solution ofL--proline (3.31 g, 28.73 mmol) in methanol (50 ml) was added thionyl 
chloride (5.21 g, 3.2 ml, 43.86 mmol, 1.5 eq) dropwise at 0 °C. After complete addition, 
the reaction mixture was stirred at room temperature for 4 h. Excess methanol was 
removed under reduced pressure. The residue was treated with ether (20 ml) and 
concentrated under reduced pressure to yield the title compound as a pale yellow oil 
(4.7 g, 100%). [a]0 = -34.0 ( c 1.11, MeOH), (lie4 = -33.0 (c 1.00 H20)); oH (400 MHz; 
s, C02CH3), 9.19 (IH, s, CHC02CH3), 10.59 (IH, s, NH); &c(100 MHz; DMSO) 23.08 
(CH2CH2), 29.94 (CH), 45.04 (CH3), 58.54 (CH2), 170.24 (C=O); Ymax (CHCh)/cm"1 
3337 (NH), 2952 (aliphatic CH), 1749 (ester C=O), 1174 (C-O). 
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N-Acryloyi-L-proline methyl ester [61] 61 
C02 Me 
To a solution of L-proline methyl ester hydrochloride (4.41 g, 6.64 mmol), 
triethylamine (5.39 g, 7.42 m!, 53.28 mmol, 2 eq) and DMAP (0.65 g, 5.32 mmol, 0.8 
eq) in dichloromethane (lOO m!) at 0 °C, was added acryloyl chloride (2.89 g, 2.60 m!, 
31.93 mmol, 1.2 eq). The mixture was stirred at room temperature for 19.5 h and then 
washed with !M HCI (3 x 50 m!) followed by IM NaHC03 (3 x 50 m!). The organic 
layers were combined, dried over MgS04 and concentrated under reduced pressure to 
give a pale yellow oil. This was purified by column chromatography on silica gel 
eluting with ethyl acetate: acetone (2:1 v/v) to give a colourless oil (2.08 g, 43%). [a]o 
= -30.4 (c 1.23 CHCh); OH (400 MHz; CHCh) 2.04 - 2.25 (4H, m, CH2CH2), 3.61 -
3.80 (2H, m, NCHz) 4.55 (IH, dd, J 3.6 & 8.4, CHC02CH3); Rotational isomer A 3.74 
(3H. s, C02CH3), 5.67 (IH, dd, J 2.4 & 10, CH), 6.26 (IH, dd, J 10 & 16.4, CH), 6.37 
(IH, dd, J 2 & 16.4, CH); Rotational isomer B 3.75 (3H, s, C02CH3), 5.72 (IH, dd, J 
2.4 & 10, CH), 6.38 (IH, dd, J 2.4 & 16.8, CH), 6.49 (IH, dd, J 10.4 & 16.8, CH); Be 
(100 MHz; CDCh) 24.7 (CHz), 29.1 (CHz), 46.4 (CH2), 52.1 (CH3), 58.8 (CH), 128.3 
(CHz), 128.0 (CH), 164.4 (C=O), 172.5 (C=O); Vmax (CHCh)/cm·l 3467 (NH), 2953, 
2880 (aliphatic CH), 1741 (ester C=O), 1643 (amide C=O), 1197 (C-O). 
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1-[5-(l-tert-Butoxycarbonylaminoetbyl)-2-pbenyl-3,4-dibydro-2H-pyrazole-3-
carbonyl]pyrrolidine-2-carboxylic acid methyl ester (62] 
/NHPh 
Me~ 1 
~ "c1 
Ph 
I 
N-N 
V 0 
NHBoc 
NHBoc ):) 
Me02C 
To a solution of the hydrazone (0.77 g, 2.92 mmol) in ethyl acetate (15 ml) at 60 cc 
was added N-chlorosuccinimide (0.42 g, 3.14 mmol, 1.1 eq). The reaction mixture was 
left to stir for Ih. N-Acryloyl-L-proline methyl ester (1.08 g, 5.88 mmol, 2.0 eq), 
potassium hydrogen carbonate (1.48 g, 14.78 mmol, 5.1 eq) and a few drops of water 
were added and the reaction mixture was left to stir at 70 cc for 20h. The reaction 
mixture was filtered and the filtrate concentrated under reduced pressure to give an 
orange oil, which was purified by column chromatography on silica gel eluting with 
light petroleum: ethyl acetate (2:1 v/v) to yield the title compound (0.20 g, 15%) as a 
yellow oil which was an inseperable mixture of diastereoisomers (I: I). OH ( 400 MHz; 
CHCb) 1.35- 1.40 (13H, m, C(CH3) 3 & CH2CH2), 1.37 (3H, d, J 6.8, CHCHJ), 2.94 
(IH, dd, J 9.2 & 17.6, CH), 3.00 (IH, dd, J 9.6 & 18, CH), 3.32 (IH, dd, J 12.8 & 17.6, 
CH), 3.50- 3.58 (3H, m , CHC02CH3 & CH2), 3.63 (3H, s, C02CH3), 4.46- 4.50 (IH, 
m, CHCH3), 4.60 (IH, dd, J 9.6 & 16, CH), 4.61 (IH, dd, J 9.2 & 15.2, CH), 4.94 (IH, 
br s, NH), 6.78-6.81 (IH, m, Ph-H), 6.88-6.96 (2H, m, Ph-H), 7.13-7.18 (2H, m, 
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Ph-H); l>c(IOO MHz; CHCh) 24.7 (CHz), 28.2 (CH3), 28.4 (C(CH3)J), 29.3 (CHz), 46.3 
(CH), 46.8 (CHz), 48.6 (CHz), 52.4 (CH3), 58.9 (CH), 59.7 (CH), 122.9 (Ph-C), 124.4 
(Ph-C), 127.7 (Ph-C), 129.2 (Ph-C), 137.1 (C=N), 160.9 (C=O), 171.9 (C=O); Vmax 
(CHCh)/cm·1 3433 (NH), 2977, 2879 (aliphatic CH), 1743, 1702 (ester C=O), 1656 
(amide C=O), 1173 (C-0) 1051 (C-0); mlz (FAB) M 444.2367 (Cz3H32N40s requires 
444.2373), 328 (65), 232 (52), 172 (21 ), 171 (100), 57 (16) 
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N-tert-Butyloxycarbonylglycine methyl ester [69]'6 
To glycine methyl ester hydrochloride (5.00 g, 39.86 mmol) in dichloromethane (180 
ml) at 0 °C, di-tert-butyl dicarbonate (9.09 g, 41.65 mmol, 1.0 eq) was added. The 
mixture was stirred for 15min before triethylamine (7 .95 g, 11.0 m!, 78.57 mmol, 2.0 
eq) was added and the reaction mixture stirred for 17h. The mixture was then washed 
with citric acid solution (2M, 2 x 75 ml) and saturated brine (2 x 75 ml), then dried over 
magnesium sulfate and concentrated under reduced pressure to yield a clear oil (7.3 g, 
81%). oH(400 MHz; CHCh) 1.38 (9H, s, C(CH3)J), 3.68 (3H, s, C02CH3), 3.85 (2H, d, 
J 5.2, CHz), 5.03 (IH, br s, NH); Be (100 MHz; CDCh) 28.2 (C(CH3)J), 42.3 (CHz), 
52.2 (CH3), 155.9 (C=O), 171.0 (C=O); Ymax (CHCh)/cm·1 3371 (NH), 2978, 2935 
(aliphatic CH), 1701, 1755 (ester C=O), 1369 (ester C-0) 
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L-N-tert-Butyloxycarbonylvaline methyl ester [63]'6 
NHBoc 
To L-valine methyl ester hydrochloride (5.00 g, 29.84 mmol) in dichloromethane (I 80 
m!) at 0 °C, di-tert-butyl dicarbonate (6.89 g, 31.57 mmol, 1.1 eq) was added. The 
mixture was stirred for 15min before triethylamine (5.78 g, 8.0 m!, 57.22 mmol, 1.9 eq) 
was added and the reaction mixture stirred for I 7h. The mixture was then washed with 
citric acid solution (2M, 2 x 75 m!) and saturated brine (2 x 75 m!), then dried over 
magnesium sulfate and concentrated under reduced pressure to yield a clear oil (6.2 g, 
78%). [a]o = 184.71 ( c 1.57, CHCh); liH (400 MHz; CHCh) 0.85 (7H, dd, J 6.8 & 
26.4, CH(CH3)2), 1.38 (9H, s, C(CH3)3), 3.67 (3H, s, COzCH3), 4.14- 4.17 (IH, m, 
CHCH(CHJ)z), 4.97 (IH, br s, NH); lie (100 MHz; CDCh) 28.3 (C(CH3)J), 31.1 
(CH(CH3)z), 52.0 (CH3) 79.7 (CH), 146.8 (CH), 155.7 (C=O), 172.9 (C=O); Ymax 
(CHCh)lcm·1 3367 (NH), 2970, 2935, 2877 (aliphatic CH), 1742, 1743 (ester C=O), 
1369 (ester C-0). 
N-tert-butyloxycarbonyl ethanal (70]77 
(CHO 
NHBoc 
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To N-tert-butyloxycarbonylglycine methyl ester (3.99 g, 17.71 mmol) in dry toluene 
(60 ml) at -78 °C under nitrogen was added dropwise with stirring, over lh, DIBAL-H 
(I.OM in toluene, 44.28 ml, 44.28 mmol, 2.5 eq) with the aid of a syringe pump. After 
the addition the reaction mixture was stirred for a further 0.5h. Methanol (14 ml) was 
added, and the reaction mixture was poured into a solution of Rochelle salt (50 g) in 
water (200 ml), and stirred vigorously for 1.5h. The aqueous phase was separated and 
extracted with ethyl acetate (3 x I 00 ml). The organic layers were then combined and 
washed with saturated brine (3 x I 00 m!), dried over magnesium sui fate and 
concentrated under reduced pressure to yield a colourless oil (3.4 g, 98%) that was used 
without further purification. 8H ( 400 MHz; CDCI)) 1.38 (9H, s, C(CH3)3), 3.98 (2H, d, J 
5.1, CH2), 9.56 (IH, s, CHO); 8c(IOO MHz; CDCI)) 28.4 (C(CH3)3), 51.3 (CH2), 171.3 
(C=O), 197.5 (C=O); Vmax (CHCI))/cm"1 3356 (NH), 2978, 2931 (aliphatic CH), 1613 
(aldehyde C=O), 1519 (amide C=O), 1369 (ester C-0) 
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L-3-(N-Benzyloxycarbonylamino)methyl butanal [65]'8 
CHO 
NHBoc NHBoc 
To L-N-tert-butyloxycarbonylvaline methyl ester (2.37 g, 8.86 mmol) in dry toluene 
(30 ml) at -78 oc under nitrogen was added dropwise with stirring, over lh, DIBAL-H 
(I.OM in toluene, 22.00 ml, 22.00 mmol, 2.5 eq) with the aid of a syringe pump. After 
the addition the reaction mixture was stirred for a further 0.5h. Methanol (7 m!) was 
added, and the reaction mixture was poured into a solution of Rochelle salt (25 g) in 
water (I 00 ml), and stirred vigorously for 1.5h. The aqueous phase was separated and 
extracted with ethyl acetate (3 x 100 ml). The organic layers were then combined and 
washed with saturated brine (3 x I 00 ml), dried over magnesium sui fate and 
concentrated under reduced pressure to yield a colourless oil (1.6 g, 76%) that was used 
without further purification. OH (400 MHz; CDCI)) 0.86 (3H, d, J 6.8, CH(CH3)z), 0.95 
(3H, d, J 6.8, CH(CH3)2), 1.37 (9H, s, C(CH3)J), 2.22 (IH, m, CHCH(CH3)2), 4.16 (IH, 
m, CHCH(CH3)z), 5.09 (IH, br s, NH), 9.55 (IH, s, CHO); 15c(IOO MHz; CDCh) 19.02 
(CH3), 19.09 (CH3), 21.41 (CH), 28.36 (C(CH3)J), 58.00 (CH), 155.86 (C=O), 200.41 
(C=O); Vmax (thin film)/cm·1 3340 (NH), 2970, 2932, 2877 (aliphatic CH), 1705 
(aldehyde C=O), 1512 (amide C=O), 1366 (ester C-0) 
[2-(Phenylhydrazono)ethyl]carbamic acid tert-butyl ester [71] 
(CHO 
NHBoc 
/NHPh 
N 
I 
H 
NHBoc 
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To phenylhydrazine hydrochloride (3 .40 g, 22.81 mmol, 1.1 eq) and sodium acetate 
(6.98 g, 85.09 mmol, 4 eq) in water, was added N-tert-butyloxycarbonylethanal (4.16 g, 
21.26 mmol) in ethanol (5 m!). The solution was warmed to 70 oc for 10 min and 
cooled in an ice bath. The reaction mixture was then cooled and extracted with 
chloroform (2 x 50 ml). The organic layers were combined and washed with saturated 
brine (2 x 50 ml), dried over MgS04 and concentrated under reduced pressure to give 
an orange oil. This was purified by column chromatography on silica gel eluting with 
light petroleum: ethyl acetate (3:1) to give the desired product as an orange oil (3.19 g, 
81%); 5H(400 MHz; CDCI)) 1.40 (9H, s, C(CH3)J), 3.90 (2H, br s, CH2), 5.02 (IH, br s, 
NH), 6.74-6.77 (2H, m, Ph-H), 6.90-6.92 (IH, m, Ph-H), 6.99 (IH, br s, CH), 7.15-
7.19 (2H, m, Ph-H), 7.35 (IH, br s, NH); 5c (100 MHz; CHCI)) 28.2 (C(CH3)3), 45.7 
(CH2), 112.7 (Ph-C), 120.0 (Ph-C), 121.3 (Ph-C), 127.8 (Ph-C), 129.2 (Ph-C), 147.6 
(C=N); Vmax (CHCI))/cm·1 3418 (NH), 2976 (aliphatic CH), 1693 (amide C=O), 1601 
(NH), 1166 (C-0); mlz (FAB) M 249.1473 (C13H19N30 2 requires 249.1478), 194 (21), 
!93 (27), 133 (35), 93 (25), 57 (I 00) 
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L-[2-Methyl-1-(phenylhydrazonomethyl)propyl]carbamic acid tert-butyl ester [66] 
CHO 
NHBoc NHBoc 
To phenylhydrazine hydrochloride (1.16 g, 8.02 mmol, 1.2 eq) and sodium acetate 
(2.24 g, 27.36 mmol, 3.4 eq) in water, was added L-3-(N-
benzyloxycarbonylamino)methyl butanal (1.60 g, 6.73 mmol) that was dissolved in 
ethanol (5 ml). The solution was warmed to 70 oc for IOmin and cooled in an ice bath. 
The resulting precipitate was filtered and dried to give an orange solid (1.92 g, 96%) 
that was used without further purification; mp 152.5- 153.5 °C; [a] 0 = -60.3 ( c 1.04, 
CHCl3); OH (400 MHz; CDCh) 0.88 (6H, dd, J 2.0 & 7.2, CH(CH3)2), 1.40 (9H, s, 
C(CH3)J), 2.06 (IH, m, CHCH(CH3)2), 4.12 (IH, m, CHCH(CH3)2), 5.13 (IH, br s, 
NH), 6.77 (IH, t, J 7.2, Ph-H), 6.92 (2H, d, J 7.2, Ph-H), 6.99 (IH, br s, CH), 7.17 (2H, 
t, J 7.6, Ph-H), 7.38 (IH, br s, NH); oc (100 MHz; CDCh) 17.6 & 18.8 (CH(CH3)2), 
28.4 (C(CH3)J), 50.8 (CH(CH3)2), I 12.6 (Ph-C), 119.8 (Ph-C), 119.9 (Ph-C), 129.2 (Ph-
C), 129.2 (Ph-C), 138.1 (CH), 145.0 (C=N), 155.8 (C=O); Vmax (CHCh)/cm"1 3290 
(NH), 2965 (aliphatic CH), 1697 (ester C=O), 1602 & 1495 (arene C=C), 1168 (ester 
C-0); mlz (FAB) M 291.1949 (C16H25N202 requires 291.1947), 291 (42), 236 (57), 235 
(lOO), 192 (41), 175 (98), 93 (30), 92 (24), 57 (51) 
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5-(tert-Butoxycarbonylaminomethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid ethyl ester [72] 
N 
/NHPh 
N 
/NHPh f, f" 0 
NHBoc NHBoc OEt NHBoc 
To a solution of the L-[1-Methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl 
ester (1.23 g, 4.93 mmol) in ethyl acetate (15 ml) at 60 oc was added N-
chlorosuccinimide (0. 71 g, 5.32 mmol, 1.1 eq). The reaction mixture was left to stir for 
!h. Ethyl acrylate (0.92 g, 1.0 ml, 9.19 mmol, 1.9 eq}, potassium hydrogen carbonate 
(2.42 g, 24.17 mmol, 4.9 eq) and a few drops of water were added and the reaction 
mixture was left to stir at 70 oc for 20h. The reaction mixture was filtered and the 
filtrate concentrated under reduced pressure to give an orange oil, which was purified 
by column chromatography on silica gel eluting with light petroleum: ethyl acetate (7:1 
v/v) to yield the title compound (0.13 g, 8%) as an orange oil which was an inseperable 
mixture of diastereoisomers (1:1); 8H (400 MHz; CDCh) 1.16 (3H, t, J 6.8, 
COzCHzCH3), 1.39 (9H, s, C(CHJ)J}, 2.99 (IH, dd, J 7.2 & 17.6, CH), 3.25 (IH, dd, J 
12.4 & 17.6, CH), 4.02 (2H, d, J 5.6, CHz), 4.14 (2H, q, J 7.2, COzCH2CH3), 4.54 (IH, 
dd, J 7.2 & 12.4, CH), 4.57 (IH, dd, J 7.2 & 12.4, CH), 4.97 (IH, br s, NH), 6.79 (IH, t, 
J 7.6, Ph-H), 6.92 (2H, d, J 8.0, Ph-H), 7.16-7.20 (2H, m, Ph-H); 8c(IOO MHz; CDCh) 
14.1 (CHCH3), 28.2 (C(CH3)3), 39.9 (CHz}, 39.3 (CH), 40.0 (CH), 61.8 (CHz), 62.1 
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(CH), 113.0 (Ph-C), 119.8 (Ph-C), 126.0 (Ph-C), 128.6 (Ph-C), 129.1 (Ph-C), 145.2 
(C=N), 155.6 (C=O), 171.5 (C=O); Vmax (CHCI))/cm·1 3355 (NH), 2976 (aliphatic CH), 
1700 (ester C=O), 1501 (arene C=C), 1166 (ester C-0); mlz (FAB) M 347.1849 
(C1sH2sNJ04 requires 347.1845), 347 (43), 292 (45), 291 (41), 290 (26), 231 (100), 157 
(93), 57 (61) 
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5-(1-tert-Butoxycarbonylamino-2-methylpropyl)-2-phenyl-3,4-dihydro-2H-
pyrazole-3-carboxylic acid ethyl ester [67) 
H 
NHBoc NHBoc 
NHBoc 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.41 g, 4.81 mmol) in ethyl acetate (15 ml) at 60 oc was added N-chlorosuccinimide 
(0.73 g, 5.47 mmol, I.I eq). The reaction mixture was left to stir for !h. Ethyl acrylate 
(0.92 g, 1.0 ml, 9.19 mmol, 1.9 eq), potassium hydrogen carbonate (2.44 g, 24.37 
mmol, 5.1 eq) and a few drops of water were added and the reaction mixture was left to 
stir at 70 oc for 20h. The reaction mixture was filtered and the filtrate concentrated 
under reduced pressure to give an orange oil, which was purified by column 
chromatography on silica gel eluting with light petroleum : ethyl acetate (5:1 v/v) to 
yield the title compound (0.37 g, 20%) as an orange oil which was an inseperable 
mixture of diastereoisomers (I:!); Ymax OH (400 MHz; CDCh) 0.94 (6H, br d, J 6.4, 
CH(CH3)2), 1.02 (3H, t, J 6.8, C02CH2CH3), 1.46 (9H, s, C(CH3)3), 2.05 (IH, m, 
CH(CH3)2), 3.03 (IH, dd, J 6.8 & 17.6, CH), 3.28 (IH, dd, 12.4 & 18, CH), 4.20 (2H, 
q, J 7.2, C02CH2CH3), 4.50 (IH, br s, CHCH(CH3)2), 4.61 (IH, dd, J 6.8 & 12.4, CH), 
4.62 (IH, dd, J 6.4 & 12.4, CH), 6.85 (IH, t, J 7.2, Ph-H), 7.00 (2H, d, J 7.6, Ph-H), 
7.25 (2H, t, J 7,2, Ph-H); lie (100 MHz; CDCh) 14.1 (CH3), 19.5 ((CH3)2), 28.2 
(C(CH3)3), 28.4 (CHCH3), 61.7 (CH2), 61.8 (CH), 62.0 (CH), I 13.1 (Ph-C), I 19.7 (Ph-
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C), 129.1 (Ph-C), 145.4 (C=N), 171.5 (C=O); (CHCh)/cm·1 3345 (NH), 2974 (aliphatic 
CH), 1701 (ester C=O), 1600 & 1501 (arene C=C), 1168 (ester C-0); m/z (FAB) M 
389.2312 (C21H3INJ04 requires 389.2315), 389 (21), 316 (32), 273 (75), 260 (70), 246 
(26), 199 (I 00), 57 ( 46) 
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5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3-
carboxylic acid tert-butyl ester [73] 
/NHPh 
yl" 
/NHPh 
,l 
~ "c1 C021Bu 
NHBoc NHBoc 
NHBoc 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.29 g, 4.92 mmol) in ethyl acetate (15 ml) at 60 oc was added N-chlorosuccinimide 
(0.76 g, 5.69 mmol, 1.2 eq). The reaction mixture was left to stir for Ih. tert- Butyl 
acrylate (1.14 g, 1.3 ml, 8.89 mmol, 1.8 eq), potassium hydrogen carbonate (2.43 g, 
24.27 mmol, 4.9 eq) and a few drops of water were added and the reaction mixture was 
left to stir at 70 oc for 20h. The reaction mixture was filtered and the filtrate 
concentrated under reduced pressure to give an orange oil, which was purified by 
column chromatography on silica gel eluting with light petroleum : ethyl acetate (6:1 
v/v) to yield the title compound (0.52 g, 27%) as an orange solid which was an 
inseperable mixture of diastereoisomers (1:1); mp 85.5 - 88.3 °C; OH (400 MHz; 
CDCh) 1.32 & 1.33 (9H, s, C(CH3)J), 1.39 (12H, br s, CHCH3 & C(CH3)J), 3.20 (IH, 
dd,J 12.4 & 16.8, CH), 4.46 (2H, m, CHCH3 & CH), 5.13 (IH, brs, Nil), 6.77 (IH, t, J 
7.6, Ph-H), 6.86 (IH, d, J 9.2, Ph-H), 6.94 (IH, d, J 8, Ph-H), 7.17 (2H, t, J 7.2, Ph-H); 
lie (100 MHz; CDCh) 27.5 (CH3), 27.9 (C(CH3)J), 28.4 (C(CHJ)J), 62.8 (CH), 63.0 
(CH), 113.1 (Ph-C), 114.2 (Ph-C), 128.9 (Ph-C), 129.0 (Ph-C), 145.4 (C=N), 155.2 
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(C=O), 170.5 (C=O); Vmax (CHCh)/cm·1 3416 (NH), 2976 (aliphatic CH), 1701 (ester 
C=O), 1600 (NH), 1499 (arene C=C), I 152 (ester C-0); mlz (FAB) M 389.2312 
(Cz1H31N304 requires 389.2315), 288 (24), 266 (32), 251 (35), 232 (88), 217 (85), 205 
(42), 171 (100), 57 (40) 
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5-(1-tert-Butoxycarbonylaminoethyl)-3-methyl-2-phenyl-3,4-dihydro-2H-pyrazole-
3-carboxylic acid tert-butyl ester [74] 
/NHPh yl, /NHPh yl" co21Bu 
NHBoc NHBoc 
NHBoc 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.30 g, 4.92 mmol) in ethyl acetate (15 ml) at 60 oc was added N-chlorosuccinimide 
(0.74 g, 5.54 mmol, 1.1 eq). The reaction mixture was left to stir for lh. tert-Butyl 
methacrylate (1.40 g, 1.6 ml, 9.85 mmol, 2.0 eq), potassium hydrogen carbonate (2.42 
g, 24.17 mmol, 4.9 eq) and a few drops of water were added and the reaction mixture 
was left to stir at 70 oc for 20h. The reaction mixture was filtered and the filtrate 
concentrated under reduced pressure to give an orange oil, which was purified by 
column chromatography on silica gel eluting with light petroleum : ethyl acetate (5:1 
v/v) to yield the title compound (0.50 g, 25%) as an orange solid which was an 
inseperable mixture of diastereoisomers (1:1); mp 109.3 - 112.7 °C; ()H (400 MHz; 
CDCh) 1'1 diastereoisomer 1.36 (9H, d, J 3.6 C02C(CHJ)J), 1.47 (9H, d, J 1.2 
C(CH3)3), 1.53 (3H, d, J 5.6, CHCH3), 4.47 (IH, br s, CHCH3); 2"d diastereoisomer 
1.47 (9H, d, J 3.6, C(CH3)3), 1.53 (3H, d, J 7.2, CHCH3) 4.49 (IH, br s, CHCH3); both 
diastereoisomers 2.86 ( IH, dd, J 3.2 & 17.2, CH), 3.31 (IH, dd, J 4 & 17.2, CH), 6.85 
(IH, t, J 7,2, Ph-H), 6.96 (IH, d, J 6.8, Ph-H), 7.03 (1H, d, J 8, Ph-H), 7.16 (1H, d, J 
9.2, Ph-H), 7.21 (IH, tJ 7.2, Ph-H); 1ic(100 MHz; CDCh) 19.3 (CH3), 21.2 (CHJ), 27.7 
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(C(CH3)3), 28.4 (C(CH3)3), 39.5 (CH2), 46.1 (CH), 50.1 (CH), 114.8 (Ph-C), 115.7 (Ph-
C), 120.0 (Ph-C), 124.6 (Ph-C), 144.3 (C=N), 155.3 (C=O), 172.1 (C=O); Vmax 
(CHCh)/cm·1 3375 (NH), 2977 (aliphatic CH), 1718 (ester C=O), 1598 & 1496 (arene 
C=C), 1166 (ester C-0); mlz (FAB) M 403.2466 (C22H33N304 requires 403.2471), 403 
(26), 302 (35), 280 (44), 265 (36), 246 (91), 231 (70), 219 (53), 185 (100), 57 (29) 
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5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-3,4-dihydro-2H-pyrazole-3,4-
dicarboxylic acid dimethyl ester (75) 
/NHPh yl, co2Me 
NHBoc 
C02 Me 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.30 g, 4.94 mmol) in ethyl acetate (15 ml) at 60 oc was added N-chlorosuccinimide 
(0.74 g, 5.54 mmol, 1.1 eq). The reaction mixture was left to stir for !h. Dimethyl 
fumarate (1.40 g, 9.71 mmol, 2.0 eq), potassium hydrogen carbonate (2.44 g, 24.37 
mmol, 4.9 eq) and a few drops of water were added and the reaction mixture was left to 
stir at 70 oc for 20h. The reaction mixture was filtered and the filtrate concentrated 
under reduced pressure to give an orange oil, which was purified by column 
chromatography on silica gel eluting with light petroleum : ethyl acetate (5: I v/v) to 
,yield the title compound (0.25 g, 12%) as an orange oil which was an inseperable 
mixture of diastereoisomers (1:1); ()H (400 MHz; CDCh) 1.39 (12H, br s, CHCH3 & 
C(CH3)J), 3.70 (3H, s, COzCH3), 3.73 (3H, s, C02CH3), 4.14 (IH, dd, J 2.8 & 10.4, 
CH), 4.61 (IH;m, CHCH3), 4.98 (IH, dd, J 7.2 & 10.4, CH), 6.83 (IH, t, J 7.2, Ph-H), 
6.90 (IH, d, J 9.2, Ph-H), 6.97 (IH, d, J 8.0, Ph-H), 7.14 (IH, d, J 8.8, Ph-H), 7.20 (IH, 
t, J 8.4, Ph-H); <>c (100 MHz; CDCh) 20.1 (CH3), 28.3 (C(CH3)3), 46.1 (CH), 49.7 
(CHz), 53.1 (CH3), 53.2 (CH3), 56.5 (CH), 65.6 (CH), 113.4 (Ph-C), 114.6 (Ph-C), 
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120.6 (Ph-C), 129.1 (Ph-C), 143.1 (C=N), 168.4 (C=0),170.1 (C=O), 170.4 (C=O); . 
Ymax (CHCI))/cm·1 3403 (NH), 2977 (aliphatic CH), 1741 (ester C=O), 1716 (ester 
C=O), 1598 (NH), 1497 (arene C=C), 1167 (ester C-0); mlz (FAB) M+ 406.1972 
(C2oH2sN306 requires 406.1978), 324 (31), 323 (46), 290 (63), 289 (100), 263 (40), 229 
(69), 197 (33), 57 (33) 
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(S)-5-(1-tert-Butoxycarbonylaminoethyl)-2-phenyl-2H-pyrazole-3-carboxylic acid 
methyl ester [76) 
/NHPh yl, /NHPh yla 
NHBoc NHBoc 
NHBoc 
To a solution of L-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(0.70 g, 2.65 mmol) in ethyl acetate (10 ml) at 60 oc was added N-chlorosuccinimide 
(0.40 g, 3.00 mmol, 1.1 eq). The reaction mixture was left to stir for !h. Methyl 
propiolate (0.5 g, 0.5 m!, 5.95 mmol, 2.2 eq), potassium hydrogen carbonate (1.37 g, 
13.68 mmol, 5.2 eq) and a few drops of water were added and the reaction mixture was 
left to stir at 70 oc for 20h. The reaction mixture was filtered and the filtrate 
concentrated under reduced pressure to give an orange oil, which was purified by 
column chromatography on silica gel eluting with light petroleum : ethyl acetate (7: I 
v/v) to yield the title compound (0.21 g, 25%) as an orange oil; [a]0 = -43.5 (c 1.15, 
MeOH); OH (400 MHz; CDCh) 1.38 (9H, s, C(CH3)J), 1.46 (3H, d, J 6.8, CHCH3), 3.71 
(3H, s, C02CH2CH3), 4.86 (IH, br s, CHCH3), 5.09 (IH, br s, NH), 6.84 (IH, s, CH), 
7.33-7.41 (5H, m, Ph-H); Be (lOO MHz; CDCb) 21.8 (CH3), 28.2 (C(CH3)3), 45.0 (CH), 
52.1 (C02CH3), 110.0 (CH), 126.0 (Ph-C), 128.6 (Ph-C), 128.7 (Ph-C), 133.6 (C), 
140.1 (C=N), 155.2 (C=O), 159.3 (C=O); Ymax (CHCI))/cm·1 3349 (NH), 2975 
(aliphatic CH), 1717 (ester C=O), 1597 & 1499 (arene C=C), 1237 & 1167 (C-0); mlz 
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(El) M 345.1644 (CtsH23N304 requires 345.1688), 289 (100), 244 (62), 230 (64), 57 
(44) 
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(S)-5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyi-2H-pyrazole-3-carboxylic acid 
methyl ester [76] 
/NHPh 
N 
I 
Cl 
NHBoc 
NHBoc 
A solution of the hydrazonyl chloride 52 (1.41 g, 3.96 mmol), methyl propiolate (1.0 g, 
1.0 ml, 11.89 mmol, 3.0 eq) and tetrahexylammonium chloride (0.15 g, 0.36 mmol, 0.1 
eq) in sodium hydrogen carbonate (O.IM, 20 ml) was stirred for 20h. The reaction 
mixture was then taken up in dichloromethane (75 ml) and washed with water (100 ml), 
dried over sodium sulfate and concentrated under reduced pressure to give an orange 
oil. This was purified by column chromatography on silica gel eluting with light 
petroleum :ethyl acetate (2:1 v/v) to give an orange oil (0.54 g, 40 %); oH (400 MHz; 
CDCh) 1.38 (9H, s, C(CH3)3), 1.46 (3H, d, J 6.4, CHCH3), 3.71 (3H, s, C02CH3), 4.85 
(lH, br s, CHCH3), 5.23 (IH, br s, NH), 6.84 (IH, s, CH), 7.33 -7.40 (5H, m, Ph-H) 
NMR Data are consistent with those of 76 listed above. 
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(DL)-N-tert-Butyloxycarbonylalanine methyl ester [78]'9 
To Dlr-alanine methyl ester hydrochloride (10.00 g, 71.67 mmol) in dichloromethane 
(360 m!) at 0 °C, di-tert-butyl dicarbonate (IS.60 g, 71.48 mmol, 1.0 eq) was added. 
The mixture was stirred for !Smin before triethylamine (14.S2 g, 20.0 m!, 143.49 
mmol, 2.0 eq) was added and the reaction mixture stirred for 17h. The mixture was then 
washed with citric acid solution (2M, 2 x ISO ml) and saturated brine (2 x ISO m!), then 
dried over magnesium sulfate and concentrated under reduced pressure to yield a clear 
oil (14.6 g, 90 %). OH (400 MHz; CDCh) 1.32 (3H, d, J 7.2, CHCH3), 1.38 (9H, s, 
C(CH3)3), 3.68 (3H, s, C02CH3), 4.2S (IH, m, CHCH3), S.18 (IH, br s, NH); Be (100 
MHz; CDCI3) 18.5 (CH3), 28.S (C(CH3)3), S2.3 (CH3), 79.7 (CH), 1SS.S (C=O), 174.0 
(C=O); Ymax (CHCh)/cm·1 3363 (NH), 2940, 2882, (aliphatic CH), 1728 (amide C=O), 
1689 (ester C=O), !36S (ester C-0) 
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(DL)-2-(N-tert-Butyloxycarbonylamino)propanal [79]80 
YCHO 
NHBoc 
To DL-N-tert-butyloxycarbonylalanine methyl ester (2.61 g, 12.84 mmol) in dry 
toluene (30 ml) at -78 oc under nitrogen was added dropwise with stirring, over 1h, 
DIBAL-H (l.OM in toluene, 44.00 ml, 44.00 mmol, 3.4 eq), with the aid of a syringe 
pump. After the addition the reaction mixture was stirred for a further 0.5h. Methanol 
(14 ml) was added, and the reaction mixture was poured into a solution of Rochelle salt 
(25 g) in water (200 ml), and stirred vigorously for 1.5h. The aqueous phase was 
separated and extracted with ethyl acetate (3 x 100 ml). The organic layers were then 
combined and washed with saturated brine (3 x 100 ml), dried over magnesium sulfate 
and concentrated under reduced pressure to yield a colourless oil (2.1 g, 95 %) that was 
used without further purification. OH (400 MHz; CDCh) 1.31 (3H, d, J 7.6, CHCH3), 
1.45 (9H, s, C(CH3)3), 4.20 (1H, br s, CHCH3), 5.33 (IH, br s, NH), 9.54 (IH, s, CHO); 
Be (100 MHz; CDCh) 21.4 (CH3), 28.4 (C(CH3)3), 55.5 (CH), 125.3 (Ph-CH), 128.2 
(Ph-CH), 129.0 (Ph-CH), 137.8 (Ph-C), 155.5 (C=O), 200.0 (CHO); Vmax (CHCI))/cm·1 
3426 (NH), 2934 (aliphatic CH), 1736 (C=O) 
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DL-[1-Methyl-2-(phenylhydrazono)ethyl)carbamic acid tert-butyl ester [80) 
YCHO 
NHBoc 
/NHPh 
N 
I 
H 
NHBoc 
To phenylhydrazine hydrochloride (3.13 g, 21.64 mmol, 1.6 eq) and sodium acetate 
(4.56 g, 55.59 mmol, 4.0 eq) in water, was added DL-[1-methy1-2-
(phenylhydrazono )ethyl] carbamic acid tert-butyl ester (2.40 g, 13.9 mmol) that was 
dissolved in ethanol (5 ml). The solution was warmed to 70 oc for 10min and cooled in 
an ice bath. The resulting precipitate was filtered and dried to give an oily orange solid 
(3.18 g, 88%) that was used without further purification; OH (400 MHz; CDCl3) 1.36 
(3H, d, J 7.2 CHCH3), 1.51 (9H, s, C(CH3)3), 4.50 (IH, br s, CHCH3), 5.24 (IH, br s, 
NH), 6.82-6.89 (2H, m, Ph-H), 7.00-7.02 (IH, m, Ph-H), 7.12 (IH, s, CH), 7.25-7.29 
(2H, m, Ph-H), 7.53 (1H, br s, NH); Be (100 MHz; CDCh) 19.2 (CHCH3), 28.4 
(C(CH3)3), 41.4 (CH), 112.6 (Ph-C), 112.6 (Ph-C), 119.6 (Ph-C), 119.9 (Ph-C), 129.2 
(Ph-C), 139.8 (CH), 145.3 (C=N), 151.1 (C=O); Vmax (CHCh)/cm·1 3410, 3302 (NH), 
2978 (aliphatic CH), 1694 (ester C=O), 1601 (C=N); mlz (El) M 263.1637 (CI4H21N302 
requires 263.1634) 207 (28), 108 (41), 93 (100), 92 (47), 77 (44), 57 (66) 
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5-(1-tert-Butoxycarbonylaminoethyl)-2-phenyi-2H-pyrazole-3-carboxylic acid 
methyl ester [81] 
/NHPh 
y" 
NHBoc 
NHBoc 
To a solution ofDL-[1-methyl-2-(phenylhydrazono)ethyl]carbamic acid tert-butyl ester 
(1.36 g, 4.77 mmol) in ethyl acetate (25 m!) at 60 oc was added N-chlorosuccinimide 
(0.81 g, 6.07 mmol, 1.3 eq). The reaction mixture was left to stir for 1h. Methyl 
propiolate (1.0 g, 1.0 ml, 11.89 mmol, 2.5 eq), potassium hydrogen carbonate (2.62 g, 
26.17 mmol, 5.5 eq) and a few drops of water were added and the reaction mixture was 
left to stir at 70 oc for 20h. The .reaction mixture was filtered and the filtrate 
concentrated under reduced pressure to give an orange oil, which was purified by 
column chromatography on silica gel eluting with light petroleum : ethyl acetate (7: 1 
v/v) to yield the title compound (0.50 g, 30 %) as an orange waxy solid. OH (400 MHz; 
CDCh) 1.38 (9H, s, C(CH3)3), 1.46 (3H, d, J 6.8, CHCH3), 3.71 (3H, s, C02CH3), 4.42 
(IH, br s, CHCH3), 5.10 (IH, br s, NH), 6.84 (1H, s, CH), 7.32-7.39 (5H, m, Ph-H); 
Be (1 00 MHz; CDCh) 21.1 (CHCH3), 28.2 (C(CH3)3), 45.0 (CH), 52.1 (C02CH3), 110.0 
(CH), 126.0 (Ph-C), 128.7 (Ph-C), 133.8 (C), 140.1 (C=N), 155.2 (C=O), 159.5 (C=O); 
Vmax (CHCh)/cm"1 3349 (NH), 2977 (aliphatic CH), 1713 (ester C=O), 1598 & 1500 
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(arene C=C), 1166 (ester C-0); mlz (El) M 345.1644 (C18H23N304 requires 345.1689), 
289 (100), 244 (62), 230 (64), 57 (44) 
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(S)-5-(1-tert-Butoxycarbouylamiuoethyl)-2-phenyi-2H-pyrazole-3-carboxylic acid 
[82] 
NHBoc NHBoc 
(S)-5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyi-2H-pyrazole-3-carboxylic acid 
methyl ester (0.75 g, 2.18 mmol) was stirred at room temperature in a mixture of 
tetrahydrofuran (20 ml) and 2M NaOH (20 ml) for 3 h. After this period aqueous HCI 
was added to pH 3, the mixture was extracted with ethyl acetate (2 x 50 ml) and the 
combined organic layers were washed with water (50 ml). The organic layers were 
dried over sodium sulfate and concentrated under reduced pressure to give the title 
compound as an orange oil (0.70 g, 97 %) that was used without further purification. cSH 
(400 MHz; CDCh) 1.38 (9H, s, C(CH3)3), 1.45 (3H, d, J 6.4, CHCH3), 4.85 (IH, m, 
CHCH3), 6.84 (IH, s, CH), 7.33-7.40 (5H, m, Ph-H); Be (lOO MHz; CDCh) 21.1 (CH3), 
28.4 (C(CH3)J) 44.3 (CH), 114.2 (CH), 126.0 (Ph-C), 128.6 (Ph-C), 128.6 (Ph-H), 
164.8 (C=O), 171.3 (C=O); Vmax (CHCh)/cm'1 3345 (NH), 1666 (C=O), 1652 (C=O), 
1527 (C=N); mlz (El) M 331.1526 (C17H21N304 requires 331.1532), 289 (88), 275 (38), 
244 (67), 230 (100), 216 (31), 77 (25), 57 (67) 
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(S)-{[5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-2H-pyrazole-3-carbonyl]-
amino}acetic acid methyl ester [83) 
C02H 
NHBoc NHBoc 
0 
NH 
~C02 Me 
5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-2H-pyrazole-3-carboxylic acid (0.60 g, 
1.8 I mmol), glycine methyl ester hydrochloride (0.29 g, 2.27 mmol, 1.3 eq) and EDCI 
(0.48 g, 2.50 mmol, 1.4 eq) were dissolved in anhydrous diethyl ether (90 ml), cooled to 
0 oc and stirred for 1 h. The reaction mixture was then warmed to room temperature 
and stirred for a further 1 h. After this period the reaction mixture was again cooled to 
0 oc and Et3N (0.3 ml was added over a period of 0.5 h. When the addition was 
complete the reaction mixture was warmed to room temperature and stirred for a further 
17 h. Water (25 ml) was added to dissolve any precipitated material, the organic layer 
separated and the aqueous extracted with ethyl acetate (2 x 10 ml). The combined 
organic phases were dried over magnesium sulfate, filtered and evaporated to give a 
dark orange residue. The crude product was purified by column chromatography on 
silica gel using hexane and ethyl acetate (1: I v/v) as eluent to give an orange oil (0.33 
g, 46 %); 0H(400 MHz; CDCh) 1.38 (9H, s, C(CHJ)J), 1.46 (3H, d, J 6.8, CHCHJ), 3.71 
(3H, s, C02CH3), 4.12 (2H, s, CH2C02Me), 4.85 (1H, m, CHCH3), 5.09 (IH, br s, NH), 
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6.72 (IH, s, NH), 6.84 (IH, s, CH), 7.33 -7.41 (5H, m, Ph- H); oc (1 00 MHz; CDCh) 
21.3 (CH3), 28.3 (C(CHJ)J), 43.8 (CH), 44.4 (CH2), 52.1 (OCHJ), 119.5 (CH), 126.0 
(Ph-CH), 127.6 (Ph-CH), 128.6 (Ph-CH), 128.8 (Ph-CH), 129.6 (Ph-CH), 133.8 (C), 
140.0 (C=N), 153.8 (C=O), 159.4 (C=O), 168.7 (C=O); Vmax (CHCh)/cm·l 3371, 3330 
(NH), 1756 (amide C=O), 1674 (C=O), 1521 (C=N); mlz (El) M 402.1913 (C2oH26N40s 
requires 402.1903) 
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tert-Butoxycarbonylaminoacetic acid [85)65 
To a solution of glycine (5.1 I g, 68.05 mmol) in 1,4-dioxane, water and !M sodium 
hydroxide (280 m!) (2:1:1 v/v/v) at 0 oc was added di-tert-butyl dicarbonate (14.58 g, 
66.80 mmol, 1.0 eq). The solution was stirred for 90 min at 0 oc then allowed to warm 
to room temperature and stirred for a further 30 min. The reaction mixture was 
concentrated under reduced pressure to approx. 70cm3 then cooled to 0 °C. Ethyl 
acetate was added and the biphasic mixture acidified to pH 3 with a solution of 
potassium hydrogen sulfate (2M). The aqueous layer was separated, then extracted with 
ethyl acetate (2x50cm3). The organic layers were combined, dried over magnesium 
sulfate and concentrated under reduced pressure to give a white solid that was 
recrystallised from hexane: ethyl acetate (1:1 v/v) to give a white solid (7.3 g, 61%); 
mp 90.2- 92.5 °C (Iit65 86-89 °C); I>H (400 MHz; CDCI)) 1.48 (9H, s, C(CH3)3), 3.94 
(IH, s, OH), 3.99 (2H, br s, CH2), 5.06 (IH, br s, NH); l>c (lOO MHz; CDCh) 28.2 
(C(CH3)), 42.2 (CH2), 156.1 (C=O), 174.0 (C=O); Vmax (CHCI))/cm"1 3364 (OH), 2982, 
2936 (aliphatic CH), 1713 (amide C=O), 1694 (C=O), 1527 (NH) 
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(S)-1-(5-Methoxycarbonyl-1-phenyl-1 H -pyrazol-3-yl)ethylammoninm chloride [84) 
NHBoc 
(S)-5-(l-tert-Butoxycarbonylaminoethyl)-2-phenyl-2H-pyrazole-3-carboxylic acid 
methyl ester (0.94 g, 2.72 mmol) was dissolved in dichloromethane (70 ml), 
trifluoroacetic acid (14.0 ml) was added and the reaction mixture was stirred at room 
temperature for 2 h. The solvent was removed under reduced pressure then 2M HCI (20 
ml) was added and the reaction mixture was stirred for 1 h. The solvent was removed 
under reduced pressure. Water (20 ml) and ethyl acetate (20 ml) were added, the two 
phases separated and the aqueous layer collected. The water was removed and the 
residue taken up in toluene (I 0 ml) which was then removed under reduced pressure to 
give a brown solid (0.50 g, 65 %); ()H (400 MHz; d6-DMSO) 1.58 (3H, d, J 6.8, 
CHCH3), 3.85 (3H, s, C02CH3), 4.54 (IH, m, CHCH3), 7.28 (1H, s, CH), 7.46-7.53 
(5H, m, Ph-H), 8.59 (3H, br s, NH3); Be (100 MHz; DMSO) 18.9 (CHJ), 52.3 
(C02CH3), 110.5 (CH), 125.7 (Ph-C), 128.7 (Ph-C), 133.8 (C=O), 140.0 (C=N); Vmax 
(CHCI})/cm·1 3410 (NH), 2924 (aliphatic CH), 1736 (ester C=O), 1389 (ester C-0); 
mlz (El) M (-HCl) 245.1170 (CnHtsN302 requires 245.1164), 231 (15), 230 (100), 77 
(9)~ 
Page 1173 
(S)-5-[1-(2-tert-Butoxycarbonylaminoacetylamino)ethyl]-2-phenyl-2H-pyrazole-3-
carboxylic acid methyl ester [86) 
C02 Me C02Me 
)'" 
BocHN 
(S)- I -(5-Methoxycarbonyl-1-phenyl-IH-pyrazol-3-yl)ethylammonium chloride (0.49 g, 
1.23 mmol) was suspended in DCM (60 ml). Et3N (0.36 g, 0.5 ml, 3.59 mmol, 2.9 eq) 
was added and the reaction mixture was stirred for IO min. Water (50 ml) was added 
and the organic layer was separated, dried over magnesium sulfate and concentrated 
under reduced pressure to give the free amine (0.32 g), which was used immediately in 
the coupling reaction. 
tert-Butoxycarbonylaminoacetic acid (0.29 g, 1.66 mmol, 1.3 eq) and EDCI (0.28 g, 
1.46 mmol, 1.2 eq) were dissolved in anhydrous DCM (30 ml) and stirred at 0 °C for I 0 
min. The free amine (0.32 g, 1.23 mmol) in anhydrous DCM (10 ml) was added and the 
solution was allowed to reach room temperature. The reaction mixture was then stirred 
for a further I9 h. After this period, water (50 ml) was added and the organic layer 
separated. This was dried over magnesium sulfate and concentrated under reduced 
pressure to give a dark orange oil. This was purified by column chromatography in 
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silica gel using hexane : ethyl acetate (I: I v/v) as the eluent to give an orange oil. (0.06 
g, 13 %); [u]o= -52.9 ( c 0.74, CHCl)); liH(400 MHz; CDCl)); 1.35 (9H, s, C(CH3)J), 
1.48 (3H, d, J 6.8, CHCHJ), 3.71 (3H, s, C02CH3), 3.75 (2H, br d, CH2), 5.16 (IH, br s, 
CHCH3), 6.68 (IH, br s, NH), 6.84 (IH, s, CH), 7.32- 7.41 (5H, m, Ph-H); lie (100 
MHz; CDCh) 21.3 (CHJ), 28.3 (C(CHJ)J), 43.8 (CH), 44.5 (CH2), 52.1 (C02CH3), 
110.1 (CH), 126.0 (Ph-C), 128.6 (Ph-C), 128.8 (Ph-C), 133.7 (C), 140.0 (C), 140.0 
(C=N), 153.8 (C=O), 159.4 (C=O), 168.7 (C=O); Vmax (CHCh)/cm·1 3367, 3321 (NH), 
1717 (amide C=O), 1666 (C=O), 1527 (C=N); mlz (El) M 402.1908 (C2oH26N40s 
requires 402.1903), 402 (41), 346 (55), 244 (76), 230 (84), 229 (100), 57 (43) 
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(S)-5-[1-(2-tert-Butoxycarbonylaminoacetylamino)ethyl)-2-phenyi-2H-pyrazole-3-
carboxylic acid [87) 
C02Me co,H 
)'" 
BocHN 
(S)-5-[ 1-(2-tert-Butoxycarbonylaminoacetylamino )ethyl)-2-phenyl-2H-pyrazole-3-
carboxylic acid methyl ester (0.18 g, 0.44 mmol) was stirred at room temperature in a 
mixture of tetrahydrofuran (20 ml) and 2 M NaOH (20 ml) for 3 h. After this period 
aqueous HCl was added to pH 3, the mixture was extracted with ethyl acetate (2 x 50 
ml) and the combined organic layers were washed with water (50 ml). The organic 
layers were dried over sodium sulfate and concentrated under reduced pressure to give 
the title compound as an orange oil (0.12g, 70 %) that was used without further 
purification. oH (400 MHz; CDCh) 1.40 (12H, s, C(CH3)3 & CHCH3), 3.87 (2H, br s, 
CHz), 5.05 (IH, m, CHCH3), 5.36 (IH, br s, NH), 6.84 (IH, s, CH), 7.33-7.40 (5H, m, 
Ph-H); lie (lOO MHz; CDCh) 21.1 (CH3), 28.2 (C(CH3)3), 43.6 (CH), 44.2 (CHz), ll0.1 
(CH), 125.9 (Ph-C), 128.8 (Ph-C), 129.6 (Ph-C), 133.7 (Ph-C), 139.9 (C=C), 153.8 
(C=N), 156.2 (C=O), 160.7 (C=O), 174.9 (C=O); Vmax (CHCh)/cm·1 3324 (NH), 2977, 
3931 (aliphatic CH) 1716 (C=O), 1683, (C=O), 1652 (C=O), 1557 (C=N); m/z (FAB) 
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M+ 389.1825 (C19H24N40s requires 389.1817), 347 (39), 176 (79), 154 (lOO), 137 (63), 
136 (86), 107 (29), 89 (21), 57 (37) 
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(S)-({5-[1-(2-tert-Butoxycarbonylaminoacetylamino)ethyl]-2-phenyl-2H-pyrazole-
3-carbonyl}amino)acetic acid methyl ester [88) 
co,H 
0)'' 
BocHN 
)'" 
BocHN 
(S)-5-[ 1-(2-tert-Butoxycarbonylaminoacety !amino )ethyl]-2-phenyl-2H -pyrazole-3-
carboxylic acid (0.20 g, 0.53 mmol), glycine methyl ester hydrochloride (0.08 g, mmol, 
1.3 eq) and EDCI (0.16 g, mmol, eq) were dissolved in anhydrous diethyl ether (30 
ml), cooled to 0 oc and stirred for I h. The reaction mixture was then warmed to room 
temperature and stirred for a further I h. After this period the reaction mixture was 
again cooled to 0 oc and Et3N (0.1 ml was added over a period of 0.5 h. When the 
addition was complete the reaction mixture was warmed to room temperature and 
stirred for a further 17 h. Water (25 ml) was added to dissolve any precipitated material, 
the organic layer separated and the aqueous extracted with ethyl acetate (2 x I 0 ml). 
The combined organic phases were dried over magnesium sulfate, filtered and 
evaporated to give a dark orange residue. The crude product was purified by column 
chromatography on silica gel using hexane and ethyl acetate (I: I v/v) as eluent to give 
an orange oil (0.03 g, 33 %); 0H(400 MHz; CDCh) 1.35 (9H, s, C(CH3)3), 1.41 (3H, d, 
J 6.8, CHCH3), 3.68 (2H, s, CH2), 3.70 (2H, s, CH2) 3.79 (H, s, C02Me), 5.12 (IH, br 
s, NH), 5.11 (IH, br s, NH), 5.49 (IH, m, CHCH3), 6.82 (IH, s, CH),7.13(1H, br s, 
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NH) 7.27-7.43 (5H, m, Ph- H); llc (100 MHz; CDCb) 21.3 (CH3), 28.3 (C(CH3)3), 
43.8 (CH), 44.4 (CH2), 51.8 (CH2), 52.1 (OCH3), 119.5 (CH), 126.0 (Ph-CH), 127.6 
(Ph-CH), 128.6 (Ph-CH), 128.8 (Ph-CH), 129.6 (Ph-CH), 133.8 (C), 140.0 (C), 153.8 
(C=O), 156. 15 (C=O), 159.4 (C=O), 168.7 (C=O); Vmax (CHCb)/cm·l 3308 (NH), 1756 
(amide C=O), 1739 (amide C=O), 1692 (C=O), 1662 (C=O), 1597 (C=N); m/z (FAB) 
M+ 459.2130 (CzzHz9Ns06 requires 4592118) 
Page 1179 
Ethyl 2-chloro-2-ethoxyacetate (90]53 
Phosphorus pentachloride ( 4.50 g, 21.61 mmol, 1.1 eq) was added at 0 oc to ethyl 
diethoxyacetate (3.46 g, 3.50 m!, 19.62 mmol) over a period of 10 min. After this 
period the reaction mixture was heated at 80° C for 19 h. Dichloromethane (50 ml) was 
added and the reaction mixture was washed with water (3 x 50 ml), dried over 
magnesium sulfate and concentrated under reduced pressure to give a yellow liquid. 
This was purified by vacuum distillation to give a clear colourless liquid (2.34 g, 72%); 
0H(400 MHz; CDCh) 1.31 -1.36 (6H, m, C02CH2CH3 & COCH2CH3), 3.68 (IH, dq, J 
6.8 & 7.2, CH), 4~04 (1H, dq, J 7.2 & 7.2, CH), 4.30 (2H, q, J 6.8, CH2CH3), 5.82 (IH, 
s, CH); Se (100 MHz; CDCh) 14.3 (CH2), 62.6 (CH3), 66.4 (CHJ), 88.6 (CH2), 167.4 
(C=O); Vmax (CHCh)/cm·1 2986, 2901 (aliphatic CH), 1759 (C=O), 1373 (ester C-0), 
779 (C-C!). 
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(Benzylhydrazono)acetic acid ethyl ester [91]53 
Benzylhydrazine dihydrochloride (4.26 g, 21.84 mmol,) was suspended in water (10 
ml) and the pH adjusted to approximately 4. Ethyl 2-chloro--2-ethoxyacetate (4.19 g, 
25.14 mmol, 1.2 eq) in dioxane (25 ml) was added in portions at 0 °C. The reaction 
mixture was stirred at room temperature for I h then neutralized to pH 8 with I M 
aqueous sodium hydroxide and concentrated under reduced pressure to half the volume. 
Water (30 ml) was added and the resulting emulsion extracted with dichloromethane (2 
x 30 ml). The organic layers were combined, dried over magnesium sulfate and 
concentrated under reduced pressure to give a yellow oil. This was purified by column 
chromatography on silica gel eluting with diethyl ether: dichloromethane (4:1 v/v) to 
give the title compound as a yellow oil (4.0 g, 77%), that was used without further 
purification. OH (400 MHz; CDCh) 1.32 (3H, t, J 6.8, C02CH2CH3), 4.27 (2H, q, J 6.8, 
COzCH2CH3), 4.40 (2H, d, J 4.4, CH2-Ph), 6.78 (IH, br s, NH), 6.87 (IH, br s, CH), 
7.28....: 7.38 (5H, m, Ph-H); Be (lOO MHz; CDCh) 14.2 (CH3), 51.5 (CHz), 67.0 (CHz), 
97.5 (CH), 127.4 (Ph-C), 127.7 (Ph-C), 128.5 (Ph-C), 128.6 (Ph-C), 135.3 (C=N), 
167.6 (C=O); Vmax (CHCh)/cm"1 3333 (NH), 2901 (aliphatic CH), 1705 (ester C=O), 
1551 (NH), 1496 (C=N). 
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(Phenylhydrazono )acetic acid ethyl ester [93) 
To phenylhydrazine hydrochloride (4.25 g, 29.39 mmol, 1.4 eq) and sodium acetate 
(6.24 g, 62.33 mmol, 2.9 eq) in water, was added ethyl glyoxylate (2.2 g, 2.0 ml, 21.55 
mmol) that was dissolved in ethanol (5 ml). The solution was warmed to 70 oc for 
I Omin and cooled in an ice bath. The resulting precipitate was filtered and dried to give 
a yellow solid (2.11 g, 56%) that was used without further purification; mp 130.9 -
132.3 oc; oH (400 MHz; CDCh) 1.38 (3H, t, J 7.2, C02CH2CH3), 4.34 (2H, q, J 7.2, 
C02CH2CH3), 7.01 (IH, t, J 7.2, Ph-H), 7.10 (IH, s, CH), 7.19 (2H, d, J 7.6, Ph-H), 
7.32 (2H, t, J 7.6, Ph-H), 8.39 (1H, br s, NH), oc (lOO MHz; CDC13) 14.2 (CH3), 61.0 
(CH2), 113.9 (Ph-C), 122.4 (Ph-C), 122.7 (CH), 125.6 (Ph-C), 129.4 (Ph-C), 164.5 
(C=O); Vmax (CHCh)/cm'1 3241 (NH), 3063 (aromatic CH), 2978, 2909 (aliphatic CH), 
1705 (esterC=O), 1551 (C=N) 
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1-Benzyl-4,5-dihydro-1H-pyrazole-3,5-dicarboxylic acid diethyl ester [102]30 
Bn 
I N-N 
Eto,cN-co,Et 
To a solution of (benzylhydrazono)acetic acid ethyl ester (1.06 g, 5.13 mmol) in ethyl 
acetate (20 m!) at 60 °C was added N-chlorosuccinimide (0.74 g, 5.54 mmol, 1.1 eq). 
The reaction mixture was left to stir for !h. Ethyl acrylate (0.92 g, 1.0 m!, 9.23 mmol, 
1.8 eq), potassium hydrogen carbonate (2.59 g, 25.87 mmol, 5.0 eq) and a few drops of 
water were added and the reaction mixture was left to stir at 70 oc for 20h. The reaction 
mixture was filtered and the filtrate concentrated under reduced pressure to give a 
yellow oil, which was purified by column chromatography on silica gel eluting with 
light petroleum :ethyl acetate (3:2 v/v) to yield the title compound (1.22 g, 78 %) as a 
yellow oil. OH (400 MHz; CDCI)) 1.17 (3H, t, J 7.2, C02CHzCH3), 1.27 (3H, t, J 7.2, 
COzCHzCH3), 3.12 (2H, d, J 12.4, CH2-Ph), 3.98 (IH, t, J 4.0, CH), 4.04 (2H, q, J 7.2, 
C02CH2CH3), 4.23 (2H, q, J 7.2, C02CH2CH3), 4.51 (IH, d, J 14.8, CH), 4.73 (IH, d, J 
14.8, CH), 7.20- 7.28 (5H, m, Ph-H); Se (100 MHz; CDCI3) 14.1 (CH3), 14.4 (CH3), 
36.1 (CH2), 49.5 (CH), 59.8 (CH2), 61.5 (CH2), 61.6 (CH2), 64.8 (CH3), 128.6 (Ph -
CH), 128.7 (Ph- CH), 129.2 (Ph- CH), 135.5 (Ph-C), 138.2 (C=N), 170.0 & 170.8 
(C=O); Vmax (CHCi])/cm·1 2982 (aliphatic CH), 1740, 1701 (ester C=O), 1559 (C=N) 
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1-Benzyl-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid ethyl ester [103]30 
/NHBn 
N 
Et02CAH 
/NHBn 
~ Et02C Cl 
Bn 
I 
N-N 
Et02CAAPh 
To a solution of (benzylhydrazono)acetic acid ethyl ester (1.49 g, 7.23 mmol) in ethyl 
acetate (20 ml) at 60 oc was added N-chlorosuccinimide (1.03 g, 7.71 mmol, 1.1 eq). 
The reaction mixture was left to stir for !h. Styrene (1.99 g g, 2.2 ml, 19.14 mmol, 2.6 
eq), potassium hydrogen carbonate (3.67 g, 36.66 mmol, 5.1 eq) and a few drops of 
water were added and the reaction mixture was left to stir at 70 oc for 20h. The reaction 
mixture was filtered and the filtrate concentrated under reduced pressure to give a 
yellow oil, which was purified by column chromatography on silica gel eluting with 
light petroleum :ethyl acetate (9:1 v/v) to yield the title compound (0.61 g, 29%) as a 
yellow oil; 0H(400 MHz; CDCh) 1.27 (3H, t, J 6.8, C02CH2CH3), 2.82 (IH, dd, J 13.6 
& 17.2, CH), 3.25 (IH, dd, 12.4 & 17.2, CH), 4.24 (2H, q, J 6.8, C02CH2CH3), 4.38 
(IH, t, J 12.4, CH), 5.20 (2H, s, CH2 -Ph), 7.09 (2H, d, J 6, Ph-H), 7.17 -7.31 (!OH, m, 
Ph-H); oc (100 MHz; CDCh) 13.1 (CH3), 40.3 (CH2), 52.4 (CH2), 59.9 (CH2), 67.0 
(CH), 126.5 (Ph-CH), 126.6 (Ph-CH), 127.2 (Ph-CH), 127.4 (Ph-CH), 127.8 (Ph-CH), 
127.9 (Ph-CH), 128.1 (Ph-CH), 130.2 (Ph-CH), 132.0 (Ph-CH), 134.5 (Ph-C), 136.7 
(Ph-C), 138.5 (C=N), 158.6 (C=O); Ymax (CHCh)/cm·1 3063, 3028 (aromatic CH), 
2982, 2932 (aliphatic CH}, 1740 (ester C=O), 1551 (C=N) 
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Attempted Synthesis of 5-Aminomethyl-1-benzyl-4,5-dihydro-1H-pyrazole-3-
carboxylic acid ethyl ester [104] 
Bn 
I N-N 
f 
Eto2c 
To a solution of (benzylhydrazono)acetic acid ethyl ester (0.50 g, 2.43 mmol) in ethyl 
acetate (20 ml) at 60 oc was added N-chlorosuccinimide (0.35 g, 2.62 mmol, 1.1 eq). 
The reaction mixture was left to stir for !h. Allylamine (0.23 g, 0.3 ml, 4.00 mmol, 1.6 
eq), potassium hydrogen carbonate (1.19 g, 11.89 mmol, 4.9 eq) and a few drops of 
water were added and the reaction mixture was left to stir at 70 oc for 20h. The reaction 
mixture was filtered and the filtrate concentrated under reduced pressure to give a 
yellow oil, which was purified by column chromatography on silica gel eluting with 
light petroleum: ethyl acetate (4:1 v/v) to yield a product (0.30 g, 47%) as a yellow oil; 
OH (400 MHz; CDCb) 1.35 (3H, t, J 6.4, COzCHzCH3), 4.12 (2H, br s, CHzNHz), 4.33 
(2H, q, J 7.2, COzCHzCH3), 5.13 (2H, dd, J 20.8 & 34, CHz), 5.88 (IH, m, CH), 7.23-
7.33 (3H, m, Ph- H), 7.66- 7.68 (2H, m, Ph- H), 8.41 (2H, s, NH2); lie (100 MHz; 
CDCb) 14.1 (CH3), 46.8 (CHz), 62.7 (CHz), 116.5 (CH2), 128.4 (Ph-C), 128.7 (Ph-C), 
129.8 (Ph-C), 133.4 (C=N), 134.7 (Ph-C), 158.1 (C=O); Vmax (CHCl3)/cm·1 3391 (NH), 
1736 (C=O), 1586 (C=N) 
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Prop-2-ynylcarbamic acid tert-butyl ester (105] 82 
BocHN~ 
To propargylamine hydrochloride (0.65 g, 8.35 mmol) in dichloromethane (60 ml) at 0 
°C, di-tert-butyl dicarbonate (1.95 g, 8.93 mmol, 1.1 eq) was added. The mixture was 
stirred for 15min before triethylamine (1.67 g, 2.3 ml, 16.50 mmol, 2.0 eq) was added 
and the reaction mixture stirred for 17h. The mixture was then washed with citric acid 
solution (2M, 2 x 30 ml) and saturated brine (2 x 30 m!), then dried over magnesium 
sulfate and concentrated under reduced pressure to yield a clear oil (1.25 g, 96 %). OH 
(400 MHz; CDCh) 1.38 (9H, s, C(CH3)3), 2.15 (IH, t, J 2.8, CHCCH2), 3.85 (2H, br s, 
CHCCH2), 4.84 (1H, br s, NH); oc(100 MHz; CDCh) 28.5 (C(CH3)J), 30.3 (CH2), 85.2 
(CH), 146.7 (CCH), 156.3 (C=O); Ymax (CHCI))/cm'1 3306 (NH), 2982 (aliphatic CH), 
1701 (ester C=O) 
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N-Propargyl-p-toluenesulfonamide [105a]81 
To a solution of dichloromethane (40 ml) and p-toluenesulfonyl chloride (1.92 g, 10.10 
mmol, 1.0 eq) was added propargylamine hydrochloride (0.93 g, 10.19 mmol) followed 
by triethylamine (2.18 g, 3.0 ml, 21.52 mmol, 2.1 eq). The reaction mixture was stirred 
at room temperature for 12 h. After this period the reaction mixture was diluted with 
dichloromethane and washed with I M hydrochloric acid (50 m!). The organic phase 
was dried over magnesium sui fate and concentrated under reduced pressure to give a 
white solid (1.64 g, 77 %) that was used without further purification. mp 73.4-75.2 
°C; 5H (400 MHz; CDCh) 2.09 (IH, t, J 2.8, CH), 2.40 (3H, s, CH3), 3.79 (2H, dd, J 
2.4 &, 5.46, CH2), (IH, t, J 6.0, NH), 7.29 (2H, d, J 8.0, Ph-H), 7.77 (2H, d, J 8.0, Ph-
H); l>c(IOO MHz; CDCh) 21.4 (CH3), 32.8 (CH2), 78.1 (CH), 127.4 (Ph-C), 129.7 (Ph-
C), 136.5 (C), 143.84 (CCH); Vmax (CHCh)/cm'1 3282 (NH), 3067 (aromatic CH), 1157 
(S=O); 
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N-tert-Butyloxycarbonyl f3-alanine ethyl ester (116) 
To f3-alanine ethyl ester hydrochloride (4.63 g, 30.14 mmol) in dichloromethane (180 
ml) at 0 °C, di-tert-butyl dicarbonate (6.84 g,) was added. The mixture was stirred for 
15min before triethylamine (11.0 ml,) was added and the reaction mixture stirred for 
17h. The mixture was then washed with citric acid solution (2M, 2 x 75 ml) and 
saturated brine (2 x 75 ml), then dried over magnesium sulfate and concentrated under 
reduced pressure to yield a clear colourless yellow oil (6.6 g, 66%). OH (400 MHz; 
CDCI)) 1.27 (3H, t, J 7.2, COzCHzCH3), 1.42 (9H, s, (CH3)3), 2.50 (2H, t, J 6, 
CHzCHzCOzCHzCHJ), 3.73 (2H, q, J 6, CHzCHzCOzCHzCH3), 4.97 (2H, q, J 7.2, 
COzCHzCH3), 5.07 (lH, br s, NH); oc(lOO MHz; CDCI)) 14.2 (CH3), 28.5 (C(CH3)3), 
34.6 (CHz), 36.1 (CHz), 60.6 (CHz), 155.8 (C=O), 172.5 (C=O); Ymax (CHCI))/cm·1 
3357 (NH), 2976, 2932 (aliphatic CH), 1693 (C=O) 
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(3-0xopropyl)carbamic acid tert-butyl ester [117] 
ICHO 
NHBoc 
To N-tert-butyloxycarbonyl-~-alanine ethyl ester (3.88 g, 17.86 mmol) in dry toluene 
(60 ml) at -78 oc under nitrogen over lh, DIBAL-H (!.OM in toluene, 44.0 ml, 44.0 
mmol, 2.5 eq) was added dropwise with stirring, with the aid of a syringe pump. After 
the addition the reaction mixture was stirred for a further 0.5h. Methanol (I 4 ml) was 
added, and the reaction mixture was poured into a solution of Rocheile salt (50 g) in 
water (200 ml), and stirred vigorously for 1.5h. The aqueous phase was separated and 
extracted with ethyl acetate (3 x I 00 ml). The organic layers were then combined and 
washed with satur~ted brine (3 x I 00 ml), dried over magnesium sui fate and 
concentrated under reduced pressure to yield a colourless oil (3.6 g, 100%) that was 
used without further purification. 8H (400 MHz; CDCh) 1.35 (9H, s, C(CH3)3), 2.59 
(2H, t, J 6, CH2CH2CHO), 3.32 (2H, q, J 6, CH2CH2CHO), 5.08 (IH, br s, NH), 9.69 
(IH, s, CHO); 8c (100 MHz; CDCI)) 28.5 (C(CH3)3), 32.7 (CHz), 44.2 (CHz), 137.8 
(C=O), 156.3 (C=O), 201.5 (CHO); Vmax (CHCI))/cm"1 3357 (NH), 2976, 2932 
(aliphatic CH), 1693 (C=O); mlz (El) M 173.1084 (C8H15N03 requires 173.1052), 155 
(37), 136 (39), 118 (48), 102 (40), 57 (lOO) 
[3-(Phenylhydrazono)propyl)carbamic acid tert-butyl ester [118) 
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.rJ'NHPh 
N ICHO 
NHBoc BocHN~H 
To phenylhydrazine hydrochloride (6.04 g, mmol, eq) and sodium acetate (6.17 g, 
mmol, eq) in water, was added the crude (3-oxopropyl)carbamic acid tert-butyl ester 
(3.60 g, 20.79 mmol) in ethanol (5 ml). The solution was warmed to 70 °C for 10min 
and cooled in an ice bath. The resulting precipitate was filtered and dried to give an 
orange solid (2.69 g, 47%) that was used without further purification. liH (400 MHz; 
CDCh) 1.36 (9H, s, C(CH3)3), 2.41 (2H, q, J 4.8, CH2CH2), 3.34 (2H, q, J 6, CH2CH), 
6.77 (1H, t, J 7.2, Ph-H) , 6.88 (2H, d, J 7.6, Ph-H), 7.00, {IH, t, J 4.8, CH=N), 7.17 
(2H, t, J 6.8 Ph-H), 7.20 (IH, s, NH); lie {lOO MHz; CDCh) 28.4 (C(CH3)3), 32.7 
(CH2), 37.7 (CH2), 79.3 (CH), 112.5 (Ph-C), 112.8 (Ph-C), 119.8 (Ph-C), 129.2 (Ph-C), 
137.1 {CHN), 145.1 (C), 156.0 (C=O); Vmax (CHCh)/cm'1 3354 {NH), 2977, 2929 
(aliphatic CH), 1690 (C=O) 1610 (C=N); mlz (El) M 263.1755 (C14H21Nl02 requires 
263.1734), 208 (37), 199 (41), 155 (37), 154 (42), 136 (29), 93 (24), 57 (95). 
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Appendix I X-Ray Crystal Data of 48 
Cl 51 
Cl111 
a 
0 
b 
Table I. Crystal data and structure refinement for rcfj20. 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient J.l 
F(OOO) 
rcfj20 
c,.H,N,O, 
361.44 
120(2) K 
MoKa, 0.71073 A 
monoclinic, P21 
a=5.14990(10)A 
b= 11.4316(4)A 
c = 16.8254(6) A 
984.52(5) A' 
2 
1.219 g/cm3 
0.086mm-1 
388 
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a=90° 
p = 96.320(2)0 
y= go• 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
goniostat 
9 range for data collection 
Index ranges 
Completeness to 9 = 27.52° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F'>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
SM. 
Extinction coefficient 
Largest and mean shiftlsu 
Largest diff. peak and hole 
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colourless, 0.36 x 0.09 x 0.04 mm3 
2323 (9 range 2.91 to 27.48°) 
Bruker-Nonius 95mm CCD camera on K-
~ & ro scans 
3.02 to 27.52° 
h-6to6,k-14to 14,1-21 to21 
99.2% 
0% 
11290 
2363 (R;,,. = 0.0376) 
2223 
semi-empirical from equivalents 
0.970 and 0.997 
direct methods 
Full-matrix least-squares on F2 
0.0316, 0.2720 
2363111244 
RI= 0.0351, wR2 = 0.0811 
RI= 0.0388, wR2 = 0.0833 
1.080 
10(10) Friedels merged, chirality known from 
0.027(6) 
0.000 and 0.000 
0.192 and -0.167 e A-3 
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Table 2. Atomic coordinates and equivalent isotropic displacement param_eters (A2) 
for rcfj20. U,q is defined as one third of the trace of the orthogonalized U'' tensor. 
X y z u •• 
N(1) 0.3470(3) 1.09947(14) 0.67683(10) 0.0182(4) 
N(2) 0.3942(4) 0.98977(1 5) 0.64632(11) 0.0225(4) 
C(1) 0.2231(4) 0.89913(18) 0.67345(12) 0.0201(4) 
C(2) 0.0953(4) 0.96363(19) 0.73957(13) 0.0229(4) 
C(3) 0.1800(4) 1.08753(17) 0.72746(12) 0.0176(4) 
C(4) 0.5478(4) 0.97658(18) 0.58424(12) 0.0182(4) 
C(5) 0.7125(4) 1.06709(18) 0.56410(12) 0.0202(4) 
C(6) 0.8805(4) 1.0488(2) 0.50639(12) 0.0233(4) 
C(7) 0.8862(4) 0.9424(2) 0.46690(12) 0.0232(5) 
C(8) 0.7166(4) 0.85410(19) 0.48465(12) 0.0220(4) 
C(9) 0.5479(4) 0.87026(18) 0.54277(12) 0.0204(4) 
C(10) 0.3831(4) 0.79576(18) 0.70784(12) 0.0196(4) 
0(1) 0.5722(3) 0.80348(14) 0.75611(9) 0.0280(4) 
0(2) 0.2819(3) 0.69443(12) 0.67880(8) 0.0199(3) 
C(ll) 0.4187(4) 0.58875(18) 0.70813(14) 0.0230(4) 
C(12) 0.6511(4) 0.5647(2) 0.66379(14) 0.0290(5) 
C(13) 0.0795(4) 1.18818(19) 0.77279(11) 0.0204(4) 
C(14) 0.1972(5) 1.3053(2) 0.75280(14) 0.0294(5) 
N(3) 0.1242(3) 1.16463(16) 0.85831(10) 0.0207(4) 
C(15) -0.0716(4) 1.15655(19) 0.90467(12) 0.0221(4) 
0(3) -0.3022(3) 1.16507(17) 0.88072(9) 0.0318(4) 
0(4) 0.0274(3) 1.13785(18) 0.98119(8) 0.0321(4) 
C(16) -0.1486(4) 1.1252(3) 1.04442(13) 0.0339(6) 
C(17) -0.3165(5) 1.0172(3) 1.02883(16) 0.0387(6) 
C(18) 0.0448(5) 1.1073(4) 1.11865(15) 0.0550(10) 
C(19) -0.3036(5) 1.2367(3) 1.05115(16) 0.0404(6) 
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Table3. Bond lengths [A] and angles [0 ) for rcfj20. 
N(I}-C(3) 1.283(3) N(I}-N(2) 1.387(2) 
N(2}-C(4) 1.386(3) N(2}-C(I) 1.465(3) 
C(I}-C(IO) 1.518(3) C(I}-C(2) 1.541(3) 
C(2}-C(3) 1.502(3) C(3}-C(13) 1.504(3) 
C(4}-C(9) 1.401(3) C(4}-C(5) 1.403(3) 
C(5}-C(6) 1.386(3) C(6}-C(7) 1.388(3) 
C(7}-C(8) 1.389(3) C(8}-C(9) 1.390(3) 
C(I0}--0(1) 1.201(2) C(I0}--0(2) 1.340(2) 
0(2}-C(II) 1.457(2) C(I1}-C(I2) 1.504(3) 
C(l3}-N(3) 1.457(2) C(13}-C(I4) 1.523(3) 
N(3}-C(I5) 1.344(3) C(l5}-0(3) 1.215(2) 
C(l5}--0(4) 1.349(2) 0(4}-C(l6) 1.479(2) 
C( 16}-C( 17) 1.514(4) C(I6}-C(I9) 1.514(4) 
C(I6}-C(I8) 1.523(3) 
C(3}-N(I}-N(2) 107.90(17) C(4}-N(2}-N(I) 121.01(16) 
C(4}-N(2}-C(I) 124.78(17) N(I}-N(2}-C(I) 112.84(16) 
N(2}-C(I}-C(IO) 11 0.44(16) N(2}-C(l }-C(2) 101.88(16) 
C(IO}-C(I}-C(2) 110.75(17) C(3}-C(2}-C(I) 101.52(16) 
N(I}-C(3}-C(2) 114.60(18) N(I}-C(3}-C(I3) 123.29(18) 
C(2}-C(3}-C(13) 122.10(17) N(2}-C(4}-C(9) 120.08(18) 
N(2}-C(4}-C(5) 120.80(18) C(9}-C(4}-C(5) 119.07(18) 
C( 6}-C( 5}-C( 4) 119.90(19) C( 5}-C( 6}-C(7) 121.05(19) 
C(6}-C(7}-C(8) 119.14(19) C(7}-C(8}-C(9) 120.8(2) 
C(8}-C(9}-C( 4) 120.01(19) 0(1}-C(I0}--0(2) 124.32(19) 
0(1}-C(IO}-C(I) 124.50(19) 0(2}-C(IO}-C(l) 111.16(16) 
C(I0}--0(2}-C(I1) 116.06(14) 0(2}-C(II}-C(l2) 111.42(18) 
N(3}-C(I3}-C(3) 109.50(17) N(3}-C(l3}-C(l4) 110.93(18) 
C(3}-C(13}-C(I4) 113.15(17) C(I5}-N(3}-C(l3) 122.60(17) 
0(3}-C(I5}-N(3) 124.75(19) 0(3}-C(I5}--0( 4) 125.62(18) 
N(3}-C(I5}--0( 4) I 09.63(17) C(I5}--0(4}-C(I6) 120.33(16) 
0(4}-C(I6}-C(I7) I 09.8(2) 0(4}-C(I6}-C(I9) 110.0(2) 
C(I7}-C(I6}-C(I9) 113.82(19) 0(4}-C(I6}-C(I8) 101.88(17) 
C(I7}-C(I6}-C(I8) 110.0(3) C(I9}-C(I6}-C(I8) 110.7(3) 
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Table 4. Hydrogen coordinates and isotropic displacement parameters (A2) for rcfj20. 
X y z u 
H(1) 0.0891 0.8740 0.6292 0.024 
H(2A) --().0974 0.9561 0.7319 0.027 
H(2B) 0.1618 0.9344 0.7934 0.027 
H(5) 0.7088 1.1408 0.5900 0.024 
H(6) 0.9936 1.1100 0.4937 0.028 
H(7) 1.0046 0.9301 0.4282 0.028 
H(8) 0.7158 0.7818 0.4567 0.026 
H(9) 0.4327 0.8092 0.5544 0.024 
H(11A) 0.2972 0.5214 0.7017 0.028 
H(11B) 0.4775 0.5977 0.7658 0.028 
H(12A) 0.7794 0.6276 0.6743 0.043 
H(12B) 0.5948 0.5606 0.6063 0.043 
H(12C) 0.7305 0.4900 0.6819 0.043 
H(13) --().1136 1.1931 0.7578 0.024 
H(14A) 0.3858 1.3043 0.7692 0.044 
H(14B) 0.1162 1.3680 0.7813 0.044 
H(14C) 0.1654 1.3191 0.6951 0.044 
H(3) 0.282(5) 1.158(2) 0.8787(14) 0.025 
H(17A) --().2057 0.9505 1.0182 0.058 
H(17B) --().4453 1.0307 0.9824 0.058 
H(17C) -0.4071 1.0004 1.0758 0.058 
H(18A) 0.1536 1.1773 1.1281 0.083 
H(l8B) 0.1560 1.0397 1.1107 0.083 
H(18C) -0.0510 1.0934 1.1650 0.083 
H(l9A) --().4310 1.2451 1.0038 0.061 
H(19B) --().1846 1.3038 1.0549 0.061 
H(19C) --().3953 1.2332 1.0991 0.061 
Table 5. Torsion angles [0 ] for rcfj20. 
C(3}-N(l}-N(2}--C(4) 
C( 4}-N(2}--C(l }--C(l 0) 
C( 4}-N(2}--C(l }--C(2) 
N(2}--C(l }--C(2}--C(3) 
N(2}-N(l}--C(3}--C(2) 
C(l }--C(2}--C(3}-N(l) 
N(l}-N(2}--C(4}--C(9) 
N(l }-N(2}--C( 4}--C(5) 
N(2}--C( 4 }--C( 5}--C( 6) 
C( 4 }--C( 5}--C( 6}--C(7) 
C(6}--C(7}--C(8}--C(9) 
N(2}--C( 4 }--C(9}--C(8) 
N(2}--C(l }--C(l 0)-0(1) 
N(2}--C(l }--C(l 0)-0(2) 
0(1}--C(I0)-0(2}--C(II) 
C(I0)-0(2}--C(ll}--C(I2) 
C(2}--C(3}--C(l3}-N(3) 
C(2}--C(3}--C(l3}--C(l4) 
C(l4}--C(l3}-N(3}--C(l5) 
C(l3}-N(3}--C(l5)-0( 4) 
N (3 }--C( 15)-0( 4 }--C(l6) 
C(l5)-0( 4}--C(l6}--C(l9) 
173.58(18) 
64.8(3) 
-177.48(18) 
10.30(19) 
1.5(2) 
-8.0(2) 
-166.15(18) 
16.4(3) 
174.58(19) 
1.0(3) 
-1.8(3) 
-175.ll(l8) 
48.7(3) 
-132.87(18) 
-1.1(3) 
-81.8(2) 
54.0(2) 
178.35(19) 
115.5(2) 
-178.16(19) 
-179.8(2) 
-62.0(3) 
Table 6. Hydrogen bonds for rcfj20 [A and 0 ]. 
D-H ... A 
N(3}-H(3) ... 0(3') 
d(D-H) 
0.85(3) 
Symmetry operations for equivalent atoms 
' x+I,y,z 
d(H ... A) 
2.14(3) 
Page lvii 
C(3}-N(l}-N(2}--C(l) 
N(l}-N(2}--C(l}--C{IO) 
N(l }-N(2}--C(l }--C(2) 
C(I 0}--C(l }--C(2}--C(3) 
N(2}-N(l }--C(3}--C{l3) 
C( I }--C(2}--C(3 }--C( 13) 
C( I }-N(2}--C( 4}--C(9) 
C(l }-N(2}--C( 4}--C(S) 
C(9}--C( 4 }--C( 5}--C( 6) 
C( 5}--C( 6}--C(7}--C(8) 
C(7}--C(8}--C(9}--C( 4) 
C( 5}--C( 4 }--C(9}--C(8) 
C(2}--C(l }--C(l 0)-0(1) 
C(2}--C(l }--C(l 0)-0(2) 
C(l}--C{I0)-0(2}--C(II) 
N(l}--C{3}--C(l3}-N(3) 
N(l}--C(3}--C{l3}--C(l4) 
C(3}--C(l3}-N(3}--C( 15) 
C(l3}-N(3}--C(l5)-0(3) 
0(3}--C(l5)-0( 4}--C(l6) 
C(l5)-0( 4}--C{l6}--C(l7) 
C( 15)-0( 4 }--C( 16}--C( 18) 
d(D ... A) 
2.937(2) 
<(DHA) 
156(2) 
6.3(2) 
-128.47(18) 
-10.8(2) 
127.77(18) 
-179.72(17) 
173.27(17) 
--{).5(3) 
-177.88(18) 
-2.9(3) 
1.3(3) 
0.0(3) 
2.4(3) 
-63.4(3) 
ll5.04(18) 
-179.58(17) 
-124.6(2) 
-0.3(3) 
-II8.9(2) 
1.8(3) 
0.3(4) 
64.0(3) 
-179.4(2) 
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Appendix 11 HPLC Data and Spectra of 76 and 81 
Area % Report 
Data File: C:\EZChrom Elite\Enterprise\Projects\farah\Data\Yohan\les 193 
231007a.dat 
Method: C:\EZChrom Elite\Enterprise\Projects\ben\Method\99.1 0.5ml50min Laura.met 
Acquired: 23/10/2007 10:43:34 
Printed: 23/10/2007 11:41:54 
uv 
Retention Time 
40 40 
~ 20 
"' 
20 ~ 
"' 
"' o' 
m 
M ,_ 
,[ M 
_I 0 - - "" .. 0 I 
0 5 10 15 20 25 30 35 40 45 50 
Minutes 
UVResults 
Retention Time Area Area% Height Heil;lht% 
34.370 21888830 93.00 182113 93.44 
39.573 1646835 7.00 12793 6.56 
Totals I 
235356651 100.00 I 1949061 100.00 I 
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Area % Report 
Data File: C:\EZChrom Elite\Enterprise\Projects\farah\Data\Y ohan\les racemic 
221007.dat 
Method: C:\EZChrom Elite\Enterprise\Projects\ben\Method\99.1 O.Sm150min Laura.met 
Acquired: 22/10/2007 15:36:23 
Printed: 23/10/2007 09:43:12 
20 
10 
-uv 
Retention Time 
' 
' 
' 
0 5 
UVResu1ts 
Retention Time 
35.063 
39.520 
10 15 20 25 
Minutes 
Area 
10607066 
11332943 
Totals I 
219400091 
.., 
"' q 
.., .., 
30 35 40 45 
Area% Hei~ht 
48.35 80534 
51.65 72542 
100.00 I 1530761 
20 
10 
0 
50 
~ 
~ 
Height% 
52.61 
47.39 
100.00 I 
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